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Common fragile sites are a set of genomic locations with a propensity to form 
lesions, breaks and gaps on mitotic chromosomes upon induction of replication 
stress. While the exact reasons for their fragility are unknown, CFS display instability 
in a cell-type specific manner, suggesting a substantial contribution from an 
epigenetic component. CFSs also overlap with sites of increased breakage and 
deletions in tumour cells, as well as evolutionary breakpoints, implying that their 
features shape genome stability in vivo. Previously, factors such as delays in 
replication timing, low origin density and transcription of long genes have been 
implicated in instability at CFS locations but comprehensive molecular studies are 
lacking. Chromatin structure, an important factor that fits the profile of cell-type 
specific contributor, has also not been investigated yet. 
Throughout their efforts to determine the factors that lead to the appearance of 
CFS lesions, investigators have focused on a single component at a time, potentially 
missing out complex interactions between cellular processes that could underlie 
fragility. Additional difficulties come from the cell-type specificity of CFS breakage: it 
indicates that only cell type-matched data would be informative, limiting the scope 
for studies using publicly available data.  
To perform a comprehensive study defining the role of different factors in 
determining CFS fragility, I explored replication timing, transcriptional landscapes 
and chromatin environment across a number of CFSs in two cell types exhibiting 
differential CFS breakage. Initially, I characterised the patterns of CFS fragility in the 
two cell types on both the cytogenetic and the molecular level. I then used a FISH-
based technique to investigate the process of mitotic compaction at active CFS sites 
and found that the cytogenetically fragile core of these sites sits within larger 
regions which display a tendency to mis-fold in mitosis. The aberrant compaction of 
these regions could be observed on cytogenetically normal metaphase 
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chromosomes, suggesting that finer scale abnormalities in chromosome structure 
underlie the cytogenetically visible breaks at fragile sites. I also investigated the 
links between transcription of long genes and CFS fragility using two approaches: I 
quantified levels of expression across all fragile sites using RNA-seq and modified 
transcription at a single active CFS using the CRISPR genome engineering 
methodology. My results indicate a complex interplay between transcription and 
CFS fragility: no simple linear correlation can be observed, but an increase of 
transcriptional levels at the active CFS led to a corresponding increase in fragility. To 
investigate the influence of the cell type specific replication programme and 
replication stress on CFS instability, I mapped replication timing genome-wide in 
unperturbed cells and under conditions of replication stress in both cell types. I 
found that replication stress induces bi-directional changes in replication timing 
throughout the genome as well as at CFS regions. Surprisingly, the genomic regions 
showing the most extreme replication timing alterations under replication stress do 
not overlap with CFS, implying that CFS instability is not fully explained by 
replication delays as previously suggested. Instead, I observed a range of 
replication-stress induced timing changes across CFS regions: while some CFSs 
appear under-replicated, others display switches to both earlier and later 
replication as well as differential recruitment of both early and late origins, implying 
that dis-regulation of replication timing and origin firing, rather than simply delays, 
underlie the sensitivity to CFS regions to replication stress. Finally, I investigated 
large-scale chromatin states at two active CFSs throughout S phase and into G2, the 
cell cycle stages most relevant stage for CFS breakage. I found that changes in large-
scale chromatin architecture accompany the replication timing shifts triggered by 
replication stress, raising the possibility that such alterations contribute to 
instability.  
In conclusion, I assessed the influence of multiple relevant factors on CFS fragility. I 
found that bi-directional replication timing changes and alterations in interphase 
chromatin structure are likely to play a role, converging to promote mitotic folding 
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problems which ultimately result in the well-described cytogenetic lesions on 
metaphase chromosomes and genomic instability. 
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1. Chapter 1: Introduction 
In mammalian cells, the long DNA molecules comprising the genome are wrapped in 
proteins to form a complex called chromatin. Chromatin fibres are then folded 
multiple times within the nucleus of the cell, allowing lengthy genomes to fit inside 
a much smaller nucleus. Apart from overcoming space constraints, the folding of 
the genome also has a regulatory function, influencing fundamental processes such 
as gene expression, genome replication and DNA damage repair (DDR) (Wolffe 
1998). 
As the physical context in which the genetic information is read, translated and 
maintained, chromatin plays an important role in preserving genome stability and 
responding to DNA damage; apart from serving as a structural template on which 
DNA repair takes place, chromatin components play an active role in the 
recruitment and retainment of a range of DNA repair factors. The role of chromatin 
in DNA repair has been studied extensively, but mostly in non-physiological systems 
where DNA breaks were induced by expression of exogenous restriction enzymes, 
lasers, UV and chemical mutagens (Kruhlak et al. 2006; Roukos et al. 2014). 
Although studies in these systems have generated valuable insights, a more current 
view of genomic instability is focused on the mechanisms through which internal 
factors and fundamental cellular processes such as transcription and replication also 
pose a risk to genome stability (Saponaro et al. 2014; Reijns et al. 2015). Unlike 
external factor-mediated instability, which usually arises from stoichiometric 
interactions of the damage-inducing agents with DNA and results in predictable 
outcomes, internally mediated instability is stochastic: it is likely to result from a 
combination of factors, including the exact chromatin context at the location where 
problems arise. 
 Common fragile sites (CFS), a set of genomic loci which become unstable in 
response to replication stress or oncogenesis, illustrate how a combination of 
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factors including transcription, replication timing and chromatin context are likely to 
play a role in inducing instability (Durkin & Glover 2007).  As such, CFS represent a 
chance to study how the interaction of chromatin states and cellular processes may 
induce instability in a physiological system with disease relevance. 
1.1 Chromatin components 
Chromatin is a complex structure with different levels of organisation.  At the most 
basic level, chromatin is made up of nucleosomes- 147 base pairs of DNA wrapped 
around a protein octamer consisting of 8 histone proteins. Arrays of nucleosomes 
are then further folded to form a fibre measuring 30-nm in diameter; the 30-nm 
fibres are then arranged into larger-scale structures forming domains with differing 
structural and functional properties, which ultimately form chromosomes-the 
largest units of chromatin organisation (Wolffe 1998). AN overview of chromatin 




Figure 1-1 Overview of chromatin organisation. Multiple levels of chromatin organisation are 
depicted. At the primary level, the DNA strands are wrapped around nucleosomes, made up of 
classical and variant histones; variant histones shown in yellow (discussed in Chapter 1.1.1 and 
1.1.2). Nucleosomal interactions give rise to the 30nm fibre conformation, which is disrupted in 
places to facilitate nuclear processes such as transcription and replication (Chapter 1.2.1); 
chromatin remodellers, shown in green, shift nucleosomes and alter their composition to induce 
alteration in the fibre structure (Chapter 1.1.4). Interactions between fibres give rise to large-scale 
structures, which are additionally folded in metaphase (Chapter 1.2.2 and 1.3.2). Figure 




1.1.1  Histones 
Apart from DNA, chromatin contains numerous proteins with structural and 
regulatory functions. Among them, histone proteins are the most prominent. Core 
histones form nucleosomes-the basic repeat unit of chromatin, while linker histones 
form the connections between nucleosomes. Histone proteins can be post-
translationally modified on their N-terminal tails, with different modifications 
exerting different effects on the chromatin fibre structure, adding a regulatory as 
well as a structural role to the range of histone functions.  These post-translational 
modifications include acetylation, methylation and phosphorylation as well as 
other, less well-characterised marks. In addition to the canonical histone proteins 
the histone family also includes many histone variants, which can replace their 
classical counterparts in chromatin in a carefully regulated manner and in specific 
circumstances.  
The histone proteins that form the nucleosome particle are called “core histones” 
and include H2A, H2B, H3 and H4 as well as their variants.  Each nucleosome is an 
octamer consisting of two copies of each H2A, H2B, H3 and H4, arranged as an 
H3/H4 tetramer and two H2A/H2B dimers. The core histones are positively charged 
proteins, rich in lysine and arginine residues. They bind to DNA non-covalently, 
through electrostatic interactions between positive charges on histones and the 
negatively charged DNA molecule. Nucleosomes are separated by linker DNA, 
whose length is not constant, but can vary from 10 to 100 bp between species, cell 
types and genomic position along the DNA.  Histone proteins binding to this linker 
DNA are called linker histones and include H1 and its variant H5, which is found in 
chicken erythrocytes (Harshman et al. 2013). Like core histones, H1 is also positively 
charged and is associated with both the linker DNA and the nucleosome particle. 
The H1 molecule consists of a globular domain and two tails, with the globular 
domain sitting at the nucleosome dyad, while the tails contact the linker DNA and 
drape along the chromatin fibre where it stabilises the folding of nucleosomes into 
a 30-nm fibre structure (Allan et al. 1980). 
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1.1.2 Histone variants 
Histone variants-proteins with a high degree of sequence similarity to their 
canonical counterparts, can replace the classical histone molecules in the 
nucleosomes and linker regions; H2A, H2B, H3 and H1 all have non-canonical 
variants. Different variants replace canonical histones in the fibre in different 
circumstances in a replication-dependant, replication independent or tissue-specific 
manner. A class of proteins called histone chaperones carefully regulates this 
process. The incorporation of histone variants can have many effects, including a 
change in the fibre conformation (causing chromatin to become more or less tightly 
folded) or recruitment of regulatory proteins. Consequently, histone variants are 
indispensable for many biological processes, ranging from transcriptional activation 
to DNA repair and chromosome segregation (Henikoff et al. 2004).  
An interesting example of a histone variant with a proposed dual structural and 
regulatory role is CENP-A, an H3 variant present specifically at centromeres, 
deposited by a histone chaperone called HJURP. The presence of CENP-A is 
necessary for recruitment of kinetochore components, but it is possible it also has a 
structural impact on the chromatin fibre. Although the precise effects of CENP-A 
incorporation into nucleosomes in vivo are unclear, a 2010 study found that 
nucleosomal arrays containing CENP-A are more condensed compared to arrays 
containing canonical H3, suggesting that the presence of CENP-A helps to establish 
an unusual chromatin structure at centromeres (Panchenko et al. 2011). Other well-
characterised H3 variants include H3.1 and H3.3, which differ by just five residues in 
humans. H3.1 is incorporated into chromatin in a replication-dependent manner via 
the chaperone CAF-1 and is the major form of H3 in cells. Conversely, H3.3 can be 
integrated into nucleosomes at any time during the cell cycle via its own chaperone-
HIRA; it is often found at transcribed genomic locations and promoters (Wirbelauer 
et al. 2005; Ahmad & Henikoff 2002). 
Well studied H2A variants include macro H2A, found at the inactive X and H2AZ, a 
histone associated with active transcription which may promote nucleosome 
6 
 
destabilisation upon incorporation (Suto et al. 2000). As an important function of 
chromatin, locating and signalling DNA damage is associated with a separate 
histone variant-H2AX, an H2A variant representing around 11% of H2A in cells 
(West & Bonner 1980). H2AX replaces H2A in nucleosomes interspersed throughout 
the genome and differs from H2A in its C-terminal sequence. Upon DNA damage, 
the serine 139 position of the C-terminal portion of H2AX becomes phosphorylated. 
This phosphorylation is one of the primary events at sites of DNA damage and plays 
an essential role for DNA damage signalling, detection and repair.  
1.1.3 Histone modifications 
In addition to histone variants, chromatin fibre structure and composition can also 
be affected by post-translational modifications (PTMs) present on the N-terminal 
tails of the histone proteins. These modifications include acetylation, methylation, 
phosphorylation and ubiquination and similarly to the presence of histone variants, 
can act by directly modifying chromatins structure or by recruiting regulatory 
factors recognising specific post-translational marks. Numerous post-translational 
marks exist and their effects, both individual and combinatorial, are still under 
investigation.  
Acetylation of lysine residues in the N-terminal tails of H3 and H4 is a mark 
associated with active transcriptional states. Acetylation neutralises the charge of 
the lysine residue, which is expected to weaken histone-histone and histone-DNA 
interactions, resulting in opening up of the chromatin fibre. However, a careful in-
vitro study performed on short arrays of nucleosomes reconstituted on a repetitive 
DNA sequence failed to demonstrate significant opening of the chromatin, 
suggesting the effects of acetylation may depend on the wider chromatin context 
(Neumann et al. 2009).  H3 and H4 can be acetylated at numerous positions, 
including H3K9, H3K14, H3K18, H4K5, H4K8, H4K12 and H4K16.  Acetylation marks 
on H3 and H4 are recognised by bromodomains, protein domains present on some 
transcriptional activators and chromatin remodellers. The acetylation mark is added 
on histone molecules by a class of enzymes called histone acetyltransferases (HATs) 
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and removed by histone deacetylases (HDACs). The importance of maintaining 
acetylation states for genome stability is illustrated by the finding that loss of HDAC 
function is associated with instability, including aneuploidy and lagging 
chromosomes (Dovey et al. 2013). 
Methylation occurs on lysine and arginine residues. Up to three methyl groups can 
be added on lysines, while arginines can only be mono- or di-methylated. Unlike 
acetylation, methylation does not change the charge of the residue affected. 
Lysines are methylated by lysine methyltransferases (HKMTs), which are very 
specific and methylate particular residues only. Multiple HKMTs have been 
identified, all of which share a domain called SET (Su(var)3-9, Enhancer-of-zeste and 
Trithorax). Arginine residues are modified by arginine methyltransferases, also 
known as PRMTs, while removal of the methyl residues is catalysed by 
demethylases. A few classes of lysine demethylases exist, including lysine-specific 
demethylase 1 (LSD1), which can demethylate different lysine residues depending 
on different accessory proteins and the jumonji domain demethylases, which act on 
tri-methylated lysine residues. Methyl marks on H3 and H4 residues can be 
associated with active and inactive chromatin states. Examples include H3K9me3-a 
repressive mark which recruits the heterochromatin protein HP1 and H3K4me3- a 
mark present in actively transcribed regions. Similar to the case for histone 
acetylation, a direct relationship between appropriate methylation patterns and 
genome instability has been demonstrated via depletion of Suv39h, an H3K9 
methyltransferase involved in establishing H3K9me3 at pericentromeric chromatin. 
Mice lacking Suv39h are prone to tumour formation, while embryonic fibroblasts 
derived from the animals had extremely unstable karyotypes (Peters et al. 2001). 
While the H3K9 methylation mark probably exerts its effects on genomic stability 
through maintaining the structural state of certain genomic regions, another 
methylation mark, H3K79me, has been implicated in the DNA damage response in a 
signalling manner. This mark is established by the DOT1 lysine methylase and is 
important for recruitment of 53BP1, a protein integral to the DDR to a break site. 
53BP1 recruitment by H379Kme is through a Tudor domain in the 53BP1 protein, a 
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domain recognising methylated residues; however, it is unclear whether the mark is 
established in response to a DNA break or whether chromatin changes within the 
vicinity of a break cause the mark to be exposed and recognised by 53BP1 (Huyen et 
al. 2004). 
Another important PTM, phosphorylation, can be added on serine, threonine and 
tyrosine residues. This modification is placed by kinases and removed by 
phosphorylases. Unlike acetylation and methylation, which are related to 
establishing chromatin domains with different properties, phosphorylation has a 
major role in cell cycle progression. The serine 10 position on H3 is phosphorylated 
genome-wide by the Aurora B kinase as the cells progress through late G2 and into 
mitosis (Wei et al. 1999) in a manner that is inter-dependant with other histone 
modifications, such as H3K9me (Rea et al. 2000). This modification is required for 
the mitotic condensation of chromosomes- a process in which chromosomes are 
strongly compacted to facilitate chromosome separation and minimise 
entanglements during cell division.   
 As discussed earlier, phosphorylation of the H2AX histone variant at the serine 139 
position (phospho-H2AX or gammaH2AX) is the most widely studied DNA-damage 
associated histone modification. This position is rapidly phosphorylated in response 
to DNA damage and phosphorylation is dependent on the ATM, ATR and DNA-PK 
kinases. The gammaH2AX mark spreads in large, megabase-sized domains 
surrounding the break region (Rogakou et al. 1999) and is essential for the DNA 
damage signalling and response. GammaH2AX-containing chromatin then serves as 
a platform for recruiting additional repair components, including 53BP1 and BRCA1 
(Misteli & Soutoglou 2009).  Interestingly, studies in which the H2AX 
phosphorylation site was disrupted indicated that lack of H2AX phosphorylation 
does not preclude initial recruitment of repair factors to the site (NBS1, BRCA1 and 
53BP1); however, it interferes with their retention, reinforcing the concept of the 
gammaH2AX domain as a platform for retaining the factors necessary for repair. 
Following repair, H2AX phosphorylation is reversed by phosphatase complexes 
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including PP2A and PP4 (Chowdhury et al. 2005) and through histone exchange 
mediated by the FACT complex (Heo et al. 2008). Mammalian cells lacking H2AX 
exhibit enhanced susceptibility to genomic instability and cancer (Celeste et al. 
2003). Given the coordinated structural and signalling functions of other histone 
modifications, it is tempting to speculate that phosphorylation of H2AX may act 
through structural effects on the chromatin fibre as well as through signalling in the 
DDR cascades. However, no such structural effects have been convincingly 
demonstrated to date and while changes in chromatin compaction are known to 
occur as a consequence of damage, they have been shown to be independent of the 
presence of gammaH2AX (Kruhlak et al. 2006). Other histone marks which may have 
a role in the DNA damage response include H2A ubiquitinylation (Ui et al. 2015), 
H2B phosphorylation at the serine 14 position (Fernandez-Capetillo et al. 2004) and 
H3 threonine 45 phosphorylation (Lee et al. 2015). 
While the establishment of histone marks in response to DNA damage is well 
characterised, a recent publication by the Misteli lab explored the opposite idea-can 
certain histone PTMs predispose genomic regions to instability?  Surprisingly, the 
study found enrichment of H3K4me1 and H3K27ac and depletion of the repressive 
H3K9me3 mark in genes frequently involved in translocations when compared to 
genes with similar expression patterns and levels (Burman et al. 2015). To 
demonstrate that the correlation is causal, they tethered H3K4 methyltransferase 
and H3/H4 lysine acetylase to a Lac operon (LacO) array also carrying an artificially 
introduced unique restriction enzyme site. When the frequency of breaks was 
assessed the authors found an elevated rate in the presence of both the H3K4 
methyltransferase and the H3/H4 lysine acetylase, leading them to speculate that 
the more open chromatin environment promoted by these enzymes leaves the 
genome more exposed to instability. Interestingly the H3K4me3 mark has also been 
associated with the introduction of double stranded DNA breaks during V(D)J 
recombination in lymphocytes (Stanlie et al. 2010). 
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As illustrated by the many enzymes capable of establishing and removing PTMs, 
histone marks are transient states and subject to turnover during cell cycle and 
differentiation. The propagation of PTMs during DNA replication and cell division 
has been recently studied via nascent chromatin capture (NCC) - a technique based 
on the isolation and mass spectrometry analysis of nascent chromatin strands 
(Alabert et al. 2014).  Application of NCCs in Hela cells showed that there is no 
erasure of PTMs during replication and that old histones carrying PTMs are 
integrated equally in the two nascent chromatin fibres. Newly integrated histones 
are then modified to copy the modifications already present in the fibre and PTMs 
are fully restored within the next cell cycle, with the exception of the trimethyl 
marks on H3K9 and H3K27, which appear to be accumulated slower over a number 
of cell cycles. 
1.1.4 Chromatin remodellers 
Apart from histones, chromatin contains a range of other proteins with diverse 
roles. One of the most important classes of non-histone proteins in chromatin are 
chromatin remodellers: proteins that can reposition and remove nucleosomes or 
change their composition in an ATP-dependant manner. Consequently, they 
introduce small-scale alterations in the state of the chromatin fibre and the 
accessibility of the DNA template. Chromatin remodellers are required for many 
nuclear processes, including transcription, replication, cell cycle progression and of 
course, DNA repair. Numerous mammalian chromatin remodellers exist and they 
can be broadly divided into four families: SWI/SNF, ISWI, INO80 and CHD.  
The SWI/SNF family of remodellers includes two main complexes, BAF and PBAF. 
Both complexes contain an ATPase subunit (either BRM or BRG1) and three main 
core subunits: BAF155, BAF170 and BAF47.  BAF and PBAF also can contain many 
different accessory subunits, which generate functional diversity and tissue 
specificity.  The many functions of these enzymes include both transcriptional 
activation and repression and they are also implicated in tissue differentiation. 
Genes encoding remodellers of the SWI/SNF family are frequently mutated in 
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cancer and components of the SWI/SNF complexes, BAF and PBAF, have been 
shown to localise to sites of DNA damage. PBAF subunit BAF180 has a role in 
silencing transcription at sites of DNA breaks (Kakarougkas et al. 2014), while BRG1, 
the ATPase subunit common to BAF and PBAF, is involved in sister chromatid 
decatenation at the G2/M boundary and its inhibition results in anaphase bridges 
and lagging chromosomes (Dykhuizen et al. 2013). Hinting at the wide range of roles 
these remodellers have, the PBAF complex was also found to promote sister 
chromatid cohesion, especially at centromeres, with chromosomal breaks and 
abnormalities following its inhibition (Brownlee et al. 2014).  
ISWI remodelling complexes are characterised by the presence of the SNF2H or 
SNF2L ATPase subunits as well as other accessory subunits; the family includes the 
complexes ACF, CHRAC and NURF, among others. These remodelling complexes also 
have numerous roles, can either act to activate or repress transcription and are also 
involved in replicating heterochromatin (Corona & Tamkun 2004). ACF-1, a 
component of two ISWI-type complexes, ACF and CHRAC, was also found to bind at 
laser-induced DNA breaks, co-localising with gammaH2AX (Lan et al. 2010). Cells 
depleted of ACF-1 were very sensitive to DNA damage, and the authors determined 
that ACF-1 facilitates the binding of NHEJ protein Ku at double strand DNA breaks. 
The CHD class of remodellers derive their name by possessing chromodomains, 
which can read methyl marks on histones. An example is the nucleosome 
remodelling and deacetylase complex (NuRD), which promotes nucleosome 
compaction in heterochromatin. The CHD4 subunit of the NuRD complex is 
phosphorylated by ATM in response to genome damage (Polo et al. 2010) and is 
rapidly recruited to sites of damage (Larsen et al. 2010). In the same studies the 
authors observed increased rates of genomic breaks in CHD4-depleted cells, 
suggesting not only that CHD4 is essential for repair but that its depletion might 
make chromatin more susceptible to breaks. In contrast, NuRD complexes 
containing an alternative CHD3 isoform were released from heterochromatin upon 
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treatment with ionizing radiation, promoting chromatin relaxation (Goodarzi et al. 
2011). 
INO80-type remodelling complexes are characterised by an insertion within their 
ATPase domains, which leads to incorporation of Rvb 1/2 helicases, mammalian 
homologues of bacterial proteins mediating strand exchange and recombination. 
These complexes are thought to be involved in the turnover of H2AZ and H2AX in 
nucleosomes. INO80 is also involved in replication and S-phase progression, with 
fork collapse, slower S-phase progression and H2AZ mis-incorporation shown in 
yeast and mammalian cells in the absence of the complex (Hur et al. 2010). 
Mammalian cells depleted of the INO80 remodeller also exhibit DNA repair 
problems, with homologous recombination specifically affected as INO80 seems to 
be involved with 5’-3’ resection of DNA at breaks sites (Gospodinov et al. 2011). 
Depletion of p400, an INO80 component primarily involved in the incorporation of 
the H2AZ variant at transcriptionally active regions, also makes cells sensitive to 
DNA damage (Courilleau et al. 2012). P400 was also shown to incorporate H2A.Z at 
double-stranded breaks, contributing to opening up of the chromatin in the break 
region to allow access for repair proteins (Xu et al. 2012). Another INO80 subunit, 
TIP60, which acetylates H2A and H4, has been implicated in restoring the chromatin 
environment following DNA damage response by removing the phosphorylated 
H2AX from the affected regions (Kusch et al. 2004). Another role for TIP60 includes 
acetylation of histones in heterochromatic breaks to allow chromatin relaxation for 
repair. 
Overall, the study of the role of chromatin remodellers and their roles in 
maintaining genome stability is a very active field of research complicated by the 
many functions of these enzymes. In addition, as chromatin remodellers tend to 
have a serious impact on gene expression, studies have to exclude indirect effects 
on genome instability due to altered gene expression.  This underlies the need for 
better and more representative in-vitro chromatin models, which would enable the 
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study of direct structural effects of the remodellers separately from their other 
roles.  
1.1.5 Topoisomerases 
The family of topoisomerases encompasses a number of enzymes present in 
chromatin, which act to resolve DNA catenanes and relieve topological stress by 
introducing breaks in the DNA strands and passing the strands around each other. 
Two main types of topoisomerases exist: type I topoisomerases introduce single 
strand DNA breaks, while type II topoisomerases break both strands of the DNA 
helix. Type I topoisomerases can be further classified into type IA and IB; type IA 
enzymes work to relax negatively supercoiled DNA, while type IB enzymes work by 
introducing a nick and allowing the strands surrounding the breaks to rotate 
relatively to each other and can act both on positively and negatively supercoiled 
DNA. Type II enzymes are categorised into two distinct families- IIA and IIB, based 
on similarity of structure and work by catalysing the passage of one DNA duplex 
through another.  
Many chromatin processes, including transcription, replication and chromosome 
segregation generate topological stress and necessitate the action of 
topoisomerases. During transcriptional elongation, RNA polymerases generate 
positive supercoils ahead and negative supercoils behind and Top1 is involved in 
relieving the resulting topological tension. A 2013 study found that inactivation of 
Top1 affects genes longer than 200 kb specifically, underlying a possible association 
between Top1 mutations and autism (King et al. 2013). Secondary effects of Top1 
may be related to avoiding direct and topological conflicts between the processes of 
transcription and replication, as illustrated by the finding that depletion of Top1 in 
mammalian cells causes replication fork stalling via transcriptional inference (Tuduri 
et al. 2009). 
 Topological tension associated with replication is thought to be resolved by 
topoisomerase II (Top2) enzymes. In addition to relieving topological stress 
generated during replication these enzymes may also play a role at sites of 
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converging replication forks (Baxter & Diffley 2008)- it has been speculated that 
replisome rotation during replication causes catenation of the daughter DNA 
strands behind the replisome, which can only be resolved through Top2 cleavage. In 
addition, Top2enzymes also play a role in chromosome condensation, both 
functionally and structurally, with topoisomerase II (Top2A) shown to be a major 
component of metaphase chromosomes, forming a structural axis along the length 
of the chromosomes (Gimenez-Abian et al. 1995). Inhibition of Top2 through RNAi 
or inhibitors in various cell types and species has been shown to impair 
chromosome condensation and segregation to varying degrees, resulting in 
different chromosome morphologies in different organisms and cell types 
(Carpenter 2004; Uemura et al. 1987; Adachi et al. 1991). Conditional depletion of 
Top2A in human cells resulted in many serious defects, including activation of a G2 
cell cycle checkpoint, partial condensation of chromosomes, anaphase 
abnormalities such as lagging chromosomes and generation of polyploid cells, 
underlying the role of this enzyme in cell cycle progression and chromosome 
segregation (Curanovic et al. 2013). However, as the compaction of chromosomes 
for mitosis and the resulting structures of mitotic chromosomes are still not 
completely identified, the precise role of Top2A in chromosome compaction and 
segregation is still unclear. 
An interesting characteristic of topoisomerases is their ability to introduce single-
stranded or double-stranded DNA breaks in a controlled manner. A number of 
topoisomerase poisons work by trapping the enzyme on the DNA strand following 
break generation, preventing the catalytic cycle from completion and resulting in a 
permanent break. As a result, the presence of these inhibitors causes genome-wide 
DNA damage and subsequent checkpoint activation, preventing progression 
through the cell cycle.  Exploiting this property of topoisomerases and their 
inhibitors has led to a number of topoisomerase poisons becoming used as 
important anti-cancer agents (Ashour et al. 2015).  
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1.1.6 Condensin and cohesin  
Another important class of chromatin components are the structural maintenance 
of chromosomes (SMC) proteins, a group covering two highly conserved complexes-
cohesin and condensin. The main role of the SMC proteins is in maintaining and 
modifying chromosomal structure in the context of gene expression, mitotic 
compaction and chromatid separation. 
Each of these two related complexes is composed of two SMC subunits and a 
kleisin-type component along with additional, complex-specific, subunits but always 
maintaining a ring-shaped configuration. In both complexes, the two SMC units 
form anti-parallel coiled coils that fold back on each other forming two “arms”, 
which contact the kleisin subunit. For the cohesin complex, EM images estimate a 
length of 65 nm length for the SMC arms, potentially allowing chromatin fibres to 
be encircled by the complex (Haering et al. 2002). Due to this conserved ring-
shaped structure of both of these complexes, it is thought that their interaction 
with DNA is topological rather than sequence-based (Murayama & Uhlmann 2014). 
Cohesin contains SMC1 and SMC3 as well as the kleisin subunit RAD21 and the non-
kleisin unit SA (also called STAG).  In the case of condensin, two different complexes 
exist in mammalian cells: both share SMC2 and SMC4 as components; condensin I 
carries the kleisin unit CAP-H and the additional subunits CAP-D2 and CAP-G, while 
condensin II has the CAP-H2 kleisin component as well as CAP-D3 and CAP-G2.  
While cohesin and condensin share many similarities, their main roles are in a sense 
contradictory: the main role of cohesin is to hold sister chromatids together 
following the process of replication, while condensin acts to compact chromosomes 
in preparation of mitosis and facilitate separation of the chromatids.  
Cohesin is first loaded onto chromosomes in early G1, but only becomes truly 
“cohesive” in S-phase. The initial loading is supported by the cohesin loader NIPBL 
in an ATP-dependent process. During G1, cohesin is continually loaded onto 
chromosomes and unloaded in a process mediated by WAPL and PDS5. In S-phase, 
the binding of cohesin to chromatin is stabilised and the complex acts to bring 
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together the two sister chromatids following replication until its release from 
chromosomes in mitosis. This release happens in two stages: at prophase, the 
complex is released from chromosome arms, due to phosphorylation by CDK1 and 
Aurora B to allow separation of the sister chromatids, while a small fraction is 
retained around centromeres; then, at anaphase, the kleisin subunit of the residual 
cohesin is cleaved by separase, allowing for chromosomes to be pulled apart by 
microtubules. The cohesin complexes are then deacetylated by HDAC8 and recycled 
back onto chromosomes in G1.  
Historically, the cell-cycle related role of cohesin in sister chromatid cohesion was 
recognised first and this was subsequently followed by characterisation of its role 
throughout interphase. In addition to keeping replicated chromatids together, 
cohesin also has a role in organising large-scale chromatin structure at a global 
level, demarking chromatin domains and mediating enhancer-promoter interactions 
with resulting effects on gene expression. The first indication of this additional role 
for cohesin came with the discovery that cohesin binding sites along chromosomes 
coincide with CTCF binding sites, another protein involved in establishing large-scale 
chromatin domains (Parelho et al. 2008). It is thought that this role is executed by 
cohesin establishing topological linkages, similar to the linkages keeping sister 
chromatids together, but on a single DNA strand. Yet another role for cohesin was 
established with the finding that it is recruited to DNA damage sites following laser 
irradiation, but only in the S and G2 phases of the cell-cycle (Kim et al. 2002). The 
cell cycle specificity of this DDR repair recruitment of cohesin suggests that it may 
function in the homologous recombination (HR) DNA repair pathway, working to 
keep damaged chromatids and repair template in close proximity. 
As a protein with such essential and diverse roles, mutations in cohesin subunits or 
in the proteins responsible for loading it onto chromosomes lead to serious 
pathologies, termed cohesinopathies. The best-studied cohesinopathy is Cornelia 
de Lange Syndrome (OMIM 122470), caused by mutations in all of the cohesin 
subunits, as well as in its loader, NIPBL.  CdLS is clinically characterised by cognitive 
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impairment, limb defects and delayed development amongst others.  Interestingly, 
the main defect of cells carrying CdLS mutations appears to be related with 
transcription rather than chromosome cohesion (Liu et al. 2009) suggesting that the 
most pathologically relevant consequences of cohesin depletion stem from its role 
in transcription regulation. Somatic mutations of cohesin subunits have also been 
described in various types of cancers (Solomon et al. 2011) including colorectal 
cancer and leukaemia (Barber et al. 2008; Kon et al. 2013).  
The primary function of condensins is to assist folding of chromosomes in 
preparation for mitosis. Although extensively studied, the process of mitotic 
compaction is still unresolved and as a result, the precise manner in which 
condensins fulfil their primary function is still unknown. However, the structure of 
the condensin complexes and their localisation in interphase and metaphase are 
well described. Condensin in vertebrate cells exists as two distinct complexes, 
condensin I and condensin II.  Within the context of mitotic folding, the two 
complexes have different roles. Condensin I acts to compact chromosomes laterally, 
while condensin II acts to compact chromosomes longitudinally-surprisingly, the 
exact ratio of condensin I to condensin II was found to impact on chromosome 
shape: samples prepared with Xenopus extracts with high condensin I: condensin II 
ratios chromosomes were longer and thinner compared to chromosomes prepared 
in extracts with a 1:1 ratio (Shintomi & Hirano 2011). The two complexes show 
differential localisation for most of the cell cycle: condensin I-is excluded from 
nucleus during interphase and localises to chromatin following nuclear envelope 
break down in the early stages of mitosis; in contrast, condensin II shows nuclear 
localisation throughout interphase and remains associated with chromatin during 
mitosis (Ono 2004).  However, it appears that condensin II changes its binding to 
chromatin during S phase: a 2013 study found that it is not stably attached to 
chromatin in G1 and early S-phase; instead, it becomes stably localised only to 
replicated regions in S phase, forming “sister axes” and also working to resolve 
sister chromatids (Ono et al. 2013). Interestingly, this process was mildly impaired in 
cells exposed to replication stress suggesting that the behaviour of condensin II in  S 
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phase links successful replication to mitotic folding and sister chromatid resolution. 
Later in the cell cycle, as condensin I gains access to chromatin in prometaphase, 
the two condensin complexes localise in an alternating pattern to axial structures 
extending along the length of the chromatids. The condensins then dissociate from 
chromosomes in telophase as chromatin decondenses.  
Illustrating the importance of the condensin proteins, their depletion in chicken 
DT40 cells has shown that these proteins are essential for survival and their absence 
results in polyploidy.  Codensin II depletion results in a high incidence of anaphase 
bridges; condensin I depleted chromosomes are wider and shorter and show diffuse 
scaffolds, while condensin II depleted chromosomes do not show scaffold defects 
but appear to lack axial rigidity (Green et al. 2012).  
1.1.7 Additional chromatin components 
Beyond the components mentioned above, chromatin contains numerous other 
proteins with a variety of roles which reflect the tasks and challenges of transcribing 
and duplicating the genome while maintaining its integrity. An example is provided 
by a family of helicases-the RecQ helicases, named “caretakers of the genome”. 
Helicases are a class of ATP-dependent enzymes specialised in separating the two 
strands of a nucleic acid duplex. They are involved in replication, transcription and 
DNA repair. In humans, the RecQ family includes the Werner syndrome protein 
(WRN), Bloom syndrome protein (BLM), RECQL4, RECQL and RECQL5. These 
proteins share a conserved helicase domain as well as a common function in 
preserving genome integrity.  The contexts in which the RecQs work to prevent 
instability have been particularly well studied in the case of WRN and BLM, which 
have replication-related roles and RECQL5, which works to avoid transcription-
induced fragility.  
The genome-protecting properties of BLM and WRN are evidenced by the fact that 
disorders caused by germline mutations of these helicases are characterised by an 
increased cancer risk and other marks of genome instability. Ex-vivo lymphocytes 
from patients suffering from Werner syndrome (OMIM 277700), a monogenic 
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disorder caused by mutations in the WRN protein, show chromosomal instability 
(Gebhart et al. 1988) and an increased sensitivity to replication stress (Pirzio et al. 
2008).  Cells derived from Bloom syndrome patients deficient in BLM exhibit 
increased rates of sister chromatid exchange (SCE) (Traverso et al. 2003).  Both 
proteins change their localisation in response to replication stress and form foci 
upon hydroxyurea treatment (Constantinou et al. 2000; Bischof et al. 2001);  they 
also share an ability  to unwind x-shaped and forked DNA structures (Mohaghegh et 
al. 2001), associated with stalled replication forks and holiday junctions. Despite 
similarities between the two, it is thought that they have subtly different roles, as 
suggested by the different characteristics of Bloom and Werner syndrome and the 
dissimilar defects seen in cells derived from these patients. The consensus is that 
WRN is specialised in rescuing stalled replication forks while BLM resolves holiday 
junctions. 
The genome care-taking role of another member of the RecQ family, RECQL5, has 
been revealed by focusing on the process of transcription (Saponaro et al. 2014). 
RECQL5 interacts with RNA Polymerase II and slows it down in regions that are 
difficult to transcribe. Long-term depletion of RECQL5 led to recurrent loss and gain 
of chromosomal segments, specifically at long genes. Depletion of RECQL5 has also 
been shown to increase cell sensitivity to the Top I inhibitor camptothecin (Hu et al. 
2009) and live imaging of cells with laser-induced DNA breaks has demonstrated 
that RECQL5 is recruited to DNA damage sites (Popuri et al. 2012). 
1.2 Chromatin structure 
Investigating the fine details of chromatin structure is a challenging task. Chromatin 
forms a dense mass inside nuclei that cannot be resolved by current microscopy 
techniques.  Observations of synthetic chromatin fibres by electron microscopy has 
been informative, but such systems leave out the complexity of living cells and 
provide very reductionist results. However, advancements in microscopy and 
molecular techniques for investigating chromatin structure have added to our 
understanding and hold further promise for the future. 
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1.2.1  Nucleosomes and the 30nm fibre 
Independent of any variants or post-translational modifications that may be 
present, core histones are invariably arranged in nucleosome structures, containing 
two H2A:H2B dimers and two H3:H4 dimers. 147 bp of DNA are wrapped around 
each nucleosome, with 10-100 bp “linker” DNA, bound to the histone H1 linking up 
different nucleosomes.  With the help of linker histones, arrays of nucleosomes are 
folded into a fibre measuring 30 nm in diameter, the exact structure of which is still 
under intense debate (Figure 1-1). A number of models have been proposed for the 
arrangement of nucleosomes in the 30 nm fibre structure, including a solenoid 
model, where nucleosomes are organised in a helical array, a zig-zag model with a 
zig-zag arrangement of nucleosomes and an irregular fibre model with irregular 
arrangement and spacing of nucleosomes. Various techniques have been used in 
the last three decades to try and resolve the structure of the 30 nm fibre, including 
variations of electron microscopy, X-ray diffraction and most-recently-super-
resolution microscopy (Grigoryev & Woodcock 2012; Ricci et al. 2015). While 
successful observation of the 30 nm fibre structure is possible in chromatin 
reconstituted in situ and in some rare types of nuclei, it has proven impossible to 
resolve the fibres in vivo in nuclei, with chromatin appearing instead as a dense 
mass. 
In reality, as chromatin structure is very dynamic in living cells, it is likely the 
structure of the 30 nm fibre in living nuclei is not homogenous but instead is made 
up of a mixture of the models proposed with some regions being more compact and 
others more disrupted. In another illustration of the structure/function rule, it has 
been shown that constitutively transcriptionally inactive parts of the genome show 
a regular folding at the 30 nm level while bulk genome has a less regular 
conformation interspersed with irregularities (Gilbert & Allan 2001). Nucleosomes 
can be moved and shuffled by chromatin remodellers to allow proteins such as 
transcription factors, replication-related proteins and DNA repair proteins to bind to 
the naked DNA template. It is easy to envisage how these movements of 
nucleosomes can introduce transient local disruptions in the chromatin fibre. A 
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frequently used method to investigate nucleosome occupancy and 30-nm fibre 
structure is performed by testing the accessibility of the naked DNA by nuclease 
digestion. 
1.2.2 Large-scale structures 
At a further level of chromatin organisation, interactions between the 30-nm fibres 
give rise to so-called higher order structures. The fine details of this level of 
organisation are unknown (although looping of fibres is likely to be involved) and 
currently not many methods are available to investigate the folding of higher order 
chromatin structures. Overall, these structures are organised into segments with 
differing functional properties, determined by a combination of sequence 
composition (AT:GC content) and the presence of different histone modifications 
and chromatin bound proteins. A simplistic and classical view is to split the genome 
into gene rich segments with more open structures and silenced regions containing 
repeats and satellites where the folding of higher orders structures are more 
compact. However, a more current classification of the differing properties of 
higher order domains splits them into five functional categories: yellow 
(constitutively transcriptionally active regions), red (tissue-specific active regions), 
blue (repressed development and differentiation-related regions), black (silenced 
regions containing genes) and green (constitutively inactive repeats and satellites) 
chromatin (van Steensel 2011). The first two categories contain the transcriptionally 
active portion of the genome, which is enriched in acetylated H3 and H4. The 
chromatin structure in such regions is likely to have more disruptions at the 30-nm 
level and more “open” structures at the higher order level, facilitating easy access 
of transcription, replication and DNA repair factors to the DNA template. In 
contrast, the chromatin structure within the other classes is likely to be more 
compacted and less dynamic. Processes that require access to the DNA template 
such as replication and DNA repair may necessitate chromatin remodelling to open 
up chromatin in these regions of the genome. In fact, some recent data suggests 
that permanently silenced regions may act as a barrier to the DNA damage response 
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and that breaks within these regions may take longer to detect and repair (Goodarzi 
et al. 2008). 
1.2.3  Nuclear organisation of chromatin 
Within cells chromatin is contained within the nucleus-a complex organelle shaping 
the 3D organisation of the genome. Positioning of the genome in the nucleus has 
important functional consequences; nuclear position is a significant characteristic of 
a locus, impacting on its transcriptional activity, replication timing and proximity to 
other loci. Changes in the nuclear positioning of loci accompany development and 
differentiation, demonstrating the biological relevance of nuclear organisation. 
The exact positioning of loci within the nucleus is probabilistic-it is not the same in 
every cell but is guided by a set of rules. With few exceptions, in mammalian cells, 
gene-rich, transcriptionally active regions of the genome are located towards the 
nuclear interior, while the gene-poor and heterochromatic regions are located 
towards the periphery. As a result, rather than having precisely defined locations, 
chromosomes have preferred radial positions in the nucleus. Centromeres also tend 
to be located towards the periphery (Gilchrist et al. 2004), while telomeres are 
distributed through the nuclear volume.  
The nuclear periphery is defined by its interaction with the nuclear lamina- a part of 
the inner nucleoplasmic membrane. The genomic regions that interact with the 
lamina are known as lamina-associated domains (LADs); they measure 0.1 to 10 Mb 
in size and overlap with chromatin features such as low gene density and repressive 
histone marks. LADs can be divided into a facultative and a constitutive class. 
Facultative LADs are cell type-specific, while constitutive LADs are shared between 
cell types. Interestingly, disruptions in the lamina structure have been associated 
with genome instability, as illustrated by a class of diseases known as 
laminopathies, caused by mutations in the genes coding for the proteins that make 
up the nuclear lamina.  The best studied among them is the Hutchinson-Gilford 
progeria syndrome (HGPS), a rare premature aging syndrome caused by mutations 
in the LMNA gene. Cells from patients with HGPS show microscopically visible 
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disruptions to the shape of the nuclear envelope, loss of the heterochromatic 
protein HP1 at the nuclear periphery and altered histone modifications pattern. 
Although not deficient in any of the components of the DDR response, HGPS cells 
are sensitive to ionizing radiation and accumulate DNA damage when grown in 
culture (Musich & Zou 2011).  They also display increased levels of -H2AX and 
ATR/ATM activation.  
1.2.4  Chromosome territories 
Rather than being dispersed throughout the nucleus, each chromosome occupies a 
distinct volume, called a chromosome territory. This has been demonstrated by 
chromosome painting-a FISH-based technique where the genome is hybridised to a 
large number of chromosome-specific probes to allow visualisation of individual 
chromosomes within the nucleus. The radial positioning of a chromosome is 
strongly influenced by its composition -gene-poor chromosomes tend to occupy 
positions closer to the nuclear periphery while gene rich chromosomes are more 
frequently located towards the interior (Boyle et al. 2001). This trend is illustrated 
by human chromosomes 18 and 19, which are very similar in size but have very 
different sequence composition: chromosome 18 is gene poor, while 19 is gene-
rich. The Bickmore lab used chromosome territory FISH to investigate the positions 
of the two chromosomes in the nucleus and found that chromosome 18 was 
consistently located closer to the nuclear periphery than chromosome 19 in both 
lymphoblastoid and fibroblast cell lines (Croft et al. 1999). The radial positioning of 
chromosomes in the nucleus was also found to be tissue-specific, with more closely 
related cell types exhibiting more similar chromosome positioning (Parada et al. 
2004). The human genome also contains 5 acrocentric chromosomes, containing 
rDNA sequences –chromosomes 13, 14, 15, 21 and 22 which are usually clustered 
around the nucleolus-the site of transcription and processing of ribosomal RNA. 
The radial rule of chromosome positioning also influences the positioning of 
alternating gene rich and gene-poor segments within chromosomes-in this case, 
gene rich segments are located more centrally while gene-poor regions occupy 
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regions closer to the periphery. In addition, within chromosome territories, 
transcriptionally inactive segments are located internally and transcriptionally 
active segments are at the surface of the territory (Boyle et al. 2011). This 
arrangement allows transcriptionally active regions ready access to the 
transcription machinery and domains rich in mRNA metabolic factors such as SC-35 
foci (Shopland et al. 2003).  However, the fine-detail structure of chromosome 
territories is yet unclear, reflecting our lack of knowledge of the chromatin 
structures that shape them.  
From a genome stability perspective, an important consequence of chromosome 
positioning patterns relates to translocations, the most frequent chromosomal 
abnormality seen within the human population. It is well established that the 
physical proximity of two chromosomes in the nucleus affects the probability of a 
translocation occurring between them. An analysis between the frequencies of 
different non-pathogenic translocations in the human population and the preferred 
radial positions of chromosomes in the nucleus found that chromosomes with 
similar nuclear positions form translocations more frequently than expected by 
chance (Bickmore & Teague 2002).  Another study was able to demonstrate close 
proximity between the BCR and ABL loci, involved in the well characterised t (9; 22) 
translocation forming a “Philadelphia” chromosome in chronic myeloid leukaemia. 
The authors showed that the BCR and ABL loci were closer in B-lymphocytes than in 
hematopoietic progenitor cells, suggesting that cell-type specific aspects of nuclear 
organisation may contribute to the association of certain translocations with 
particular cancer types. In 2013, the Misteli lab published a study exploring the 
dynamics of double strand breaks and subsequent translocation formation in an 
elegant system: NIH3T3duo cells encode a small number of SceI restriction enzyme 
sites integrated on different chromosomes, with some sites adjacent to a LacO 
array, while other sites neighboured a TetO array (Roukos et al. 2013). Upon break 
induction by the SceI enzyme, it was possible to track the breaks which were 
marked by fluorescently tagged Lac (LacR) and Tet (TetR) repressor proteins; 
translocation formation was indicated by long-lasting, stable co-localisation of the 
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LacR and TetR signals. The authors were able to demonstrate that most 
translocations are formed by loci that are closely located prior to break induction 
(contact-first model) rather than as a result of a movement of double strand breaks 
to proximal locations (breakage-first model).  
1.2.5  Nuclear scaffolds 
An unresolved question, widely discussed in the 1980s and reframed today is 
whether chromatin and other nuclear components are freely suspended in the 
nucleus or are instead attached to an underlying nuclear structure. Careful 
observations by electron microscopy found some evidence of an internal nuclear 
matrix, composed of irregular fibres connected to the nuclear lamina. These 
structures were resistant to DNase treatment but vulnerable to RNases, which 
suggested the presence of an RNA component. Various biochemical approaches 
were used in attempts to characterise the exact components of these nuclear 
structures and their relationships to the genomic sequence. Techniques aiming to 
isolate the genomic sequences associated with the matrix showed that satellites 
and  G-bands were over-represented (Craig et al. 1997) . The search for the protein 
components was less successful: a family of ribonucleoproteins, hnRNPs, were 
thought to be involved but due to an inconsistency of experimental procedures, the 
full composition and structure of the nuclear matrix was never resolved and the 
idea was abandoned.  Although the concept as defined in the 1980s is unpopular 
today, recent literature has also addressed the role of non-coding RNAs as possible 
molecular scaffolds. A 2014 study found that C0T-1 RNA, transcribed from 
interspersed repetitive elements, associates with chromatin in a fractionation 
resistant manner, occupies defined chromosome territories and persists after 
transcriptional inhibition (Hall et al. 2014). A well-studied example is also provided 
by XIST, a 19 kb long non coding RNA expressed from the X chromosome, which is 
essential for the process of X chromosome inactivation. XIST localises precisely to 
the territory occupied by the inactive X and maintains its association even after 
histone extraction (Clemson et al. 1996).  Yet another case is HOTAIR, a long non-
coding RNA which associates with target genes and targets the silencing PRC2 
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complex (Rinn et al. 2007), illustrating the duality of functional and structural roles 
integral to most chromatin components. 
One of the hnRNP proteins identified as a component of the nuclear matrix is 
hnRNPU, also called SAF-A. SAF-A is an abundant nuclear protein which was first 
identified among proteins bound to the matrix attachment regions (Romig et al. 
1992). It has been implicated in many processes, including splicing, mitotic 
progression and DNA repair (Britton et al. 2014; Ma et al. 2011). Recent data from 
the Gilbert lab (Ryu-suke Nozawa, mnuscript in preparation) indicates that SAF-A 
affects DNA structure at transcriptionally active regions- depletion of SAF-A results 
in a change towards more compacted chromatin states. Interestingly, SAF-A 
depletion also resulted in an increase in gammaH2AX staining, implying an exciting 
link between this structural chromatin component, chromatin compaction and 
genome instability. 
1.2.6  Methods for investigating large scale chromatin 
structure 
Two complementary methods are often used to study the 3D organisation of the 
genome at the level of higher order domain structure: FISH-based methods and 
chromosome confirmation capture methods (Bickmore & van Steensel 2013). FISH 
relies on hybridisation of fluorescently labelled probes to visualise individual loci, 
defined portions of the genome or whole chromosomes. It provides a snapshot of 
nuclear structure at the single cell level, but disadvantages are that it is time-
consuming and provides a limited amount of information at a low resolution. 
Chromatin conformation capture (3C) techniques rely on “freezing” the nuclear 
structure by cross-linking interactions within the nucleus, ligating DNA fragments 
held in proximity by the cross-links, followed by PCR or next-generation sequencing 
to identify hybrid DNA fragments, indicative of contacts. At the most sophisticated 
end, these techniques can theoretically identify all possible interactions throughout 
the genome, but there are also disadvantages. Unlike FISH, 3C techniques work on 
populations of cells rather than at a single cell level, producing a population average 
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which may reflect a number of different contact configurations at the single cell 
level. Despite the caveats, 3C methodologies have been very influential in the field 
of 3D genome organisation, contributing the concept of topologically associating 
domains (TADs), defined as regions measuring ~900 kb, where contact maps show 
increased interactions. The full human genome is divided into approximately 2000 
TADs which also overlap with the distribution of histone marks and other genomic 
features such as replication timing (described in Section 1.2.7). However, they are 
not cell-type specific and the question of what level of structural organisation they 
reflect and their functional importance is still open to debate. Interestingly, the 
translocation frequency pattern seen with chromosome territories can be also 
traced to the TAD level of organisation-a study conducted in B-cells found that the 
likelihood of translocation between two loci is strongly related to the contact 
frequency between them, as defined by chromosome confirmation capture-
generated contact maps (Zhang et al. 2012). 
As the only techniques currently available to study higher order chromatin 
structure, a natural question is how to reconcile the results produced by 
conformation capture techniques and FISH. FISH-based studies have shown that 
probes located within a TAD are physically closer than probes not located within the 
same TAD but separated by a similar “linear” genomic distance (Bickmore & van 
Steensel 2013; Nora et al. 2012).  On the other hand, confirmation capture 
generated maps sometimes indicate physical contacts between loci separated by 
very large linear distances, such as whole chromosome. A study at the HoxD locus 
drew attention to the fact that results from the two techniques are not always 
compatible and urged caution when interpreting results (Williamson et al. 2014). 
Despite caveats, FISH and conformation capture techniques have transformed our 
understanding of higher order chromatin structure and many efforts are under way 
to improve them and transcend their limitations. The chromosome conformation 
capture technique has been combined with sequence capture methodology to yield 
Capture-C, a technique that allows higher resolution mapping at defined genomic 
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loci for reduced sequencing costs. A high-throughput FISH assay has also been 
developed (Shachar et al. 2015). An exciting development has come from utilising 
the Cas9-CRISPR system to label and monitor endogenous loci using live imaging 
(Chen et al. 2013). As a novel method, this technique has been mostly limited to 
repetitive loci and currently requires a large number of gRNAs which render it 
impractical for most uses. However, it promises to provide unprecedented insight 
into real time chromatin dynamics in future. 
1.2.7  Transcription and replication in the nucleus 
The structurally and functionally complex chromatin structure described above 
exists as the background for the two most important genomic processes-
transcription and replication. Therefore, chromatin should always be considered in 
the context of these two fundamental processes. As we have seen above, the 
nucleus is a site of many correlations: radial position, gene density, histone mark 
enrichments and transcriptional activity.  
Another correlation comes from the process of replication: the exact timing of 
replication of a locus also correlates with its nuclear position, as well as with its 
transcriptional activity. Replication proceeds in a well-controlled timely manner 
across the genome: alternating segments of chromosomes replicate at different 
times throughout S-phase, with gene-rich, transcriptionally active segments 
replicating early in S-phase and heterochromatic regions replicating last. These 
replication domains measure from 400 to 800 kb and control of replication timing is 
achieved by simultaneous firing of clusters of origins within the replication domains 
at defined times during S-phase. The correlation between replication timing and 
nuclear position is so strong that it gives rise to striking S-phase patterns visible in 
nuclei stained with markers of active replication early replicating cells show diffuse 
staining with markers excluded from the nuclear periphery; cells in mid-S have 
speckled patterns; and in nuclei in the latest stages of replication the staining 
overlaps with the nuclear periphery and heterochromatic regions. Replication 
timing domains partially overlap with TADs, however some replication domains are 
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cell-type specific and change during development and differentiation, along with 
changes in transcription. About 80% of the genome has constant replication timing 
between cell types, with 50% showing development and differentiation-related 
changes (Ryba et al 2010).  
A few studies to date have tried to separate out the effects of chromatin state, 
transcription and replication timing to investigate the real determinants of nuclear 
positioning. A recent study by the Bickmore lab indicated that the chromatin 
compaction state may be the primary factor, whilst replication timing was shown to 
be a consequence of transcriptional state (Therizols et al. 2014). However, other 
studies have argued that replication plays a role in the establishment of nuclear 
organisation. A recent chromatin confirmation capture study revealed that TAD 
structure is established during early G1, at the same time as the replication timing 
program (Dileep et al. 2015). Another recent study used high throughput FISH to 
screen for factors affecting nuclear positioning of a small number of loci; it found 
that a number of replication-related proteins significantly affected positioning and 
also that replication was needed to maintain correct nuclear  positioning (Shachar 
et al. 2015). 
1.3 Chromatin changes throughout the cell cycle 
Most of the in vivo studies in the field of chromatin research have been focused on 
cells in interphase and G1 cells in particular. However, chromatin structure is not 
static and undergoes many changes throughout the cell cycle to facilitate the 
replication of the genome and its equal separation between daughter cells during 
the process of cell division. 
1.3.1 Chromatin changes during replication 
The duplication of the genome is a challenging time for chromatin: it necessitates 
the disruption of chromatin fibres to individual nucleosomes, their subsequent 
reassembly, maturation of the nascent chromatin fibre and re-establishment of the 
preceding epigenetic states.  
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The replication fork passage through a chromatin fibre causes displacement of 
nucleosomes. The rate of nucleosome displacement is very high: assuming a fork 
speed of 2-3 kb/min amounts to 10-15 nucleosomes displaced per minute. Upon 
displacement, each parental nucleosome is split into two H2A-H2B dimers and an 
H3-H4 tetramer, which remain in the vicinity of the replication fork. These parental 
histones are then recycled back onto the nascent DNA strands, split in a random 
manner between the parental and the daughter. The recycling of parental histones 
is not an entirely passive process: histone chaperones, such as FACT and ASF1 act as 
acceptors of the ejected histones and deposit them onto the newly replicated DNA.  
These recycled parental histones carry the PTMs they have acquired prior to 
replication, allowing the local histone landscape to be propagated. In addition to 
the recycled histones from the previous cell cycle, newly synthesised histones are 
also deposited on the nascent DNA-experiments utilising SILAC pulses to mark old 
histones showed a nearly equal rations of old to new histones in replicated 
chromatin (Alabert et al. 2015). In the case of H3 and H4, they are placed as a dimer 
by the chaperone CAF-1, which in turn is targeted to sites of active replication via an 
interaction with the replication clamp protein, PCNA. A well-known characteristic of 
newly synthesised H3 and H4 histones is that they are acetylated; the acetylation 
marks are then removed 20 to 60 minutes following replication. An interesting 
suggestion is that the presence of these acetylated histones on the nascent 
chromatin allows a window of time in which the chromatin structure is more open 
and amenable to DNA repair processes and re-establishment of transcription. 
However a failure to remove that de-acetylation can be detrimental: HDAC1 can be 
found at sites of active replication and it is possible that some of the negative 
effects of HDAC inhibitors could be associated with a failure to restore the 
chromatin state following replication (Milutinovic et al. 2002). The demand for 
synthesis of classical histones is unique to the S-phase of the cell cycle. Their 
production is tightly regulated to avoid both insufficient histone supply and 
accumulation of unincorporated histones. The rate of replication is also affected by 
the availability of histones; DNA combing experiments in conditions of reduced 
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histone supply showed that fork speed slows down and S-phase was prolonged 
(Mejlvang et al. 2014). 
Following the initial deposition of histones, chromatin “matures”. This process can 
be assayed by digestion of newly synthesised chromatin with DNase. Such 
experiments were first performed as early as the 1980s and found that recently 
replicated DNA was more easily digested than bulk chromatin (Cusick et al. 1983). 
Later studies demonstrated that newly synthesised chromatin starts to produce a 
nucleosomal periodicity comparable to pre-replication chromatin within 10 to 20 
minutes post-replication. This reinstatement of the preceding chromatin structure is 
termed “maturation”. 
Further to the question of restoring chromatin structure post replication is the 
question of restoring epigenetic states. The maintenance of epigenetic states in 
chromatin is a complex process, impacted by many modifying enzymes and 
transcriptional activity. During replication, these states are transiently disturbed; in 
most cases, epigenetic states are restored through the incorporation of parental 
histones and the symmetrical recovery of the marks they carry. However, this is not 
the case with states determined by some histone variants which cannot be 
incorporated during replication- for example, domains of H2A.Z marking 
transcriptionally active regions are depleted after replication.  Comparison of 
histone composition of pre and post-replication chromatin shows that histone 
marks are diluted two fold in newly assembled chromatin and are then gradually 
restored until the marks reach pre-replication levels, contrary to an alternative 
model where marks are restored immediately on new histones in replication-
coupled manner. An extreme case are the H3 repressive marks H3K9me3 and 
H3K27me3- full restoration for them can take more than a single cell cycle (Alabert 
et al. 2015).  Interestingly, replication stress has been shown to affect histone marks 
on ASF1 associated histones, suggesting it may interfere with the re-establishment 
of epigenetic states (Jasencakova et al. 2010). 
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1.3.2 Chromosome compaction in mitosis 
Following replication, the next major cell-cycle related change is the compaction of 
chromosomes for mitosis. The folding of chromosomes in preparation for mitosis is 
the most radical structural change the genome undergoes throughout a cell’s 
lifetime. It achieves a 10,000 times level of folding compared to the linear DNA 
molecule and results in reproducible chromosome morphology and binding 
patterns. Despite the fact that this process has fascinated biologists for decades, 
neither the underlying molecular events, nor the resulting fine structure of the fully 
compacted metaphase chromosomes are resolved at present. 
Attempts to deduce the chromatin structure of a fully compacted metaphase 
chromosome can be traced back to the 1970s, when SEM and TEM techniques were 
first used to image isolated chromosomes. Decades of electron microscopy imaging 
and multiple adjustments to the sample preparation methods yielded many models 
of chromosome folding, some of which show significant compatibility with modern 
molecular data. Among them are the radial loop model and the successive helical 
coiling model. In the radial loop model, loops of higher order chromatin fibres are 
arranged radially around a proteinaceous scaffold. The helical coiling model is based 
on observations of metaphase chromosomes prepared under specific conditions 
(such as hypotonic shock and in the presence of urea) in which the sister chromatids 
are seen to follow a helical, zig-zag path. Similarly to the radial loop model, 
chromatin loops are radially arranged around a proteinaceous scaffold, however in 
this model the scaffold is twisted in a helical path. More complicated models 
envision a hierarchy of folding structures which may be not be sequentially formed 
(Belmont et al. 1987). In recent years, novel imaging approaches have signalled the 
end of the EM era of chromosome analysis. Nowadays, atomic force microscopy 
(AFM) and super-resolution methods such as SIM and STORM promise to provide 
further insights into mitotic chromosome structure, however passive observation of 
isolated chromosomes will always have a supplementary role to molecular 
investigations of the processes involved. 
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Atomic force microscopy (AFM) is a type of microscopy which uses a scanning probe 
with a sharp tip over the surface of a sample, measuring the force between the 
probe and a sample to determine the properties of the sample. AFM studies on 
metaphase chromosomes have identified features named ridges and grooves along 
the length of the chromatids. Ridges correspond to the Giemsa positive, AT-rich 
bands (G-bands) and grooves correspond to the Giemsa-negative R-bands.  Ridges 
and grooves are roughly symmetrical on sister chromatids. In addition to the ridges 
and grooves, globular structures can be seen on surface of chromosomes, which 
appear to be produced by strongly twisted fibrous structures measuring 50-nm in 
size. The twisted structures are more tightly packed in ridges and sparser in groves. 
This observation could reflect an underlying structural difference between the 
folding of gene-poor and gene-rich bands or could reflect preferential extraction of 
proteins from the grooves during the preparation procedure. Another observation 
from AFM imaging of mitotic chromosome is the presence of fibrous structures 
measuring 50-60 nm which appear to connect the two sister chromatids. These 
structures are present throughout the chromosome in prometaphase, but can only 
be seen in ridges in late metaphase (Ushiki & Hoshi 2008).  
A major drawback of EM and AFM is the complex sample fixation and preparation 
procedure, which may distort the chromosome structure and limit information 
about the behaviour of chromatin in live cells. Due to that, live imaging studies may 
be needed to complete the picture of mitotic folding. A good example is a 2015 
study using live imaging in cells expressing fluorescent H2B, allowing observation of 
chromatin movement in the period between prophase and metaphase (Liang et al. 
2015). Authors found that chromatin became less dense from mid-prophase to late 
prophase, then denser in metaphase, suggesting that chromatin expands and then 
contracts in the run-up to metaphase. In addition, they could observe the 
individualisation of each sister chromatid in late prophase by imaging topoII, 




As a step away from imaging based methods, chromosome confirmation capture 
has also been used in an attempt to define the mitotic chromatin structure 
(Naumova et al. 2013). However, these experiments were more successful in 
stressing the differences between interphase and mitotic chromatin organisation 
than defining mitotic structures. The contact maps generated from cells in G1 and S 
phase differed sharply from contact maps from mitotic cells; the well-described TAD 
compartments present in interphase cells were absent in mitosis. Instead, a linear 
decrease in contact probability could be seen with an increasing genomic distance 
up to 10 Mb, followed by a sharp drop off in the contact frequencies for distances 
larger than 10 Mb, reflecting the linear nature of mitotic chromosomes. However, it 
is arguable if Hi-C, a technique optimised in interphase cells, can be informative 
when applied to the dense, protein-rich structures of mitotic chromosomes. 
In addition to the histone: DNA fibres, metaphase chromosomes have a central 
structural axis made up of topoII and condensin I and II. The concept of 
chromosomal axis was first defined in experiments in which histones were removed 
from chromosomes; histone-depleted chromosomes appeared as halos of DNA, 
interpreted as chromatin loops, surrounding a central proteinaceous structure 
(Adolph et al. 1977). The scaffold is thought to anchor chromatin loops, however its 
fine structure and mode of interaction of DNA is not defined. TopII, condensin I 
and condensin II can be seen localising to the axis in an alternating manner and 
depletions of either one of the three proteins results in changes in chromosome 
morphology. In addition to changes in morphology, condensin depletion, also 
changes the elasticity of chromosomes, suggesting that axis formation is important 
for withstanding the stress of chromosome segregation and potentially, the 
contraction and expansion cycles leading to compaction. Live imaging has shown 
splitting of the axis during late prophase, which in turns precedes the parting of 
sister chromatids.  
Another important signal of mitotic compaction is the cell-cycle dependent 
phosphorylation of the serine 10 position of H3.  H3 phosphorylation, driven by the 
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Aurora B kinase, starts to appear in late G2 and peaks at metaphase.  Good 
correlation can be observed between H3 phosphorylation and chromosome 
condensation and it is well-known that drugs which can induce H3 phosphorylation 
also induce premature chromosome condensation-a process in which chromosomes 
condense independently of cell cycle stage (Wei et al. 1999). However, such drugs 
are not specific enough to establish causality between H3 phosphorylation and 
condensation. H3 is de-phosphorylated in anaphase in a process which precedes 
microscopically visible decondensation in telophase. However, dephosphorylation 
of H3 has also been described in the absence  of chromosome decondensation, 
suggesting a complicated relationship between the two (Magalska et al. 2014). 
An interesting example of specialised mitotic chromosome structures is presented 
by telomeres. Telomeres are ribonucleoprotein structures composed of kilobases of 
conserved TTAGGG repeats, covered by the protective shelterin complex. Telomere 
structures mask the ends of chromosomes to prevent DNA damage signalling and 
inappropriate repair; instead, a single stranded, G-rich strand at the end of the 
chromosome invades the conserved repeat sequences, forming a structure known 
as a T-loop. A helicase, RTEL1, has been shown to disassemble T-loops to facilitate 
replication of telomeres (Vannier et al. 2012). Depletion of the shelterin component 
TRF1 led to activation of DNA damage signalling and the appearance of “fragile 
telomeres”, suggestive of disrupted chromatin structure at telomeres in mitosis 
(Sfeir et al. 2009).  
1.3.3 Decompaction and reorganisation of nuclear 
architecture 
The process of reversal of mitotic folding and restoring interphase chromatin 
structure is also not well understood. Broadly, two stages, likely driven by different 
processes, can be recognised. The cytologically visible compaction is lost in the 
transition between anaphase and telophase, while a full re-establishment of nuclear 
architecture is not achieved until two hours into G1, when chromosome territories 
assume their preferred positions and the topological compartments are restored. 
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The initial, cytologically defined stage of decompaction is extremely fast and the 
underlying molecular events are not well understood. It is debated whether this 
quick decondensation results from a simple reversal of the molecular changes 
implicated in the compaction process: for example, condensin release from 
chromosomes and de-phosphorylation of H3, both of which happen in anaphase. 
However, observations of the decondensation of purified mitotic chromatin in 
Xenopus egg extracts indicated that ATP and GTP were necessary for 
decondensation and identified RuvB ATPases as factors that actively participate in 
the decondensation process (Magalska et al. 2014).  
Further to the microscopically obvious decompaction, finer-scale chromatin 
changes appear to be under way in early G1. As demonstrated by HiC experiments, 
the compartmentalised structure of the genome is lost in mitotic chromosomes. 
TAD domains and other features of nuclear organisation, such as the preference of 
gene-rich loci for the interior and gene-poor loci for the periphery are not re-
established in the process of anaphase to telophase decompaction. Instead, these 
features are recovered around 2 hours into G1, coinciding with the replication-
related origin decision point, in which the origins which will fire in the next S-phase 
are selected and the replication timing program is initiated (Dileep et al. 2015).  The 
molecular determinants of these two concomitant processes are unknown, but they 
could be driven by the presence of epigenetic marks or resumption of transcription 
by “bookmarking” transcription factors. Interestingly, HiC experiments at defined 
time points post mitosis showed that progression towards the re-establishment of 
TAD compartmentalisation is continuous and not sudden however it is unclear if 
that is a real finding or a result of asynchrony in the cell population. 
1.4 Chromatin and DNA repair 
A cell’s genome is frequently exposed to factors that have the potential to 
introduce changes in the DNA sequence ranging from point mutations to 
chromosome structural aberrations and even chromosome gain or loss. Classically, 
threats to genome integrity were perceived to come from external factors, such as 
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drugs, chemical compounds or UV radiation. A more current view is that internal 
factors and fundamental cellular processes such as transcription and replication also 
pose a risk to genome stability. 
Whatever the source of the threat, chromatin is the context in which the genome is 
assaulted and then repaired.  However, chromatin is more than just a passive 
background in the DNA damage response. It forms a dynamic structure that plays 
an active role in a cell’s response to genome damage and reacts to DNA damage 
with extensive changes to its structure and composition. The best accepted model 
describing chromatin dynamics upon induction of damage is the so-called “access, 
repair, restore” model (Green & Almouzni 2002). It postulates that to fully repair a 
damaged locus, chromatin first has to be disrupted to allow access to the damaged 
template, followed by recruitment of factors that facilitate the repair process and 
finally, a re-establishment of the initial chromatin structure and eviction of the DNA 
damage marks from the region.  Failure in this processes can result in serious 
predisposition to genomic damage and catastrophic consequences for the cell and 
the organism; due to that, our knowledge of mammalian DNA damage response 
would be incomplete without considering the contribution of the chromatin context 
and 3D organisation of the genome. 
1.4.1 Access, repair, restore 
As illustrated by the extensive role of chromatin remodellers in the DNA damage 
response, changes in chromatin conformation are essential for the repair process. 
There is some controversy about whether these changes are limited to the 
chromatin environment local to the break or whether they spread globally. Local 
changes have been demonstrated convincingly, using a variety of methods: HATs 
and HDACs are recruited to laser-induced tracks (Gong & Miller 2013) whilst high-
resolution imaging of chromatin in DNA repair foci shows chromatin in a state 
resembling a 10 nm fibre (Dellaire et al. 2009). Consistent with this, a live cell 
imaging study utilising a SceI/LacO system demonstrated local chromatin 
remodelling in the proximity of a break (Roukos et al. 2014).  In this study, authors 
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used a photo-activated GFP fused to H2A, allowing them to induce damage and 
photo-activate chromatin within the damaged region simultaneously. They then 
measured changes in the H2A-GFP spot size and were able to show rapid expansion 
of the spot area lasting 1.5 min, followed by a re-compaction phase lasting 15 min 
and then hyper-condensation beyond baseline level (20-30 min). A brief local 
decompaction, as demonstrated in this study, would enable access of the DDR 
proteins to breaks. Alterations in the transcriptional activity of a locus in the vicinity 
of a DNA break also accompany local compaction changes. Ubiquitination of H2A at 
break sites was shown to correlate with transcriptional silencing near break regions 
(Shanbhag et al. 2010) and  recruitment of the SWI/SNF remodeller PBAF is found to 
contribute to this silencing (Kakarougkas et al. 2014). However, a somewhat 
opposing finding was published in 2012, when Francia et al found evidence that 
transcription of small non-coding RNAs within a damaged region is required for the 
DNA damage response (2012). Whether the local changes in compaction and 
transcription spread globally is debatable. A 2006 study, using MNase digestion to 
assess genome-wide chromatin states, found evidence of global decondensation 
following DNA damage induction (Ziv et al. 2006). However a 2011 study found no 
evidence for global decompaction using the same approach or by sucrose gradient 
sedimentation to analyse the structure of soluble chromatin fibres (Hamilton et al. 
2011).   
Once the appropriate chromatin environment has been established, repair of the 
damage can proceed. The earliest step in the DDR involves rapid targeting of repair 
factors to the lesion and formation of DNA repair foci. The primary sensor is the 
MRN complex, composed of three different factors: MRE11, RAD50 and NBS1.  The 
MRN complex activates ATM, which in turn phosphorylates H2AX at the damage 
site and the flanking chromatin up to a megabase away (Rogakou et al. 1999), 
amplifying the damage signal. An interesting question in the field is whether a full 
DDR is initiated only in response to DNA breaks: surprisingly, not. Tethering of early 
repair components to genomic regions resulted in a full DNA damage response and 
cell-cycle arrest, indicating that breaks are not needed beyond the initial 
39 
 
recruitment of factors (Soutoglou & Misteli 2008).  Consistently, treatment of cells 
with the HDAC inhibitor TSA resulted in the activation of ATM raising the possibility 
that DDR can also be triggered by stimuli other than breaks, such as unusual 
chromatin structures (Lee 2007). 
Once the necessary factors have been recruited, repair can proceed. There are two 
main pathways for repair of double-strand DNA breaks - non homologous end 
joining (NHEJ) and homologous recombination (HR). Briefly, NHEJ works by joining 
the ends of the break together and is active throughout the cell cycle, while in HR, 
which is only possible in S and G2, the non-damaged homologous locus on the sister 
chromatid is used as a repair template. Interestingly, some recent evidence has 
shown that breaks located in transcriptionally active segments of the genome are 
preferentially repaired with HR, while breaks in less active regions are more 
frequently repaired vie NHEJ even as the cells transition into S and G2 (Aymard et 
al. 2014). The preferential recruitment of the HR machinery to breaks in transcribed 
regions is found to be dependent on an interaction between the H3K36me3 mark 
and LEDGF, a protein that promotes HR through CtiP recruitment (Daugaard et al. 
2012). 
1.4.2 Transcription, replication and DNA damage 
The processes of replication and transcription have been at the heart of a recent 
conceptual shift in the field of genome stability. While historically research on the 
DNA damage response was focused on external and severe mutagens such as UV 
light and carcinogenic drugs, recently it has become clear that DNA damage 
resulting from internal factors and fundamental cellular processes may be more 
physiologically relevant. A succession of recent studies have implicated replication 
and transcription as contributors to genome instability. For example a study in 2015 
determined that regions of very high mutation rates within the genome overlap 
with Okazaki fragment junctions; the underlying mechanism was found to be 
retention of short segments spanning the junctions synthesised by the error-prone 
DNA polymerase Pol-(Reijns et al. 2015). An earlier study identified replication 
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stress, physiologically present in cancer cells, as the root cause of structural and 
numerical chromosome instability in colorectal cancers with unstable karyotypes 
(Burrell et al. 2013). Transcription was implicated as a contributor to genomic 
instability in a publication by the Svejstrup lab-the authors found that inhibition of a 
transcription-associated helicase caused transcription speed to increase, resulting in 
recurrent chromosomal rearrangements at particular genomic regions (Saponaro et 
al. 2014). Another example is provided by the RNU1, RNU2, RN5S and PSU1 loci, all 
coding for tandemly repeated, highly transcribed small RNA sequences. These four 
loci exhibit fragility and appear as breaks on metaphase chromosomes upon either 
adenovirus infection or in the absence of the Cockayne syndrome group B (CSB) 
protein, which is mutated in Cockayne syndrome, a rare disorder characterised by 
neurological and developmental defects. It has been speculated that CSB loss 
causes RNA polymerase stalling and blockage at the RNU1, RNU2, RN5S and PSU1 
loci, which then interferes with chromosome condensation and consequently, the 
stability of the four regions (Yu et al. 2000). 
Unlike external factor-mediated instability, which usually arises from stoichiometric 
interactions of the damage-inducing agents with DNA and results in predictable 
outcomes, internally mediated instability is stochastic: it is likely to result from a 
combination of factors, including the exact chromatin context at the location where 
problems arise. While in the past most common strategies for studying the role of 
chromatin in genome stability involve triggering DNA damage through methods 
such as irradiation, laser marks or harsh damage-inducing agents such as 
hydroxyurea, it is clear that this new view of the field will require novel models and 
methods. A good model for how complex relationships between transcription, 
replication and chromatin influence genome stability is presented by common 
fragile sites (CFS). 
1.5 Common fragile sites 
CFS are regions of the genome prone to instability in response to replication stress, 
manifesting as beaks, gaps and constrictions on metaphase chromosomes. While it 
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is known that CFS fragility is triggered by replication stress, the exact events leading 
up to genomic instability are unknown.  As CFS fragility is cell-type specific- different 
genomic locations are fragile in different cell types- it is clear that factors beyond 
their sequence composition contribute to fragility; in particular, replication timing 
and transcription are considered important, while chromatin context is a promising 
but under-studied potential contributor. 
1.5.1 Characteristics of CFS loci 
The susceptibility of cytogenetically defined genomic loci to become fragile was first 
identified in the 1970s on metaphase chromosomes from phenotypically normal 
and disease-carrying individuals (Giraud et al. 1976). Today, over a 100 fragile 
genomic locations known to form lesions on metaphase chromosomes have been 
identified in humans and classified as either rare or common fragile sites. Rare 
fragile sites are caused by expansion of trinucleotide repeat sequences; they are 
present at a low frequency in the human population (less than 5%) and show 
Mendelian inheritance. In contrast, common fragile sites (CFS) are found in most 
individuals as a part of the normal chromosomal architecture when triggered by 
replication stress.  
Unlike rare fragile sites, CFS loci are not composed of repeat-rich sequences and 
features of the underlying sequences do not provide immediate clues to their 
fragility. However, these locations have shown a tendency for certain 
characteristics, which have guided theories about their fragility. The longest 
standing observation is that CFSs tend to be predominantly located in late 
replicating regions of the genome and that the timing of their replication is affected 
by aphidicolin. The preference of CFSs to late-replicating genomic regions was first 
inferred cytogenetically, via their localisation to late-replicating cytogenetic bands.  
An early study using FISH and immunofluorescence to define replication indicated 
that FRA3B is late-replicating and that its replication is further delayed in the 
presence of aphidicolin (Le Beau 1998). Replication changes in the presence of 
aphidicolin were also demonstrated for another fragile site, FRA7H (Hellman et al. 
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2000). Yet another FISH study, this time on the FRA6E locus, introduced a slightly 
different idea: the fragile region seemed to span a boundary between an early and 
late replicating region (Palumbo et al. 2010). The idea that CFS sites span early-late 
boundaries, rather than simply late regions has also been supported by a studies 
using consecutive staining for G-bands and R-bands to map fragile sites (Debatisse 
et al. 2006; El Achkar et al. 2005). With the advance of high-throughput sequencing 
technologies, more refined ways of mapping replication became available, including 
Repli-seq and small nascent strand (SNS)-seq. Large amounts of replication timing 
data have been generated and are now publically available.  However, analysis of 
whether CFSs align with late replication regions on the molecular level has been 
prevented by the lack of cell-type matched, aphidicolin-treated data and the fact 
that CFSs tend to be mapped at the cytogenetic, rather than the molecular level. 
Another consistent feature of CFSs across cell types is that they frequently harbour 
genes larger than 0.5 Mb. The tendency of CFSs to contain long genes was initially 
observed in lymphoblastoid cells but also held with fragile regions characterised in 
other cell types. More recently, a study mapping CFSs in a number of cell lines from 
different lineages defined a pool of possible CFS locations for all cell types, 
consisting of regions with genes larger than 300 kb (Le Tallec et al. 2013). An 
immediate question following from that observation is whether transcription of the 
encompassed genes matches with the cell-type specific expression of CFSs.  Efforts 
to correlate CFS fragility with gene expression in a cell-type specific manner have 
given conflicting results. A 2011 study showed a correlation between expression of 
the FHIT gene at the FRA3B fragile site and FRA3B fragility, accompanied by an 
increase in R-loop formation in the presence of aphidicolin (Helmrich et al. 2011). 
However a more recent study from 2013 failed to find a correlation between 
expression and fragility on a more genome-wide scale (Le Tallec et al. 2013).  The 
tendency for CFS regions to overlap with large genes has given rise to suggestions 
that their fragility may be due to interference between transcription and 
replication, which will be discussed in more details below.  
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Beyond replication timing and gene overlap, yet another similarity between CFS 
locations is seen at the sequence level.  CFSs tend to be enriched in low complexity, 
A/T-rich sequences, which are associated with increased flexibility of the DNA 
template. A/T-rich sequences were identified as a strong predictor of fragility in a 
2012 study which tried to identify features of CFS bioinformatically, selecting from 
multiple genomic features to build a logistic model including the features most 
predictive of the presence of fragile sites (Fungtammasan et al. 2012). Apart from 
the presence of A/T rich regions, authors identified R-bands and long distance from 
centromeres as other strong negative predictors, however many of the predictive 
genomic features are correlated and their separate influences are difficult to 
dissect. The enrichment of A/T sequences in fragile site regions is thought to be 
related to the propensity of such sequences to form secondary structures, which 
could cause stalling of replication forks. However, a sequence-based hypothesis of 
CFS fragility is bound to be incomplete, as it would not account for the cell type 
specific manner of CFS expression. 
1.5.2 CFS in evolution 
Cytogenetic studies show that the fragility of common fragile sites is conserved 
throughout mammalian evolution in syntenic chromosomal regions. Surprisingly, 
such regions of conserved fragility show a high degree of inter-species similarity at 
the sequence level, demonstrating that despite the local chromosomal instability, 
CFS do not accumulate mutations at elevated rates. 
CFS have been found in corresponding locations in apes and monkeys and their 
locations correspond to sites of evolutionary breakpoints (Ruiz-Herrera et al. 2002). 
CFS regions in mice correspond to syntenic human regions and have been reported 
at long genes which correspond to human CFS, for example GRID2 (associated with 
FRA4F), WWOX (FRA16D) and FHIT (FRA3B) (Helmrich et al. 2006).  Mouse tumour 
cells also exhibit instability at the FHIT locus (Shiraishi et al. 2001). 
At the human population level, CFS are assumed to be expressed within all 
individuals within a population. The main evidence for this comes from the fact that 
44 
 
the same cell lines derived from different individuals show fragility at similar 
locations. However, there is evidence that for lymphocytes at least, CFS expression 
levels may differ slightly between individuals, especially for locations that only show 
weak fragility. This was the case in a 2009 study which compared frequency of 
breakage at a large number of locations between three individuals (Mrasek et al. 
2010). Another, earlier study, sampled nine individuals and again found differences 
in the frequency of breakage at CFSs, both between individuals and also between 
cells from the same individual sampled at a different time (Craig-Holmes et al. 
1987). Overall, it appears that the most frequent CFS loci are consistently fragile 
between individuals, even if the breakage frequencies vary slightly. 
Overall, the evolutionary conservation of CFS as a feature of chromosome make up 
suggests that they are not selected against, they are an inevitable feature of 
chromosome organisation or they are beneficial for organisms. 
1.5.3 Models of CFS formation  
Most ex-vivo and tissue culture cells do not form cytogenetic CFS lesions 
spontaneously. Instead, CFS fragility can be induced by different methods, with 
each method causing instability in a distinct subset of CFS. The most frequent and 
widely studied common fragile sites are induced by low doses of the replication 
inhibitor aphidicolin (APH). Used at low doses, APH does not block replication 
entirely, but instead causes delayed replication and replication stress. The exact 
molecular events that lead up to the formation of metaphase lesions at aphidicolin-
induced common fragile sites are unknown. 
Three models have been proposed to explain how the induction of replication stress 
results in genomic instability in a locus-specific manner (summarised in Figure 1-2). 
The “replication fork collapse” model suggests that the AT-rich sequence of CFS 
makes them prone to forming secondary structures which contribute to replication 
fork stalling and collapse (Durkin & Glover 2007). The “transcription-replication 
collisions” model is based on the observation that fragile sites frequently span long 
genes, raising the possibility that CFS instability can be the result of concomitant 
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transcription and replication (Helmrich et al. 2011). The “replication-initiation 
paucity” model explains CFS fragility as a consequence of cell-type specific features 
of replication timing (Letessier et al. 2011). 
 
Figure 1-1 Models of CFS Formation: A. Origin density and model. Replication programmes are cell 
type specific. In the non-fragile cell context, the cell-type specific program specifies initiation 
events across the locus, avoiding instability. In the fragile context, paucity of initiation events 
forces replication forks to travel long distances across the locus, resulting in fragility. B.  
Transcription-replication collisions model. Co-occurring transcription and replication lead to CFS 
instability through replication perturbation and R-loop formation. C. Fork collapse model. The 
helicase complex travels ahead of the DNA polymerase, exposing single stranded regions that may 
form secondary structures. Replication fork collapses upon encountering non-B-DNA structures, 
leading to DNA breaks.  
The fork collapse model is built on a combination of two observations. The first is 
that the presence of aphidicolin appears to cause uncoupling of the replicative 
helicase MCM2-MCM7 from the rest of the replication machinery, leaving long 
stretches of uncoiled, RPA-bound single stranded DNA exposed (Walter & Newport 
2000). The second factor is the enrichment of flexible, A/T rich sequences at CFS, 
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which, when unwound and exposed by the uncoupling of the replication machinery, 
could form secondary structures that may result in stalling and collapse of the 
replication forks. The biggest flaw of this model is that it fails to explain the cell type 
specificity of fragile site expression and why sequences with similar A/T 
compositions as CFS remain stable in conditions of replication stress. Molecular 
data also appears to counteract the model – combing experiments at FRA6E 
demonstrated comparable fork speed to the rest of genome (Palumbo et al. 2010). 
A study of replication dynamics at the FRA3B locus also found that the speed of 
replication forks along the locus was not significantly different from the rest of the 
genome; in the presence of aphidicolin, there was a slow down of the fork and 
evidence of stalling at FRA3B but that was comparable to the rest of the genome 
(Letessier et al. 2011).  In support of the fork collapse model, two genetic disorders 
characterised by increased fragile site formation, Bloom Syndrome and Werner 
Syndrome, are caused by deficiencies of RecQ helicases specialised in resolving 
stalled replication intermediate structures (Mohaghegh et al. 2001). Werner 
syndrome is caused by a deficiency of the Werner syndrome protein (WRN), an ATP-
dependant helicase which efficiently unwinds structures resembling stalled 
replication bubbles such as Holliday Junctions (HJ). Cells derived from WRN-
deficient patients form breaks at CFS spontaneously in the absence of aphidicolin 
treatment, while in wild-type cells, an increased frequency of CFS formation is 
observed following WRN depletion (Pirzio et al. 2008). BLM syndrome is caused by a 
deficiency of the Bloom Syndrome protein (BLM) and is characterised by increased 
susceptibility to early onset cancers.  BLM resolves structures that mimic replication 
and recombination intermediates, such as HJs, via homologous repair in a manner 
which does not result in a crossover and BLM has been shown to localise to stalled 
replication forks in vivo (Sengupta et al. 2003). Cells from Bloom syndrome patients 
show an increased sensitivity to aphidicolin and an increased frequency of sister 
chromatid exchanges which could result from crossover-mediated repair of HJs by 
alternate nuclease complexes. Interestingly, in the absence of BLM and other 
Holliday junction dissolution mechanisms, extreme chromosome abnormalities 
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resembling multiple fragile site breaks are observed (Wechsler et al. 2011). 
Additional supporting evidence comes from a 2011 study demonstrating replication 
fork stalling at AT-rich sequences at the FRA16D fragile site, as would be expected if 
forks stalled frequently across the CFS sequence (Ozeri-Galai et al. 2011).  Overall, 
evidence suggests that fork stalling is implicated in CFS breaks, but is not sufficient 
to fully explain the sensitivity of these sites to replication stress. 
The tendency of fragile regions to encompass large genes has inspired a model 
suggesting that CFS instability results from collisions between the transcription and 
replication machinery.  Large genes require longer times for transcription, 
sometimes exceeding the length of a full cell cycle, indicating that transcription 
might be ongoing during S-phase.  Normally, S-phase transcription and replication 
are spatially separated in eukaryotic cells; most actively transcribed genes are early-
replicating and changes in transcription during development are accompanied by 
changes in replication timing (Hiratani et al. 2009).  In this model, aphidicolin 
treatment interferes with the temporal and spatial separation of replication and 
transcription at large genes, causing the occurrence of transcription and replication 
at fragile sites. The model speculates that concurrent transcription and replication 
can cause instability through the formation of RNA-DNA (R-loop) hybrids or through 
head-on collisions of the transcription machinery and the replication bubble, 
causing replication fork collapse. Efforts to correlate CFS fragility with gene 
expression in a cell-type specific manner have given conflicting results. A 2011 study 
showed a correlation between expression of the FHIT gene at the FRA3B fragile site 
and FRA3B fragility, accompanied by an increase in R-loop formation in the 
presence of aphidicolin (Helmrich et al. 2011). However a more recent study from 
2013 failed to find a correlation between expression and fragility on a more 
genome-wide scale (Le Tallec et al. 2013).  Furthermore, breaks at CFS are not 
restricted to transcribed regions and can also occur at intergenic sequences. 
Therefore unlike the RNU loci, active transcription is not required for induction of 
fragility at CFS suggesting that the transcription-replication collision model does not 
fully explain CFS lesion formation. 
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In the replication initiation paucity model of CFS formation, instability is caused by a 
cell-type specific lack of initiation events across fragile regions, forcing the forks to 
travel long distances to replicate CFS loci and causing the regions to remain 
unreplicated at the end of S phase in the presence of replication stress. Evidence 
supporting the model comes from a study demonstrating that a lack of initiation 
events across the well-studied FRA3B site correlates with its fragility in 
lymphoblastoid cells (Letessier et al. 2011); in contrast initiation events across the 
site were observed in fibroblasts, where FRA3B is stable. In addition, the authors 
demonstrated increased use of origins in response to aphidicolin treatment at the 
flanking regions, but not the core of FRA3B, showing that a failure to utilise 
additional origins during replication stress may also contribute to fragility. An 
identical analysis of replication timing across two common fragile sites in fibroblast 
cell lines showed a similar pattern of relatively large region, devoid of origins, where 
fork travel a long way to terminate over the CFS region (Le Tallec et al. 2011). 
Another study, using small nascent strand mapping to assay origins of replication, 
found four origins across a 50 kb region within the FRA3B locus but observed they 
were less efficient compared to origins in different parts of the genome (Palakodeti 
et al. 2009). Paucity of initiation events across large genomic distances is related to 
the so-called replication timing transition zones – areas separating domains with 
different replication timing. Alignment of CFS regions with such zones, based on 
molecular data, is consistent with a previous observation of cytogenetic CFS breaks 
localising at boundaries of early and late replicating chromosome bands. However, 
this model also appears to be incomplete, since not all genomic regions devoid of 
origins form active fragile sites. 
 To date, no model has been found to exclusively explain the cell-type specific 
fragility or CFS loci and it is likely that aspects of all three models contribute to CFS 
instability. While all models converge on the idea of replication perturbations 
increasing the likelihood of CSF regions remaining unreplicated or uncompacted, no 
full mechanistic explanations have been proposed yet. In addition, all models fail to 
consider a possible role for the local chromatin environment.  
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1.5.4 Fate of CFS in the cell cycle 
Unlike other models of genomic instability, fragile site instability appears to be 
linked to cell cycle progression. As the cells move through the cell cycle in 
conditions of replication stress, fragile site regions are thought to escape the G2/M 
checkpoint unreplicated, giving rise to single stranded lesions. Alternatively, it is 
feasible that CFS regions are fully replicated in G2, but fail to compact correctly or 
that sister chromatids fail to separate post-replication, forming late-replication 
intermediates and catenanes. This idea is supported by evidence that the process of 
chromosome condensation and sister chromatid separation that precedes mitosis is 
dependent on successful and timely replication. In S. cerevisae, unreplicated DNA 
fails to condense prior to mitosis and condensin binds at replication termination 
sites (Dulev et al. 2008). Condensin binding at replicated sites has also been 
demonstrated in HeLa cells (Ono et al. 2013). The Hickson group has suggested that 
unreplicated CFS catenanes are marked by the DNA damage Fanconi anaemia 
pathway protein FANCD2 from G2 to mitosis (Chan et al. 2009). These FANCD2-
marked twin foci have been observed on sister chromatids in metaphase 
chromosomes and can be seen to be physically linked following APH treatment. The 
structure-specific nuclease MUS81-EME1, which has a preference for structures 
resembling late recombination intermediates, co-localises with FANCD2 to sites of 
ongoing replication in G2/M and aids sister chromatid separation (Naim et al. 2013). 
Interestingly, multiple studies have reported that depletion of MUS81 results in a 
decrease in cytogenetically visible CFS breaks, suggesting that the structure specific 
nuclease is necessary for break formation.  In metaphase, a mixture of breaks, gaps 
and constrictions can be seen at CFS loci on compacted chromosomes following 
replication stress. This diversity may reflect a mix of underlying structures such as 
double stranded DNA breaks, single stranded DNA breaks, compaction failures with 
uncompacted DNA bridging the gaps, and sister chromatid concatenations. In 
anaphase, ultra-fine bridges (UFB), DNA structures connecting daughter DNA 
masses, have also been linked to CFS formation. Like CFS, UFBs increase in 
frequency following aphidicolin treatment. A subset of UFBs are also characterised 
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by the presence of symmetrical FANCD2 foci at each side of the bridge, leading to 
suggestions that FANCD2-positive UFBs form specifically at CFS regions. This has yet 
to be confirmed, raising the question of whether UFBs represent a stage of CFS 
formation or resolution. As aphidicolin-treated cells progress through to the 
following G1, a subset of DNA damage response proteins form foci at increased 
frequency compared to non-treated cells. 53BP1, a DNA damage response protein 
known to promote end-joining repair of double stranded breaks, forms twin foci at 
fragile sites following APH treatment (Harrigan et al. 2011). This may indicate that 
damaged CFS foci might form breaks following mitosis and become subsequently 
sequestered for repair. Interestingly, under conditions of MUS81 depletion, which 
leads to reduction in the frequency of breaks in anaphase, the number of CFS-
associated 53BP1 foci in G1 is actually increased, indicating that metaphase lesions 
may be a necessary step in the processing of CFS through the cell cycle (Naim et al. 
2013). 
As CFS appear to be processed throughout the cell cycle, it is interesting to consider 
how their fragility may be propagated through the cell cycle stages. Replication 
stress during S phase leads to mitotic problems and subsequent sequestering of CFS 
in 53BP1 foci in the following G1. It is easy to envisage that this damage-inducing 
cycle could intensify the problems at CFS loci in subsequent cell cycles under 
conditions of sustained replication stress. 
1.5.5 CFS and disease 
Although CFS are considered a normal feature of chromosomes and appear to be 
present in all individuals within a population, a small number of monogenic 
disorders are associated with increased fragility of CFSs or increased sensitivity to 
aphidicolin. These include the previously mentioned Bloom and Werner syndrome, 
as well as Seckel syndrome, caused by insufficient ATR levels (Casper et al. 2004).  
In addition, CFSs are well known to form sites of frequent deletions translocations 
and amplifications in tumours. A large proportion of homozygous deletion clusters 
genotyped in a panel of cancer cell lines were associated with CFSs (Bignell et al. 
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2010). The contribution of CFS-related changes to the tumour mutational landscape 
is likely to be under-appreciated due to a difficulty in matching tumour types to 
tissue specific CFS expression patterns. Recently, an extensive mapping study found 
that some of the most frequent deletions in human cancers overlap with defined 
CFS and speculated that this overlap is likely to increase as more CFSs are mapped 
(Le Tallec et al. 2013).  An important question is whether CFS-associated genomic 
changes in cancer are causal in the tumorigenesis process or just a by-product of 
endogenous replication stress present in cancer cells. In support of a causal 
relationship, some CFS overlap with known tumour suppressor genes, for example 
FRA3B, FHIT, FRA16D and WWOX. On the other hand, prolonged over-expression of 
the oncogenes cyclin E and H-Ras induced CFS breaks in BJ fibroblasts, indicating 
that the context of a tumour cell is sufficient to induce CFS fragility (Miron et al. 
2015). Surprisingly, each oncogene induced a subtly different subset of CFS, hinting 
at the complex pathways behind CFS expression. In the case of over-expression of 
cyclin E, another study pinpointed the cause of endogenous replication stress and 
CFS breakage to replication in conditions of reduced nucleoside concentrations 
(Bester et al. 2011). Nucleoside supplementation also rescued replication-stress 
induced structural aberrations in CIN+ cancer cell lines, illustrating how the complex 
dis-regulated environment can result in instability at sensitive locations even in the 
absence of selective pressures (Burrell et al. 2013). Overall, the propensity of CFS to 
mutate in tumour cells suggests that the pharmacological induction of fragility with 
aphidicolin is representative of a physiological process of CFS instability. 
1.6 Thesis Aims 
Common fragile sites present a complex and physiologically relevant model of 
genomic instability. Although their appearance on metaphase chromosomes has 
been observed for decades, the exact reasons for their fragility and their 
significance have remained uncharacterised. Replication timing, transcription 
through long genes and difficult to replicate sequences have been the three factors 
implicated to date, however none of the proposed models are able to fully explain 
the fragility of CFS. In addition, all of the three factors have been considered 
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separately and never in conjunction with each other for a distinct set of fragile sites.  
Given the cell type specificity of fragile sites and the role of chromatin as a template 
for all of the processes that may give rise to instability, it is surprising that 
chromatin structure has never been investigated at active fragile sites. The aim of 
my project was to map transcription, replication timing and chromatin structure 
throughout the cell cycle for a set of fragile sites to determine the contributions of 
each of these three factors as determinants of fragile site instability.  
One of the unresolved issues with regard to fragile sites is the exact nature of the 
lesions observed on metaphase chromosomes. While they were initially interpreted 
as double stranded or single stranded DNA breaks, the current pervasive idea is that 
they may represent regions of uncompacted DNA rather than physical breaks. A 
new idea is also that the cytogenetic breaks may be a necessary step in the 
processing of CFS, as indicated by the facts that they do not result in cell cycle arrest 
and that reduction in the number of lesions caused by depletion of Mus81 led to an 
increase in the number of CFS-associated DNA damage foci in the following G1. 
Therefore, I aimed to investigate the underlying chromatin structure at CFS in 
mitosis, both at chromosomes that carried lesions and also cytogenetically intact 
chromosomes. I performed these investigations by hybridising fluorescent probes 
mapping to fragile sites to chromosomes derived from cells exposed to replication 
stress and premature chromosome condensation as well as control cells.  
I also characterised RNA expression levels across a number of active and inactive 
CFSs to determine if there is a simple linear correlation between transcription and 
fragility at my selected CFSs subset. Then, I used CRISPR genome editing to modify 
transcriptional levels of an active fragile site and determined the effects of these 
changes on the fragility of the locus. Although replication timing has always been 
seen as a strong contributor to CFS fragility, it has never been mapped in 
conjunction with CFS expression and in the presence of aphidicolin. I mapped 
replication timing in two cell types expressing characterised CFSs in the presence 
and absence of aphidicolin using an improved version of a previously developed 
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technique, Repli-seq. Finally, I investigated large scale interphase chromatin 
structure at active CFSs throughout the G1-S-G2 transition in the presence and 






















2 Chapter 2:  Materials and Methods  
 
2.1 General Reagents, stock solutions and buffers 
2.1.1 Sources of reagents  
Chemicals were purchased from Sigma Aldrich, BDH Laboratory Supplies (AnalaR, 
VWR), Fisher Chemicals, and Amersham Biosciences (GE Healthcare). Enzymes were 
obtained from New England Biolabs, Promega, Roche or Life technologies. Cell 
culture reagents were purchased from Gibco (Invitrogen) unless otherwise stated. 
2.1.2 Stock solutions and buffers 
Alkaline lysis solutions: 
Buffer P1: 50mM Glucose 25mM Tris pH 8, 10mM EDTA 
Buffer P2: 0.2M NaOH 1% (w/v) SDS 
Buffer P3: 3M KoAc pH 5.5 
Buffer 1: 0.1 M Tris-HCl pH7.5, 0.15 M NaCl 
Chloramphenicol: Stock solution was prepared by dissolving chloramphenicol 
powder in ethanol to a concentration of 25mg/ml 
CuTBTA (Copper-Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) ligand 
complex: The CuTBTA complex was prepared by dissolving 25 mg of copper (II) 
sulfate pentahydrate (Sigma Aldrich, Cat No 451657)  in 5 ml distilled water and 
mixing this solution with 116 mg of TBTA (Sigma Aldrich, Cat No 678937) dissolved 
in 5.5 ml DMSO. 
DNA Gel Loading Buffer: 5xTBE with 40% Sucrose (w/v) and 0.25% Orange G (w/v) 
FISH Hybridisation buffer: 50% deionised formamide (v/v), 10% dextran sulphate 
(v/v) 1% Tween 20 (v/v), in 2x SSC. 
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Genomic Lysis Buffer: 150mM NaCl, 0.5 % SDS (v/v) and 10mM EDTA. 
Luria-Bertani (LB) Agar: Prepared by the addition of 10g of tryptone, 5g of yeast 
extract, 10g of NaCl and 15g of agar to 1 litre of water. It was brought to pH 7.0 by 
the addition of Sodium Hydroxide. Was prepared by technical services at the MRC 
Human Genetics Unit. 
Luria-Bertani (LB) Broth: Prepared by the addition of 10g of tryptone, 5g of yeast 
extract and 10g of NaCl to 1 litre of water. It was brought to pH 7.0 by the addition 
of Sodium Hydroxide. Was prepared by technical services at the MRC Human 
Genetics Unit. 
Phosphate Buffered Saline (PBS): Dulbecco’s PBS (without Ca2+ and Mg2+) was 
10mM Phosphate, 137mM NaCl and 27mM Potassium Chloride. Made from tablets 
purchased from Unipath (Oxford) by technical services at the MRC Human Genetics 
Unit. 
SSC: 3M NaCl, 0.3M tri-sodium citrate, pH7.4 was prepared as a 20x stock by 
technical services at the MRC Human Genetics Unit. 
TBS-T Buffer: 50 mM Tris, 150 mM NaCl, pH 7, 0.05% v/v Tween-20 
TE: 10mM Tris HCl (pH7.6), 0.1mM EDTA prepared by technical services at the MRC 
Human Genetics Unit. 
Triethylammonium acetate buffer (TAB): 2M trimethylamine, 2N acetic acid, pH 7.7 
Tris Borate Buffer (TBE): 90mM Tris Borate, 2mM EDTA (pH 8.0) was prepared as a 
20x Stock Solution by dissolving 108g of Tris Base, 27.5g of Boric Acid in 40ml of 
0.5M EDTA and 960ml of water and was diluted before use. Was prepared by 
technical services at the MRC Human Genetics Unit. 
TSE I: 20 mM Tris-HCl, pH 8.1, 2 mM EDTA, 150 mM NaCl, 1% Triton, 0.1% (v/v) SDS  
TSE II: 20 mM Tris-HCl pH 8.1, 2 mM EDTA, 500 mM NaCl, 1% Triton, 0.1%(v/v)  SDS 
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Transfer Buffer for Western Blots: 25mM Tris-Glycine (pH 8.3) with 20% methanol 
(v/v) 3.03g of Tris Base and 14.4g of Glycine were dissolved in 800ml of water and 
200ml of Methanol was added. 
2.2 Bacterial Culture 
2.2.1 Media 
For liquid cultures, strains were grown in Luria-Bertani (LB) -broth (Table 2-1) in a 
shaking incubator (250 rpm) at 37°C for ~16 h. For selection purposes, LB-broth was 
supplemented with ampicillin or kanamycin as required. For solid agar cultures, 
ampicillin-resistent cells were grown on ampicillin L-agar plates provided by IGMM 
Technical Services. Chloramphenicol agar plates were prepared by pouring 25 ml of 
L-Agar supplemented with 34 g/ml chloramphenicol (Sigma-Aldrich, C0378-5G) in 
sterile petri dishes. 
2.2.2 Bacterial strains 
DH5 cells (Invitrogen) cells were used for routine cloning. JM109 High Efficiency 
Competent Cells (Promega) were used for TA-cloning. DH10B cells were supplied by 
BACPAC resources and used for propagation of BAC and fosmid clones. 
2.2.3 Growth of BACs and fosmid clones 
BAC and fosmid clones were obtained from BACPAC resources as agar stabs. A 
single colony streaked from a glycerol stock was inoculated into 5 ml L-broth. 
Bacteria were grown as described earlier but incubated at 37°C in the presence of 
chloramphenicol (34 µg/ml). 
2.2.4 Bacterial glycerol stocks 
For long-term storage of bacteria, glycerol stocks were prepared by adding glycerol 
to a final concentration of 20% v/v to 500 l overnight culture and stored at -80°C.  
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2.2.5 Transformation of E. coli 
All constructs were grown in Library Efficiency DH5α competent cells (Invitrogen). 
For transformation 50 µl of cells were thawed on ice. 50 ng of ligated constructs 
were added to the cells, followed by an incubation for 15 min on ice. The cells were 
heat-shocked at 42°C for 45 s and allowed to recover on ice for 2 min. 400 l of SOC 
media (Invitrogen) were added to the cells and the culture incubated at 37°C for 30 
min. Various dilutions of the culture were spread over L-agar plates supplemented 
with antibiotics as required. 
 
2.3 DNA methods 
2.3.1  Isolation of DNA from mammalian cells 
For extraction of DNA, cells were resuspended in Genomic Lysis Buffer. RNase A/T1 
mix (Thermo Fishcer Scientific, Cat No EN0551) was added to a concentration of 
5g/ml for RNase A and 12.5U/ml of RNase T1, followed by incubation at 37°C for 
30 minutes. Proteinase K was added to 150 g/ml and the solution was then 
incubated at 55°C for 2-16 h. An equal volume of Phenol: Chloroform: Iso-amyl 
alcohol (Invitrogen, Cat No 15593031) was added and mixed by vortex. Phases were 
separated by centrifugation (12,000 g, 15 min, RT) and the aqueous phase was 
removed to a new tube. The recovered aqueous phase was chloroform extracted 
with chloroform: IAA (containing chloroform: IAA in a 24:1 ratio) to remove residual 
phenol. 
DNA was precipitated by addition of sodium acetate (pH 5.5) to a concentration of 
0.3 M and 2.5 vols of ethanol, followed by 30 min to 16 h incubaton at -20°C. For 
small-scale extractions, 20 g of glycogen (Sigma-Aldrich, Cat No G1508-5G) were 
added prior to precipitation as carrier. DNA was pelleted by centrifugation at 
12,000g, 20 min, 4°C and the pellets washed with 500 l of 70% ethanol to remove 
residual salt. The DNA was re-centrifuged at 12,000g, 5 min, 4°C, the supernatant 
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was removed and the pellet dried at RT. DNA was resuspended in TE or ultra pure 
water and quantified on a Nanodrop 1000 UV-VIS Spectrophotometer (Thermo 
Scientific) by measuring the optical density at 260 nm. Sample purity was assessed 
by measuring the absorbance at 260 nm and 280 nm, where a 260/280 nm ratio 
ranging from 1.8-2.2 was considered pure. 
2.3.2  Gel electrophoresis of nucleic acids 
DNA fragments were resolved by electrophoresis through a 1% UltraPure Agarose 
(Invitrogen, Cat No 16500-500) gel in 1 x TBE buffer, supplemented with 0.5 g/ml 
of ethidium bromide (VWR, Cat No 443922U). Prior to electrophoresis, samples 
were prepared by adding 5 x gel loading buffer containing 5 x TBE with 40% Sucrose 
(w/v) and 0.25% Orange G (w/v) to a final concentration of 1x. Unless otherwise 
stated, 500 ng of 2-log DNA ladder (NEB, N3200S) was used as reference. Gels were 
visualised on a UV transilluminator. 
2.3.3  Extraction of DNA from agarose gels 
Fragments were resolved by gel electrophoresis as described above, but Sybr safe 
(Invitrogen, S33102) was used as a nucleic acid dye instead of ethidium bromide. 1 
l of 1:10 dilution of Sybr Safe was added to each sample prior to gel loading. Gels 
were imaged using a blue light and the gel slice containing the required DNA band 
was cut out with a razor blade. DNA was then extracted using QIAquick Gel 
Extraction kit (Qiagen, Cat#28704) according to the manufacturer instructions. 
2.3.4  Purification of plasmid DNA 
Small-scale isolation of plasmid DNA (typically 5 ml of overnight culture) was 
performed using a Qiaprep Spin Miniprep Kit (Qiagen, Cat No 27104) or E.Z.N.A 
Plasmid Mini Kit I (OMEGA bio-tek, Cat No D6942-01) following the manufacturer’s 
protocol. For large-scale isolation of plasmid DNA, 200 ml of overnight culture was 
prepared by diluting a starter culture 1:1000 in L-Broth. Plasmid DNA was isolated 




2.3.5  Purification of BAC and fosmid DNA 
BAC and fosmid DNA was purified from 5 ml of overnight culture using a rapid 
alkaline lysis mini-prep as recommended by BacPac resources. Cells were pelleted 
by spinning at 3000 rpm, 10 min at 4°C. Cell pellets were resuspended in 600 l 
buffer P1.  Lysosyme was added to the resuspended cell pellets to a concentration 
of 5 mg/ml, followed by 5 l of RNase A/T1 cocktail (ThermoFisher Scientific, 
EN0551). To lyse cells, 1.2 ml buffer P2 was added to the suspension and samples 
were mixed by inversion and incubated at RT for 5 min. To stop the lysis, 900 l of 
buffer P3 was added and samples were incubated on ice for 5 min. Samples were 
centrifuged at 13,000 rpm, 4°C for 20 min. Supernatants were collected and 
percipitated with an equal volume of isopropanol and 0.3 M sodium acetate (pH 
5.5) on dry ice for a minimum of 30 min. DNA was pelleted by centrifugation at 
13,000 rpm, 20 min at 4°C. DNA pellets were washed with 70% ethanol and spun at 
13,000 rpm, 15 min at 4°C. Pellets were air dried at RT and resuspended in 400 l 
TE. To further clean up DNA, 400l phenol-chloroform was added to the suspension 
and mixed by gentle inversion. Phases were separated by centrifugation at 13,000 
rpm for 10 min at 4°C. The aqueous phases were collected and residual phenol-
chloroform was removed by addition of 400 l chloroform: IAA. Samples were spun 
at 13,000 rpm for 10 min at 4°C, the aqueous phase was collected and precipitated 
with 2.5 vol of ethanol and 0.3 M sodium acetate (pH5.5) for a minimum of 30 min 
on dry ice or at -20°C. DNA was pelleted by centrifugation at 13,000 rpm, at 4°C and 
the pellets were washed with 500 l of 70% ethanol and spun at 13,000 rpm, 4°C 
for 15 min. DNA pellets were air-dried at RT and resuspended in 20 l TE.  
2.3.6  Restriction enzyme digestion 
DNA was digested with restriction enzymes as needed according to manufacturer’s 
instructions, typically in 10-20 l reactions. Restriction digestion products were 
analysed by gel electrophoresis. 
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2.3.7 Ligation of DNA fragments 
DNA ligation was performed with the Quick Ligation kit (NEB, Cat No M2200S) 
following the kit protocol. The vector and insert were ligated in a 1:3 molar ratio for 
5 min at RT in 1x Quick Ligase Buffer (NEB) with 1 ml of the Quick Ligase enzyme in a 
10 l reaction. 
2.3.8  PCR amplification of DNA sequences 
Unless otherwise stated, PCR amplification was performed using Taq DNA 
polymerase (Invitrogen, 10342020) in a 10 to 20 l reaction containing 10-100 ng of 
template DNA and 0.5 M concentration of the required primers. Standard cycle 
conditions are shown in Table 2-2.  Primer design was performed using Primer3  
(Untergasser et al. 2012) and verified using the In-silico PCR function of the UCSC 
Genome Browser (Kent et al. 2002). For each primer set used, the optimal annealing 
temperature was established by testing a range of annealing temperatures between 
55°C and 65°C.  
Stage Conditions 
1) 98°C for 3 min 
2) 98°C for 30 seconds 
3) 61°C for 30 seconds 
4) 72°C for 30 seconds 
5) Repeat Stage 2-5 for additional 29 cycles 
6) 72°C for 5 min 
Table 2-1 PCR program conditions 
2.3.9  Real-time PCR 
Real-time PCR was performed using LightCycler® 480 SYBR Green I Master Mix 
(Roche, Cat No 04707516001). Typically, 10 l reactions were set up with a final 
primer concentration of 0.5 M. Reactions were typically set up in duplicate or 
triplicate. Q-PCR was performed on a LightCycler® 480 System (Roche), using a 
standard 40 cycle program as per Roche master mix guidelines. Ct values were 




2.3.10 PCR purification 
Depending on the expected yield and fragment size of the sample, MinElute PCR 
Purification kit (Qiagen, Cat No 28004) or QIAquick PCR Purifictaion kit (Qiagen, Cat No 
28104) were used to purify amplification products from PCR reactions. Manufacturer 
protocols were followed. Samples were typically eluted in 10 l of ultra pure water for 
MinElute-purified samples and 30 l of ultra pure water for QIAquick-purified samples 
and stored at -20˚C. 
2.3.11 Sanger sequencing of DNA 
Sanger DNA sequencing was performed using standard techniques by IGMM 
Technical Services using appropriate primers. Dye terminator sequencing reactions 
were performed using BigDye (Invitrogen, Cat No 4337455) and processed on a 
3730 genetic analyser (Applied Biosystems). DNA sequencing data was analysed 
using Sequencher 4.10.1 (Gene Codes Corp). 
 
2.4 RNA methods 
2.4.1 Purification of RNA from eukaryotic cells 
Total RNA was purified from cell cultutes using the Qiagen RNeasy mini kit (Qiagen 
Cat# 74104) per the manufacturer’s instructions. Prior to extraction, cells were 
typically trypsinised, washed in PBS and pelleted by centrifugation at 1300 rpm for 5 
min. Cell pellets were lysed in RLT Buffer (Qiagen) supplemented with 1% (v/v) -
meracaptoethanol. 350 l of RLT buffer were used for 5x106 cells or less and 600 l 
of RLT buffer were used for cell numbers over 5x106. To remove DNA, on-column 
DNase I digestion was performed using the Qiagen RNase-Free DNase I kit. Column-
bound RNA was eluted in 30 l RNase-free water, quantified on a Nanodrop 1000 
and stored at -80˚C. 
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2.4.2 Reverse transcription of RNA 
Purified total RNA was reverse-transcribed using SuperScript II Reverse 
Transcriptase (Invitrogen, Cat# 18064-022). Reverse transcription reactions were 
typically set up with 1 g of total RNA and 250 ng random hexamers in 20 l 
reactions. cDNA was then stored at -20˚C. 
2.4.3 Next Generation library preparation and sequencing of 
total RNA from eukaryotic cells 
Ribosomal RNA was depleted from 10 g of total RNA using the RiboMinus 
Transcriptome Isolation kit for human/mouse (ThermoFisher Scientific, Cat No 
K155002). Ribosomal depletion was verified on 1% agarose gel. Sequencing libraries 
were prepared from 100 ng of ribosome-depleted RNA using the NEB Next Ultra 
Directional RNA Library Prep Kit for Illumina (NEB, CatNo 7420S) following the 
manufacturer’s protocol. PCR library enrichment was performed using the NEB 
Universal Primex and an index primer to allow multiplexing of libraries. Sequencing 
libraries were quantified using a Nanodrop 1000 and the fragment distribution 
assessed by Agilent 2100 Bioanalyzer (Agilent) using the High-Sensitivity DNA kit 
(Agilent). Samples were sequenced on a HiSeq 2500 system (Illumina), producing 50 
bp, single-end reads. 
2.4.4 RNA Sequencing analysis 
Read quality was assessed with FastQC (Babraham Bioinformatics). An index of 
ribosomal DNA for the hg19 assembly was prepared with Bowtie 2 (Johns Hopkins 
University) and used to remove ribosomal reads. The remaining reads were then 
analysed with the Tophat-Cufflinks pipeline (Trapnell et al. 2012). First, reads were 
aligned to the genome using the TopHat aligner (Johns Hopkins University) with an 
hg19 bowtie2 index. The Cufflinks package (Johns Hopkins University) was then 
used to generate FPKM values for whole genes and individual transcripts. For 
visualisation purposes, TopHat-aligned bam files were first converted to bed files 
and then into bigwig files using Bedtools 2.25 (Quinlan & Hall 2010) 
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2.5 Protein analysis 
2.5.1 Preparation of protein lysates from cell cultures 
Preparation of protein lysates from mammalian cell cultures was performed using 
NuPage LDS sample buffer (Life Technologies, Cat No NP0007). Cells were typically 
grown in 6 well plates to 80% confluency, washed with PBS and lysed in 1x NuPage LDS 
sample buffer supplemented with dithiothreitol (DTT) to 12.5mM. 1 ml of LDS buffer 
was used per 10,000,000 cells.  Cell lysates were then scraped into microfuge tubes, 
incubated at 70˚C for 10 min, sonicted and stored at -20˚C.  
2.5.2 SDS-PAGE 
The NuPage Novex (Life Technologies) mini gel system was used to separate whole 
cell protein extracts according to molecular weight.  Protein extracts were thawed, 
briefly heated to 70˚C, spun at 15,000 rpm for 5 min and loaded on NuPage Novex 4-
12% Bis-Tris gels (Life Technologies, Cat No NP0322BOX). SeeBlue Plus2 Pre-Stained 
Standard (Invitrogen, Cat No LC5925) was typically used as a reference. The mini-gel 
system tanks were filled with 1x NuPAGE MOPS SDS Running Buffer (Life 
Technologies Cat No NP0001) and electrophoresis was performed at 150 V for 70 
min. 
2.5.3 Western blotting 
Whole cell protein lysates were size-separated by SDS-PAGE as described above. 
Following electrophoresis, size-separated proteins on the gels were transferred 
onto Immobilon-P polyvinylidene fluoride (PVDF) membrane (Millipore, Cat No 
IPVA00010), via electrophoretic transfer at 100 V for 90 min at 4°C in a transfer 
buffer containing 25 mM Tris base, 200 mM glycine and 20% (v/v) methanol. Prior 
to transfer, the PVDF membrane was hydrated by a brief wash in methanol, then 
rinsed in transfer buffer. Following transfer, the membrane containing the 
transferred proteins was washed in 1x TBS-T buffer and blocked in 5% w/v milk 
powder in 1 X TBS-T for 30 min at RT. The membrane was probed with primary 
antibodies in blocking solution for 2 h at RT or overnight at 4°C. Membranes were 
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then washed in TBS-T three times for 5 min and probed with secondary antibodies 
conjugated to horseradish peroxidase (HRP) in blocking solution for 1 h at RT. HRP 
bound to the membrane was detected using an enhanced chemiluminescence (ECL) 
detection kit (ThermoFisher Scientifict, Cat No 32106). ECL was added to membrane 
for 1 min and blotted to remove excess liquid, placed between two acetate sheets 
and exposed to photographic film (GE Healthcare Cat No 28906837). Film was 
developed using a Konika SRX-101A developer. 
 
2.6 Cell Culture 
 
2.6.1 Cell Lines 
Two cell lines were primarily used for experiments unless otherwise stated. RPE-1 
cells are a near-diploid retinal pigmented epithelium cell line of female origin 
transformed via expression of the hTERT gene. HCT116 is an epithelial colon cancer 
cell line derived from a male donor. HCT116 cells are chromosome instability 
negative (CIN-). 
2.6.2 Cell growth and passage 
RPE1 and HCT116 cells were cultured in Dulbecco’s Modified Eagle Medium F12 
(Gibco, Cat No 12500-062), supplemented with 10% foetal calf serum, 1% Pen-Strep 
and 1% L-glutamine. Additionally, growth media for RPE cells also contained 0.3% 
(w/v) Sodium Bicarbonate (Sigma, Cat. No S5761). Cells were typicaly maintained in 
75 cm2 flask at 37°C with 5% CO2 in a cell culture incubator. To passage, confluent 
cells were washed in PBS, trypsinised with 1x Trypsin : EDTA (Gibco, Cat No 
5400054) and re-seeded, typically at 1:10 dilution. Cells were typically passaged 
once every 3 days. 
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2.6.3 Freezing cells 
For freezing, an 80% confluent flask of cell culture was trypsinised, washed in PBS 
and pelleted by centrifugation at 1300 rpm for 5 min. The cell pellet was 
resuspended in 1.5 ml of freezing mix containing 90% FBS and 10% DMSO. The cell 
suspension was then split into three cryotubes each containing 0.5 ml of suspension 
and frozen at -80°C. For-long term storage, cells were transferred to liquid nitrogen. 
2.6.4 Thawing cells 
Frozen cell lines were rapidly thawed at 37°C and resuspended in 15 ml of growth 
medium in 75 cm2 flasks. Resuspended cells were incubated at 37°C with 5% CO2 in 
a cell culture incubator for a minimum of 4 h or overnight. Media was then 
removed, the cell culture was washed in PBS and fresh media added to remove 
residual DMSO from flask. 
2.6.5 Transfection of mammalian cell cultures 
For transfection of mammalian cell cultures, cells were plated at 70,000 cells/ml in 6 
well plates and grown overnight. Construct vectors were transfected using 
Lipofectamine 2000 (Invitrogen, Cat# 11668-019) and Opti-MEM Reduced Serum 
Medium (Invitrogen, Cat# 31985-070). For each transfection 1 g of construct DNA 
was mixed with 400 l Opti-Mem and 5 l Lipofectamine-2000. To avoid 
aggregation of DNA and Lipofectamine-2000, the DNA was pre-mixed in 200 l of 
Opti-Mem and separately, the 5 l of Lipofectamine were mixed into 200 l of Opti-
mem. The two components were then mixed together and incubated for 20 min at 
RT. This transfection mixture was added to the tissue cultures in 2 ml of antibiotic-
free media.  
2.6.6 RNAi in mammalian cell cultures  
To perform depletion of proteins using RNAi, cells were plated at 10,000 cells/ml in 
6-well plates and grown overnight. RNAi oligos were transfected using RNAi Max 
(Invitrogen, Cat. No 13778075) and Opti-MEM Reduced Serum Medium (Invitrogen 
Cat# 31985-070).  0.4 nanomoles of RNAi oligos were added to 600 l of Opti-MEM 
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and mixed by inversion; 16 l of RNAiMax were also added to 600 l of Opti-MEM 
and mixed by inversion. The two transfection mixtures were then mixed and 
incubated for 20 min at RT. 600 l of the transfection mixture were added to each 
well of a 6-well plate in 3 ml of antibiotic-free growth media. The extent of 
depletion was assessed using qPCR and Western Blotting. 
2.6.7 Synchronisation of mammalian cells 
Mammalian cells were synchronised at the G1/S boundary by addition of 
aphidicolin to 5 g/ml. Aphidicolin is an inhibitor of the replication machinery and is 
known to completely block replication at high doses (Pedrali-Noy et al. 1980). Cells 
were plated in 6-well plates or slide chambers at a density of 40,000 cells/ml and 
cultured overnight. Media containing 5 g/ml aphidicolin was then added to the 
cells for 24 h to block cell cycle and retain cells at the G1/S boundary. Cells were 
washed in PBS and released in normal growth media. FACS analysis and 
immunofluorescence of cell populations at 2h, 4h, 6h, 8h and 10h following release 
showed that cells progressed synchronously through S-phase and into G2. 
For synchronisation in G2, the CDK1 inhibitor RO-3306 was used.  Cells were plated 
into 6-well plates and slide chambers at a density of 40,000 cells/ml and grown 
overnight. Media containing RO-3306 at 9 M was added for 20 h to arrest cells in 
G2. Cells were then released in fresh media and FACS analysis showed that they 
progressed synchronously through mitosis and G1 for the next 10 h. 
2.6.8 Immunofluorescence 
Immunoflourescence was routinely performed to assess the levels of expression 
and exact localisation of proteins of interest. Cells were seeded on Superfrost + 
slides (Thermo Scientific Cat No J1800AMNZ) placed in slide chambers containing 5 
ml of media at a suitable density. For fixation, slides were washed with PBS and 
treated with 4% paraformaldehyde (PFA, Sigma Aldrich ,Cat 158127) for 10 min at 
RT. Slides were washed in PBS for 5 min at RT and permeabilised in 0.02% Triton X-
100 (Sigma Aldrich, Cat No T8787) in PBS for 10 min at RT. Following 
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permeabilisation, slides were stored in PBS at 4°C or blocked and stained 
immediately. Blocking was performed by incubating the slides in PBS containing 5% 
donkey serum for 15 min at RT in a dark humidified chamber. Following blocking, 
primary antibodies were added onto the slides at the required dilutions in blocking 
solution and incubated at RT for 1 h in a dark, humidified chamber. Slides were then 
washed in PBS / 0.01% Tween three times for 5 min at RT. Secondary antibodies, 
raised in donkey and conjugated to fluorophores (Jackson Immuno Research), were 
diluted 1:500 in a blocking solution, added to the slides and incubated for 1 h at RT 
in a humidified chamber. Slides were washed in PBS containing 0.01 % Tween-20 
three times for 5 min at RT. To detect DNA and nuclei, slides were stained in 50 g / 
ml  DAPI for 3 min at RT. Slides were then drained and mounted in Vectashield 
(Vector Laboratories, Cat No H-1000). Imaging was performed on a Zeiss 
Epifluorescence microscope using 100x objective. 
2.6.9 EdU staining of mammalian cells 
Click-it flow cytometry kit (Invitrogen, Cat No C10634) was used to visualise active 
replication in mammalian cells following the manufacturesrs instructions. To 
visualise sites of active replication, cells grown on slides were pulsed with the 
thymidine analogue 5-ethynyl-2’-deoxyuridine (EdU). EdU was added to 
exponentially growing cell cultures at a concentration of 5 M for 30 min in HCT116 
cells and 1 h in RPE1 cells to account for differences in the cell cycle dynamics 
between the two cell types. Slides were washed in PBS and fixed in 4% PFA for 10 
min. To remove residual PFA, slides were washed in PBS for 3 x 5 min, at RT. 
Permeabilisation was performed in PBS / 0.2% Triton for 10 min, after which slides 
were washed again in PBS 3 x 5 min at RT. Slides were then incubated at RT in a 
dark humidified chamber in the presence of a click reaction mixture, prepared as 
per manufacturer’s instructions, which included copper sulphate and fluorescently 
labelled azide, enabling the cyclo-addition of the fluorescently labelled azide group 
onto the alkyne group of EdU.  Following a thirty-min incubation with the click 
reaction mixture, the slides were washed in PBS 3 x 5 min to remove un-clicked 
fluorescent azide groups.  Following the click labelling, slides were typically stained 
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in a solution containing 50 g / ml DAPI for 3 min at RT to enable visualisation of cell 
nuclei. Slides were mounted in Vectashield and imaged on a Zeiss epifluorescence 
microscope using 100x objective. Replicating cells, positive for EdU, displayed 
replication-stage dependant EdU localisation patterns corresponding to patterns 
previously described in the literature for another thymidine analogue, 
bromodeoxyuridine (BrdU) and components of the active replication machinery 
such as PCNA (Dimitrova & Gilbert 1999) . Early replicating cells showed a diffuse 
pattern of staining, while in late - S EdU signal showed a focal distribution with high 
levels of signal at the nuclear periphery and heterochromatic regions.  
 
2.7 Flow cytometry analysis and sorting of mammalian 
cells  
2.7.1 Sorting of cells expressing GFP 
To sort cells expressing GFP, cell cultures were trypsinised and resuspended in 
growth media at a density of 1x106 cells/ml. For analysis, an Accuri C6 analyser (BD 
Biosciences) was used and GFP-generated fluorescence was measured in the FL1 
channel. A non-GFP expressing cell population was used to determine a negative 
population gate prior to analysis. For single-cell soring, the cell population was run 
through a FACSJazz sorter (BD Biosciences). Fluorescense was measured in the 
FITC/GFP channel and a non-transfected, GFP-negatve population was used for 
gating.  
2.7.2 Cell cycle assessment and sorting using propidium 
iodide staining 
Propidium iodide (PI) is a fluorescent, intercalating nucleic acid dye which shows a 
20-30 times increase in fluorescence when bound to nucleic acids.  PI staining was 
used to analyse the cell cycle distribution of a cell population and sort cells based on 
cell cycle stage. The cell population to be analysed was trypsinised, pelleted by 
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centrifugation at 1300 rpm for 5 min and washed in PBS. Cell pellets were then 
resuspended in PBS at a density of 1.5 x 106 cells/ml and ethanol was slowly added 
to the cell suspension to a concentration of 70% to fix and permeabilise the cells. 
Cells were then incubated on ice for a minimum of 30 min or stored at 4°C for up to 
2 weeks. For PI staining and cell cycle analysis, ethanol-permeabilised cells were 
pelleted by centrifugation at 1800 rpm for 5 min at RT and washed in PBS. The cell 
pellets were then stained in a solution containing 1 g/ml PI and 4g/ml RNase A in 
PBS at 2 x 106 cells/ml for a minimum of 30 min at RT.  
Cell cycle analysis was performed on a LSR Fortessa analyser (BD Biosciences) by 
measuring the fluorescence in the 695/740 channel. For PI based-cell sorting, nuclei 
were isolated from the fixed, permeabilised cells via pepsin digestion, as described 
in ((Dileep et al. 2012). Briefly, cells were pelleted, washed in PBS and resuspended 
in 0.015% pepsin (Sigma, CatNo P6887) and 0.01N HCl at a concentration of 400,000 
cells/ml. Pepsin digestion was allowed to proceed for 20 min at 37°C before cells 
were pelleted by spinning at 600 g for 5 min at RT. Cells were stained in a solution 
containing 1g/ml PI and 4 g/ml RNAse A in PBS at a concentration of 2x106 
cells/ml. Staining was performed at RT, for a minimum of 30 min and maximum of 2 
h. Sorting was typically performed on a FACSAria sorter (BD Biosciences) by 
measuring the fluorescence in the 685/735 channel and gating the cell population 
as required. Subsequent analysis and visualisation of FACS-analysed or sorted 
samples was performed using Flow-Jo software. 
2.7.3 PI/EdU analysis of cell cycle 
Dual PI and EdU staining was performed to simultaneously determine the cell cycle 
stage and the proportion of actively replicating cells within a population. EdU 
staining was performed using the Click-iT Plus EdU Alexa Fluor 647 Flow Cytometry 
Assay Kit (Invitrogen, CatNo C10634) following the manufacturer’s instructions. 
Exponentially growing cell cultures were pulsed with 5 M EdU for 30 min or 1 h 
(HCT116 and RPE1 cells, respectively). Cells were trypsinised and resuspended in 
300 l PBS per 5x106 cells. Cells were fixed by the slow addition of 700 l ethanol 
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and incubated on ice for a minimum of 30 min or stored at 4°C for up to two weeks. 
For staining, cells were washed in PBS and permeabilised in 1 x saponin 
permeabilisation reagent (Invitrogen) for 20 min at RT. Next, cells were 
resuspended in a click reaction mixture following the manufacturer’s instructions. 
The reaction mixture contained copper protectant (Invitrogen) and an azide 
conjugated to an Alexa 647 fluorophore (Invitrogen), which allowed the addition of 
the fluorescent group on the EdU molecule and its subsequent visualisation. 1 ml of 
click reaction mixture was used per 1 x 107 cells and the click reaction was allowed 
to continue for 30 min at RT, protected from light. Following the click reaction, cells 
were washed in 0.5 ml 1 x Saponin reagent and stained in a mixture containing 1 
g/ml PI and 4 g/ml RNAse A at a concentration of 2 x 106 cells/ml for 30 min at 
RT. Cells were typically analysed on a Fortessa analyser by measuring the signals in 
the 695/740 channel for PI and the 730/745 channel for Edu/Alexa 647.   
2.8 Fluorescent in-situ hybridisation (FISH) 
 2.8.1 Preparation of human metaphase chromosomes  
Human metaphase chromosomes were prepared from cultures of exponentially 
growing cells. To induce mitotic arrest and increase the numbers of mitotc cells, 
colcemid, (Life Technologies, Cat No 15210-040) an inhibitor of microtubule 
depolymerisation, was added to the cell cultures to a concentration of  0.1 μg/ml. 
RPE1 cells were treated with colcemid for 1 h prior to harvest, while HCT116 were 
only arrested for 30 min to account for differences in the speed of cell cycle 
progression between the two cell types. Following colcemid treatment, cells were 
harvested, washed in PBS and resuspended in 5ml hypotonic solution, containing 75 
mM KCl. The hypotonic treatment of cells was performed at RT for 10 min, after 
which cells were pelleted by centrifugation at 1200 rpm for 5 min.  Next, cells were 
fixed in 5 ml of freshly prepared solution of 3:1 ratio methanol: acetic acid (MAA). 
The MAA fixative was added to the cell pellet dropwise with constant agitation. 
Cells were pelleted by centrifugation at 1500 rpm for 5 min and the MAA fixation 
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step was repeated two more times. Chromosome preperations were stored at -
20°C. 
To prepare slides with metaphase spreads, metaphase chromosome preparations 
were dropped onto glass slides. The glass slides were pre-treated in a dilute solution 
of HCl in ethanol for at least an hour prior to use. The chromosome preparations 
were pelleted by centrifugation at 1500 rpm for 5 min and resuspended in freshly 
prepared MAA solution until the suspension became cloudy. Two drops of the 
suspension were dropped onto a pre-treated glass slide from a height of 20c m and 
dried at RT overnight before staining or hybridisation. 
2.8.2 Preparation of FISH probes 
BAC and cosmid FISH probes were isolated as described in 2.3.5. Prior to use in a 
hybridisation, probes were labelled using a nick translation reaction with the uridine 
analogues biotin-16-dUTP (Roche, CatNo 11093070910) or digoxigenin-11-dUTP 
(Roche, CatNo 11093088910). Nick translation was performed in a 20 l reaction 
volume, containing 1-1.5 g DNA with 5 μl each of 0.5 mM dATP, dCTP and dGTP 
and either 2.5 l of 1 mM biotin-16-dUTP or 1 l of 1 mM digoxigenin-11-dUTP. 
DNase I (Roche, Cat No 4716728001) was added to a final concentration of 1 U/ml 
and DNA polymerase I (Invitrogen, Cat No 18010025) was added to a final 
concentration 0.5 U/l.  The reaction was performed in 1 x nick translation salts 
(NTS) buffer, containing 50 mM Tris pH7.5, 10 mM MgSO4, 0.1 mM DTT and 50 
g/ml BSA for 90 min at 16°C. The reaction volume was then increased to 80 l by 
addition of 60 l TE and unincorporated nucleotides were removed by gel filtration 
of the NTS reaction through a G50 Sephadex spin column (Roche, Cat No G50DNA-
RO) following the manufacturer instuctions. Labelled probes were then stored at 
RT, protected from light. 
2.8.3 Quantification of Label Incorporation 
The amount of incorporated labelled nucleotides in each probe was quantified by 
spotting the labelled probes on a nitrocellulose membrane and probing the 
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membranes with alkaline-phosphatase conjugated streptavidin or anti-digoxigenin 
antibodies. Nitrocellulose membranes (Protran, Whatman, Cat No BA 85120) were 
soaked in water for 5 min, followed by immersion in 20 x SSC for 10 min. 
Membranes were allowed to dry and stored at RT until use. DNA from labelled 
probes was spotted onto the membranes in dilutions of 1/500, 1/1000, 1/5000 and 
1/10 000 in TE. Brightly labelled probes were also spotted on the membranes in 
similar dilutions to serve as controls. DNA was crosslinked to the membrane by 150 
mJ of UV irradiation. Following crosslinking, the membrane was briefly washed with 
Buffer 1 and blocked in 3% BSA w/v in Buffer 1 for 30 min at 60°C. The membrane 
was probed with either strepavidin-alkaline phosphatase, and/or anti-digoxigenin-
alkaline phosphatase Fab fragments (Roche, Cat No 11093274910 and 
11093266910), diluted 1:1000 in Buffer 1 for 2 h at RT. Excess antibody was 
removed by washing 2 x 15 min at RT with Buffer 1, after which time the membrane 
was equilibrated for 5 min in 0.1 M Tris-HCl (pH 9.5). The membrane was developed 
in a small sealed plastic bag containing two drops from components 1-3 of the 
alkaline phosphatase substrate kit IV (Vector Laboratories, Cat No SK-5300). The 
substrates in this colour reaction are 5-bromo-4-chloro-3-idolyl phosphate and 
nitroblue tetrazolium, producing a blue reaction product in the presence of alkaline 
phosphatase. A complete colour reaction could be observed within a few h to 
assess whether the probes were suitably labelled.  
2.8.4 Hybridisation of FISH Probes 
To prepare for hybridisation, slides were treated with 100 μg/ml RNaseA 
(Invitrogen, Cat No 12091039) in 2 x SSC for 1 h at 37°C, washed briefly in 2 x SSC 
and dehydrated through an ethanol series (2 min each in 70%, 90% and 100% 
ethanol). Slides were then air dried and baked at 70°C for five min before 
denaturing. Denaturation was performed in 70% formamide (v/v) in 2 x SSC (pH 
7.5). Slides containing MAA-fixed chromosome spreads were denatured at 70°C for 
1 min, while slides on which cells were cultured and then fixed in 4% PFA were 
denatured at 80°C for 20 min. Following denaturation, slides were submerged in 
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ice-cold 70% ethanol for 2 min and then dehydrated through 90% and 100% ethanol 
for 2 min each at RT.  
To prepare probes for hybridisation, 150 ng of labelled probe were combined with 5 
g of salmon sperm and 10 g of human Cot1 DNA (Invitrogen, Cat No 15279011). 
Two volumes of ethanol were added and the probe mix was spun down and dried 
under a vacuum. The dried probes were resuspended in 10 l of FISH hybridisation 
buffer containing 50% formamide (v/v), 1% Tween-20 and 10% dextran sulphate 
(Sigma Aldrich, Cat No D8906-100G) in 2 x SSC. The dried probes were dissolved in 
hybridisation buffer for a minimum of 2.5 h at RT wiith occasional agitation. Probes 
were then denatured at 70°C for 5 min and reannealed at 37°C for 15 min and 
chilled on ice.  The probes were pipetted on 22 mm square cover slips and picked 
up with the pre-treated slides. Commercially available chromosome paints 
(Cytocell), supplied in own hybridisation buffer in a ready-to-use format were also 
used. They were directly pipetted on the coverslips and picked up with slides. Liquid 
rubber (Tiptop) was applied around the coverslips and hybridisation performed in 
an enamel tray at 37°C in a waterbath overnight.   
2.8.5 Washing and detection of FISH signal 
After overnight hybridisation, the rubber seal was peeled off from the slides and the 
coverslips. The coverslips were allowed to float off in 2 x SSC and slides were then 
washed four times in 2 x SSC at 45°C for 3 min. Another four washes were then 
performed, with 0.2 x SSC at 60°C for 3 min. Slides were briefly transferred to 4 x 
SSC with 0.1% Tween 20 (v/v) and blocked in 5% milk in 4 x SSC for 5 min at RT. 
Antibodies were diluted as required in 5% milk powder (w/v) in 4 x SSC and then 
centrifugated at 13,000 rpm for 10 min to remove clumps. Detection of biotin label 
was performed with sequential layers of flourescin (FITC)-conjugated avidin, 
biotinylated anti-avidin and a further layer of FITC-avidin. DIgoxigenin was detected 
with sequential layers of Rhodamine-conjugated anti-digoxigenin and Texas-Red 
(TR) –conjugated anti-sheep IgG. The antibodies used, relevant dilutions and 
suppliers are listed in Table 2-3.  Slides were incubated with each antibody layer for 
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30 min in a moist chamber at 37°C. Between antibody layer incubations slides were 
washed 4 times in 4 x SSC 0.1% Tween 20 for 3 min at 37°C. Following the last 
antibody layer, slides were washed 4 times in 4 x SSC 0.1% Tween 20 for 3 min at 
37°C and then stained in a solution containing 50 g/ml DAPI in PBS for 3 min at RT.  
Slides were mounted in Vectashield and coverslips sealed with rubber solution 
(Pang) or nail varnish. Slides were imaged on a Zeiss epifluorescence microscope 
using a 100x objective. 
 
Antibody Dilution Supplier 
Fluorescine avidin 1/500 Vector Labs (A-2011) 
Biotin anti-avidin 1/100 Vector Labs (BA-0300) 
Texas Red anti-sheep 1/100 Vector Labs (TI-6000) 
Anti-dig rhodamine 1/20 Roche (112077509101120) 
Table 2-2 Antibodies used for detection of FISH signal 
2.8.6 Genomic Clones Used for FISH 
A variety of genomic clones were used as FISH probes throughout the project and 
they are listed, along with the corresponding genomic locations in Table 2-4. For all 
probes, the correct cytogenetic localisation of the probe was verified by 










Genomic Band Type 
RP11-436I1 136818800 137001238 2q22.1 BAC 
RP11-236P10 141182186 141337859 2q22.1 BAC 
RP11-15G12 142948672 143108539 2q22.2 BAC 
RP11-56K5 145006565 145166970 2q22.3  BAC 
RP11-952E8 70540713 70710146 1p31.1  BAC 
RP11-644A16 71956202 72140823 1p31.1  BAC 
RP11-357C16 68915438 69105214 1p31.1 BAC 
 RP11-452B11 69176951 69356842 1p31.1 BAC 
 RP11-482A14 69399135 69576878 1p31.1 BAC 
RP11-44E15 69595766 69781569 1p31.1 BAC 
RP11-795A13 69851036 70025173 1p31.1 BAC 
RP11-1085J6 139594407 139768017 4q31.1 BAC 
RP11-1066F2 139856514 140068112 4q31.1 BAC 
RP11-121K15 140158813 140344775 4q31.1 BAC 
RP11-102K5 140710991 140879524 4q31.1 BAC 
RP11-876B4 141116214 141291804 4q31.1 BAC 
RP11 -667C5  141384091 141554894 4q31.1 BAC 
RP11-104N8 141775105 141937724 4q31.1 BAC 
RP11-57O8 142285341 142467294 4q31.1 BAC 
RP11-640M2 163755124 163910201 4q32.2 BAC 
RP11-946L12 164101959 164282405 4q32.2 BAC 
RP11-780E8 164450766 164601741 4q32.2 BAC 
RP11-47H6 165289180 165432768 4q32.2 BAC 
RP11-153D1 165720700 165883800 4q32.2 BAC 
RP11-776O4 113403650 113576915 3q13.2 - 
3q13.31  
BAC 
RP11-52N10 114479903 114636091 3q13.31 BAC 
RP11-11F11 115446092 115606348 3q13.31 BAC 
RP11-354H5 116410230 116551551 3q13.31  BAC 
RP11-696L1 117376433 117552791 3q13.32 BAC 
RP11-456O4 118915065 119071586 3q13.32 - 
3q13.33 
BAC 
RP11-120C5 87485968 87659888 4q21.3 BAC 
RP11-1053C2 89213170 89389643 4q22.1  BAC 
RP11-44A17 91534737 91688609 4q22.1 BAC 
RP11-351L22 92912674 93073948 4q22.1  BAC 
RP11-479E18 94962968 95121208 4q22.2 - 4q22.3 BAC 
RP11-155A18 76612727 76795175 7q11.23 BAC 
RP11-973N8 77475501 77665434 7q11.23 - 
7q21.11 
BAC 
RP11-7N3 79600618 79780358 7q21.11  BAC 
RP11-614C5 81780834 81945425 7q21.11  BAC 
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RP11-649L8 83563011 83722404 7q21.11 BAC 
RP11-51C21 86008317 86165627 7q21.11 BAC 
RP11-975J8 87523950 87713836 7q21.12 BAC 
RP11-624N7 68576767 68749059 1p31.3 BAC 
RP11-915N9 86463555 86626921 4q21.23 BAC 
RP11-688G4 96196712 96376784 4q22.3 BAC 
RP11-6L24 97091291 97250657 4q22.3 BAC 
G248P8923F10 69453824 69492900 1p31.2 Fosmid 
G248P86197B3 68588964 68629214 1p31.3 Fosmid 
G248P85943H10 68367192 68406422 1p31.3 Fosmid 
G248P83504C1 69801869 69843403 1p31.1 Fosmid 
G248P85730E10 138827973 138869427 4q28.1 Fosmid 
G248P8075B1 139935150 139978608 4q31.1 Fosmid 
G248P8117C5 141003415 141049416 4q31.1 Fosmid 
G248P8526E8 142031870 142076104 4q31.2 Fosmid 
G248P8183F5 60950550 60993172 3p14.2 Fosmid 
G248P89337E4 59423151 59459364 3p14.2 Fosmid 
G248P8923G12 57947227 57989923 3p14.3 Fosmid 
G248P89726G8 62413310 62450319 3p14.2 Fosmid 
G248P8027H7   78087080 78125909 16q23.1 Fosmid 
G248P8890B4 76641081 76681724 16q23.1 Fosmid 
G248P81697G2 75142199 75183028 16q23.1 Fosmid 
G248P87155E4 73670724 73714216 16q23.1 Fosmid 
G248P800778H5 91076048 91117811 4q22.1 Fosmid 
G248P85108G3 92058557 92098840 4q22.1 Fosmid 
G248P84123D7 93077304 93115635 4q22.1 Fosmid 
G248P8189B8 94069299 94108069 4q22.2 Fosmid 
G248P86724A11 162609737 162647264 4q32.2 Fosmid 
G248P88037D8  163640717 163680360 4q32.2 Fosmid 
G248P85162A12 164566239 164608074 4q32.3 Fosmid 
G248P86865C5 165481486 165522185 4q32.3 Fosmid 
Table 2-3 BAC and fosmid FISH probes 
2.8.7 Investigation of large-scale chromatin compaction using 
FISH 
The use of differentially labelled FISH probes to investigate large-scale chromatin 
structure was proposed and pioneered in 1992 (van den Engh et al. 1992) and has 
been used in multiple studies. Generally, two differentially labelled fosmid probes, 
spaced 50 kb to 2 Mb apart are hybridised and the physical distance between them 
measured in a large number of nuclei. The distances between probes separated by 
77 
 
less than 50 kb or more than 2 Mb of genomic distance are thought to be 
uninformative (van den Engh et al. 1992). Fosmid probe pairs separated by 0.8 Mb-
to 1.5 Mb were used in this study. The correct genomic location for each fosmid was 
verified by hybridisation to metaphase spreads as described in 2.7.4. The distance 
between fosmid probes was measured in 50 to 100 nuclei. Three-channel images 
were taken for each nucleus, including a DAPI (blue) channel defining the 
boundaries of the nucleus and a FITC (green) and a TxRed (red) channel, defining 
the locations of the fosmid probes. To calculate the distance between the two 
probes, a script developed by P. Perry (Chambeyron & Bickmore 2004) was used. 
The area of the nucleus was calculated by segmenting the DAPI signal. After user 
identification of the probe pairs and automatic background reduction, 
segmentation was performed for the green and the red channels and the 
coordinates of the centroids of the probe signals were determined. Distance 
between the two centroids was calculated by trigonometric equations. The 
distances were calculated in pixels and converted to microns (multiplication factor 
of 0.134). Distances were normalised to account for differences in the nuclear size 
of the cells they were derived from. The script outputed a nuclear area value 
following the segmentation procedure and the nuclear radius was calculated by 
calculating the square root of the nuclear area value over.  The mean radius of the 
whole population was then calculated and a normalised radius was calculated for 
each cell by dividing the radius over the mean radius. A normalised distance was 
then derived by calculating the distance in microns/normalised radius. Unless 
otherwise stated, normalised distances were used in further statistical analysis.  
 
2.9 Mapping replication timing using Click-seq 
Repli-seq is a technique developed to investigate the replication timing at particular 
genomic regions or throughout the genome. The technique was first developed in 
2010 (Hansen et al. 2010) and was originally based on labelling newly replicated 
DNA with the thymidine analogue BrdU. In the classic Repli-Seq technique, cycling 
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cells are pulsed with BrdU for a short length of time, and then sorted through flow 
cytometry into different S-phase fractions. DNA is then extracted from each of the 
different S-phase populations and newly synthesised DNA is enriched via an anti-
BrdU antibody pull-down. The newly synthesised DNA from each fraction can then 
be hybridised on arrays, sequenced or specific regions can be interrogated using 
qPCR. I developed a new version of the Repli-seq approach, utilising the thymidine 
analogue EdU instead of BrdU and developing a new method for sequencing for the 
enriched DNA. The main advantage of using EdU compared to BrdU is because the 
EdU molecule can be stably and specifically attached to a biotinylated azide 
molecule using click chemistry. Biotinylated newly replicated DNA can then be 
enriched by streptavidin pull-down, a technique which is more robust and specific 
compared to the antibody based pull-down employed in BrdU-based Repli-seq. In 
addition, the streptavidin pull-down avoids the use of harsh denaturing treatment 
of DNA which is needed in the antibody pull-down to reveal the BrdU epitope. I 
have called this new methodology Click-seq and its details are discussed below, 
while the optimisation of the method is discussed in Chapter 4. 
2.9.1 DNA preparation for Click-seq 
Actively cycling cell cultures were pulsed with 10 m EdU for 30 min (HCT116 cells) 
or 1 h (RPE1 cells). Cells were then trypsinised, washed in PBS and fixed in 70% 
ethanol as described in 2.6.2. Following fixation, nuclei were prepared from the 
cells and PI stained following the procedure outlined in 2.6.2. Nuclei were then 
sorted on a FACSAria flow cytometer (BD Biosciences) into three fractions: early, 
mid and late - S phase populations. To keep sorting conditions similar between 
samples with differing levels of PI staining, the sorting gates were determined by 
separating the area between the middle of the G1 peak and the middle of the G2 
peak into three equal-sized windows, corresponding to early -, mid - and late -S 
phase populations. Cells were sorted into PBS supplemented with 0.25% BSA and a 
minimum of 150,000 cells were sorted for each population. Following the sort, 
nuclei were pelleted by centrifugation at 2000 rpm for 20 min. The pellets were 
resuspended in 400 l of Genomic Lysis Buffer, RNase A/T1 cocktail was added and 
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samples were incubated at 37°C for 30 min. Proteinase K was added to 150 g/ml 
and the samples were incubated at 55°C for 2-16 h. Genomic DNA was then 
fragmented by sonication. Fragmentation of samples intended for use in qPCR 
reaction was performed in a Bioruptor (DIagenode) for 18 min, 30 s on and 30 s off, 
with the samples suspended in a 4°C waterbath for the duration. Fragmentation of 
samples for next generation sequencing was performed on a Soniprep 150 probe 
sonicator, for 18 min, 30 s on and 30 s off at an ampliutude of 6m. To avoid over-
heating, the sample was submerged in ice for the duration of the sonication. The 
fragmentation of the samples was checked on an agarose gel. While the Bioruptor-
fragmented samples showed a lot of variability and a wide rage of fragments, the 
probe sonicator showed a reproducible fragmentation pattern, with all samples 
showing a tight distribution between 100 and 300 bp (Figure 2-1). DNA was purified 
from the sonicated fractions by phenol-cloroform extraction (Section 2.3.1). 
 
Figure 2-1 Comparison between Bioruptor and probe sonicator. Genomic DNA was sonicated for 
different number of cycles using the two methods. The sonicated fractions were then run out on a 
gel. 18 cycles on the probe sonicator were used to produce samples for the Click-seq methodology. 
2.9.2 Addition of biotinylated azide using click chemistry 
Click-chemistry was employed to attach a biotinylated azide to the alkyne groups of 
EdU molecules, labelling all newly synthesised DNA with a biotin tag.  The click 
reaction conditions were based on a protocol recommended by Lumiprobe. The 
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reaction was performed with up to 3 g of DNA resuspended in 18 l of water in a 
60 l reaction volume. The remaining components of the click reaction were added 
sequentially, always following the order outlined below and in Table 2-5. 
1.  3 l of 2 M triethylammonium acetate buffer, pH 7.0 
2. 30 l DMSO 
3.  6 l of freshly prepared 5 mM ascorbic acid, which was added to the 
reaction to neutralise free radicals.  
4. 1.2 l of 10mM biotin azide (Life Sciences, CatNo B10184)  
5.  3 l of 10 M CuTBTA ligand complex.  The copper in the mixture catalyses 
the click reaction, while the TBTA ligand prevents DNA damage resulting 
from free copper in the reaction.  
The reaction was mixed by vortexing and incubated at RT overnight, protected from 
light by aluminium foil. Following overnight incubation, the biotinylated DNA was 
ethanol-precipitated with 2.5 volumes of ethanol in 0.3 M sodium acetate with 20 
g glycogen as a carrier. Precipitation was usually performed on dry ice for a 
minimum of 30 min. DNA was pelleted by centrifugation at 13,000 rpm for 20 min 
at 4°C, washed with 500 l of 70% ethanol and centrifuged again at 13,000 rpm for 
15 min at 4°C. The DNA pellet was dried at RT for a few minutes and resuspended in 
20 l of TE. 3 l of ‘clicked’ DNA was used for quantification and verification of 















DNA  18 l  Up to 3 mg  
TAB Buffer 1  3 l 100 M 2 M stock prepared by mixing 2.78 
ml triethylamine, 1.14 ml acetic acid 
and 6.08 ml ddH2O. Stored at RT 
indefinitely 
DMSO 2 30 l 50%  
Ascorbic 
acid 
3 6 l 0.5 mM  Freshly prepared 5 M stock  
Biotin azide 4 1.2l 0.2 mM 10 mM in DMSO 
Cu/TBTA 5 2.5l 0.5 mM 10 mM stock prepared by preparing 
10 mM solution of copper II 
persulphate in ddH2O and 10 mM 
TBTA solution in DMSO and mixing 
equal volumes of the two solutions 
Table 2-4 Click reaction components 
2.9.3 Enrichment of biotinylated DNA by streptavidin pull-
down 
Biotinylated, newly replicated DNA was purified from total DNA by enrichment with 
streptavidin magnetic beads. 50 l of C1 streptavidin Dynabeads (Invitrogen, Cat No 
65001) were used per sample. Beads were pre-washed three times in 1 ml TE for 5 
min at RT with rotation. The volume of the clicked DNA sample was boosted to 1 ml 
and salt concentration adjusted to 0.15 M NaCl. For samples to be used in qPCR 
reactions, 100 l was saved as input. The sample was then mixed with 50 l of pre-
washed beads and 1 l of Triton X-100 (Sigma Aldrich, Cat No X100) was added to 
prevent binding of the beads to the walls of the plastic microfuge tubes. The 
sample-bead mixture was incubated overnight at 4°C with rotation. Beads, bound to 
biotinylated DNA were separated using a magnetic rack and the supernatant, 
containing non-biotinylated DNA, was discarded. The beads were then sequentially 
washed twice with 1 ml each of TSE I, TSE II and TE. For each wash, beads were 
transferred to a clean microfuge tube and washed for 3 min at RT with rotation. 
Following the final TE wash, biotinylated DNA was eluted in 50 l of elution buffer 
at 98°C for 10 min with occasional agitation. Two elution buffers were tested: water 
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and 95% formamide. While manufacturer instructions for Dynabeads recommend 
elution in 95% formamide, water was also tested to determine if degradation of 
DNA associated with boiling in formamide can be avoided. Side by side elutions of 
identical samples found that similar amounts of material are eluted in water and 
formamide. Therefore, water was predominantly used to elute biotinylated DNA, 
although some early experiments were performed with formamide elutions. When 
formamide was used to elute the enriched DNA, the samples was cleaned up with a 
MinElute purification column (QIagen) following the manufacturer instructions.  
2.9.4 Verification of biotin incorporation and pull-down 
efficiency 
Following elution, the succesfull incorporation of biotin and successful pull-down of 
newly replicated DNA was confirmed by spotting a small amount of the ‘clicked’ 
biotinylated DNA generated in the click reaction and the ‘pulled down’-DNA on a 
nitrocellulose membrane and probing the membrane with an HRP-conjugated 
streptavidin antibody. One microliter of undiluted ‘clicked’ DNA was spotted along 
with a microliter of a 1/10 and 1/100 dilution of the clicked DNA as well as a 
microliter of undiluted pulled-down DNA.  Biotinylated T7 primer was also spotted 
on the membrane in amounts ranging from 75 to 500 fmols as a standard. DNA was 
crosslinked to the membrane by exposure to 150 mJ UV irradiation. Following 
crosslinking, the membrane was briefly washed with Buffer 1 and then blocked in 
3% BSA (w/v) in Buffer 1 for 30 min at 60°C. The membrane was probed with 
ExtrAvidin Peroxidase (Sigma Aldrich, Cat No E8386), diluted 1:10 000 in Buffer 1, 
for 2 h at RT with gentle agitation. Unbound antibody was removed by a wash in 
Buffer 1 for 15 min at RT, followed by a wash in TBS-Tween for 15 min at RT. 
Peroxidase (HRP) bound to the membrane was detected using an ECL detection kit 
as in 2.5.3. ECL was added to membrane for 1 min, after which the membrane was 
placed between two acetate sheets and exposed to photographic film (as in 2.5.3). 
Film was developed using a Konika SRX-101A developer. 
83 
 
2.9.5 Synthesis of complimentary DNA strands 
The streptavidin enrichment protocol described in 2.9.3 requires heating to 98°C in 
the elution step to break the biotin-streptavidin bond and release the biotinylated 
DNA from the streptavidin beads. As a consequence, the DNA recovered after the 
elution step is single stranded. While single stranded DNA can be used a substrate 
for qPCR reactions, the conventional next generation sequencing library preparation 
protocols such as the NEBNext Ultra DNA Library Prep Kit for Illumina (NEB, Cat No 
E7370) require double-stranded DNA as starting material. Therefore, to make the 
eluted DNA compatible with library preparation methods, complimentary strand 
synthesis was performed with the NEB 2nd Strand Synthesis kit (NEB, Cat No E6111S) 
following the manufacturer instructions. Briefly, 45 l of the DNA isolated following 
streptavidin pull-down was added to 23 l ddH2O, 8 l of the 10x Second Strand 
Synthesis Reaction Buffer, 4 l of the Second Strand Synthesis Enzyme Mix and 
random hexamers. The reaction was incubated for 2.5 h at 16°C in a thermocycler 
and the DNA purified using a MinElute clean up column and eluted in 10 l of 
ddH2O. 
2.9.6 Preparation of libraries for next generation sequencing 
Library preparation for next generation sequencing was performed using the 
NEBNext Ultra DNA Library Prep Kit for Illumina. The volume of DNA prepared in 
step 2.9.5 was boosted to 55.5 l with ddH2O. An end repair reaction was set up, 
consisting of DNA, 3 l of the End Prep Enzyme Mix (NEB) and 6.5 l of 10 x End 
Repair Reaction Buffer (NEB). The reaction was incubated in a thermocycler for 30 
min at 20°C, followed by 30 min at 65°C. Ligation of the NEBNext sequencing 
adaptor was performed by adding 15 l of Blunt/TA Ligase Master Mix (NEB), 2.5 l 
of 1:10 dilution of the NEBNext Adaptor for Illumina (NEB) and 1 l of Ligation 
Enhancer. The reaction was incubated at 20°C for 15 min. To digest the hairpin 
adaptor, 3l of USER enzyme was added and the reaction incubated at 37°C for 15 
min. Adaptor-ligated DNA was cleaned using AMPure XP beads (Beckman Coulter) 
in a 1:1 ratio. 86.5 l of AMPure XP beads were added to the reaction, mixed 
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thoroughly and incubated for 5 min at RT. The beads, containing the adaptor-ligated 
fragments were separated with a magnetic rack and supernatant was removed. The 
beads were washed twice with 200 l freshly prepared ethanol for 20 s and air-
dried for 5 min at RT. To elute DNA, 17 μl of 0.1 x TE were added to the beads, mixed 
thoroughly and incubated for 2 min at RT. Beads were again separated on a magnetic 
stand and the supernatant, containing the adaptor ligated DNA was collected and used 
in the subsequent amplification reaction. The NEB Universal Primer (NEB, Cat No 
E6861A, 5’-AAT GAT ACG GCG ACC ACC GAG ATC TAC ACT CTT TCC CTA CAC GAC GCT 
CTT CCG ATC*T-3’) and a sample-specific NEB Index primer (NEB, Cat No E7335S and 
Cat No E7500S), enabling barcoding and pooling of multiple samples for the 
sequencing process were used in the amplification reaction. As samples were 
sequenced in pools of six libraries, the manufacturer-recommended combinations 
of NEB Index primers 2, 5, 7, 4, 6 and 12 were used. In the amplification reaction, 15 
l of adaptor-ligated DNA fragments were mixed with 2 l of NEB Index primer, 2l 
of NEB Universal PCR Primer, 6 l of H2O and 25 l of NEBNext Q5 Hot Start HiFi 
PCR Master Mix. Amplification was performed following the conditions in Table 2-6.  
Amplified DNA was then cleaned up with AMPure XP beads in a 0.9:1 beads to 
reaction ratio. 45 l of AMPure beads were added to the 50 l amplification 
reactions and mixed well. The beads and reaction mix was incubated at RT for 5 min 
and the beads, containing the amplified DNA fragments were separated on a 
magnetic stand. The supernatant was removed and the beads were washed with 
200 l of 80% ethanol for 2 x 30 s. The beads were air-dried for 10 min, 33 l of 0.1 
x TE were added and mixed with the beads to elute the amplified DNA. The sample 
was incubated at RT for 2 min before the beads were separated on a magnetic 
stand and 28 l of supernatant containing the eluted DNA fragments were removed 
to a new tube. Amplified DNA was quantified on a Qubit (ThermoFischer Scientific) 
using the Qubit dsDNA HS Assay Kit (ThermoFischer Scientific, Cat No Q32851). 
Fragment distribution was assessed on an Agilent Bionalayser using the DNA High 
Sensitivity chip and corresponding kit reagents (Agilent, Cat No 5067-4626). Some 
samples showed a strong peak at 127 bp indicating the presence of adaptor dimers. 
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These samples were further purified with AMpure beads in 1.2:1 bead:sample ratio, 
which removed most of the primer dimers present.  
Cycle Step Temperature Time Cycle Number 








Final Extension 65°C 5 min 1 
Hold 4°C Hold  
Table 2-5 Amplification conditions for Repli-Seq library preparations 
2.9.7 Next generation sequencing of Repli-seq samples 
Repli-seq generated libraries were sequenced by Edinburgh Genomics on an 
Illumina HiSeq 4000 sequencing system, generating 50 bp single-ended reads. Six 
barcoded libraries were pooled in equimolar amounts per single sequencing lane. 
Two biological replicates were sequenced for each sample. 
2.9.8 Analysis of Repli-seq sequencing data 
Overall assessment of the quality of the sequences was performed by FastQC 
(Babraham Bioinformatics). The fastq read files were then aligned to the genome 
using Bowtie 2 (Johns Hopkins University) and and alignment files were generated 
in the “. bam” format. PCR duplicate removal, file sorting and indexing was 
performed with Samtools 1.2 (Li et al. 2009). Read density in 1,000 bp, 10,000 bp 
and 100,000 bp windows across the genome were calculated using the multicov 
option in Bedtools 2.25 (Quinlan & Hall 2010). Normalised FPKM values were then 
generated for each window in R. Correlations between biological replicates were 
calculated using the corrplot R package. A single replication timing value was then 




The R value was used for comparison between samples. The partitioning of the data 
into replication domains is described in Chapter 4.4.2. 
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3 Chapter 3: CFS expression, mitotic chromatin 
structure and transcription in RPE1 and HCT116 
cells 
 
As discussed in Chapter 1.6.2, one of the most intriguing features of CFS regions is 
their cell type specific expression.  The differences in CFS repertoire between cell 
lines have been previously exploited in studies aiming to match cell type specific 
features with CFS fragility. Example is a study from the Debatisse lab, which 
compared the replication timing programme of FRA3B in lymphoblastoid cells and 
fibroblasts and concluded that differences in replication timing between the two 
were implicated in fragility (Letessier et al. 2011). To differentiate factors 
contributing to fragility, I compared transcription levels, replication timing and 
chromatin structure across active and inactive CFSs in the two different cell types.  
Consequently, the first stage of my study involved characterising the repertoire of 
CFS fragility in the two cell types and identifying sites with differential expression. 
CFS break mapping is usually performed cytogenetically, by visually assigning the 
breaks to a chromosome band. A small number of fragile sites have also been 
mapped at the molecular level, by hybridisation of fluorescently-labelled BAC 
probes with a known genomic location, followed by assessment of the break 
location relative to the probe (Huang et al. 1998; Becker et al. 2002). To 
characterise active CFSs in the RPE1 and HCT116 cell lines, I used a combination of 
the two approaches – an initial cytogenetic mapping was followed by a more 
detailed molecular fine-mapping for a subset of the identified locations. 
With the shift from a cytogenetic to a molecular approach for CFS characterisation, 
a transformation in the ideas about their underlying chromatin configuration has 
also occurred. Previously assumed to be caused exclusively by double stranded 
breaks, CFS-associated lesions are now suspected to be a consequence of a mixture 
of molecular outcomes, including concatenations and aberrant chromatin 
compaction in the run up to mitosis (Minocherhomji et al. 2015; Chan et al. 2009). 
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To determine if aberrant compaction is present at CFS locations in mitosis, I 
hybridised BAC probes known to cover fragile regions to metaphase chromosomes 
and used their signals as a probe for the underlying chromatin structure in a variety 
of conditions. 
Finally, I focused on the contribution of transcription to CFS fragility. I compared the 
levels of transcription across active and inactive CFSs in the two cell lines to 
determine if gene expression is necessary or conducive to fragility. I also used the 
genome engineering CRISPR-Cas9 system to modify the transcriptional level of an 
active fragile site and then characterised the effect of the alteration in gene 
expression on the fragility and mitotic structure at that CFS. 
3.1 Characterisation of CFS expression in RPE1 and 
HCT116 cells  
As mentioned in Chapter 1.6.1, the genomic locations of expressed, or “active” CFSs 
differ between different cell types. Therefore, the initial step in my study involved 
characterisation of the patterns of CFS fragility in the two cell types I selected: the 
telomerase-transformed retinal pigmented epithelium cell line RPE1 and HCT116, a 
CIN- colorectal carcinoma-derived cell line. These two cell lines were selected as 
they are fast-growing, suitable for transfection and imaging studies and carry 
normal karyotypes. HCT116 is an ENCODE Tier 3 cell line, while the RPE1 cell line 
has been used for multiple studies in the Gilbert lab. Patterns of CFS fragility have 
never been characterised in RPE1 cells whilst CFS expression in HCT116 cells has 
been previously characterised (Le Tallec et al. 2013), however I chose to reassess 
the characterisation as some variation may be present between clonal populations 
of the same cell line. To perform an initial cytogenetic screen for fragile locations, I 
treated cells with varying concentrations of the replication-stress inducing drug 
aphidicolin for 24 hours and prepared metaphase chromosome spreads. I stained 
the chromosome spreads with the DNA minor groove binder DAPI, which results in 
reproducible bands across the chromosome arms. DAPI preferentially binds AT-rich 
regions and as a result, DAPI-bright bands are predominantly gene-poor, while GC-
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rich, gene-dense regions form fainter bands. I imaged all metaphase spreads across 
a microscope slide for each cell type and each aphidicolin concentration. I also 
imaged metaphase spreads derived from control cells which were not treated with 
aphidicolin and did not find any CFS lesions. In the aphidicolin-treated slides, for 
spreads containing CFS lesions, I identified the chromosome arm harbouring the 
abnormality based on chromosome morphology and banding pattern. For a small 
number of breaks (less than 5%), it was not possible to identify the corresponding 
chromosomes and they were not considered in further analysis. I then identified the 
cytogenetic bands in which the breaks were located using two complementary 
approaches: a visual inference of the band according to the DAPI staining and a 
ratio-based approach, suggested by the NHS Lothian Clinical Cytogenetics Service. In 
the ratio-based approach, I measured (a) the total length, in pixels, of the 
chromosome arm that the break occurred on and (b) the pixel length of the 
distance between the centromere and the break. I then calculated (b)/ (a) and used 
scaled models of banded chromosomes to infer possible genomic locations for the 
breaks. I found that the ratios clustered along the chromosome arms, indicating 
recurrent breaks at CFS locations (Figure 3-1). The mid-point of each cluster was 
taken as a putative CFS location. However, as the fixation and spreading of 
chromosomes is likely to cause some distortion, molecular fine-mapping of the 





Figure 3-1: Example of ratio analysis for the localisation of breaks occurring on the p arm of chr3 
following treatment with 0.4 M and 0.6 M aphidicolin. The length of the chromosome arm (a) 
and the distance from the centromere to the breakpoint point (b) were measured.  The b/a ratios 
were plotted for all breaks occurring on Chr3p and were found to cluster, indicating recurrent lesions 
at 3p14.2, corresponding to the FRA3B site. Higher doses of aphidicolin revealed more fragile 
locations, at 3p22.1 and 3p24.2. 
3.1.1 Fragile locations in RPE1 cells 
The CFS repertoire in RPE1 cells was mapped after treatment with 0.4 M 
aphidicolin for 24 hours. I assessed a total of 64 metaphases and found 62 breaks, 
resulting in a mean rate of 0.98 breaks per metaphase.  Overall, I found breaks at 18 
genomic locations, with the five most fragile CFSs comprising 66% of all observed 
breaks. While some of the fragile regions mapped to previously identified CFSs, 
most of them were novel CFSs specific to the RPE1 cell line. However, all of the 
novel fragile locations had been previously identified as sites of very rare fragility in 
lymphocytes (Mrasek et al. 2010). This data is summarised in Table 3-1. Various 
morphologies of the CFS lesions were observed, including chromatid gaps, 
chromosome gaps, constrictions and chromatid breaks, with chromatid gaps being 
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the most frequent abnormality (Figure 3-2). There was no association between 
particular CFS locations and lesion morphologies- defects were observed at similar 
proportions across all fragile genomic locations. This suggests that the processes 
responsible for fragility at CFS regions can give rise to a number of cytogenetic 
abnormalities, implying that a fundamental effect on the mitotic chromosome 
structure is at the root of CFS expression.  When the frequency of breaks per 
metaphase was quantified, metaphases carrying one break were the most common 
and there was no indication of co-dependence of breaks: the presence of one break 
did not seem to increase the likelihood of a second break, suggesting CFS lesion 
formation is independent for each genomic location. 
Loci Associated CFS Number of breaks observed % of all breaks 
1p31.2  FRA1C 11 18.6 





12   
6 10.2 
2q22.2 FRA2F 5 8.5 
4q31.1 FRA4C 4 6.8 
13q31.1 FRA13H 3 5.1 







2q31.1 FRA2G 1 1.7 
7q31.2 FRA7G 1 1.7 
















Table 3-1: Fragile locations in RPE1 cells. Asterisk indicates locations where the genomic band 




Figure 3-2 Characteristics of CFS expression in RPE1 cells. Metaphase spreads were prepared from 
RPE1 cells treated with 0.4 M aphidicolin for 24 hours. The locations affected, the types of lesions 
produced and the numbers of breaks per metaphase were characterised. A. Representative 
metaphase, carrying two CFS breaks, at FRA1C and 2q22.2. B-E examples of various lesions present 
at CFS; B: Chromatid gap, C: Chromatid break, D: Chromosome gap, E: Constriction. F. 
Quantification of the frequency of metaphases carrying breaks. G. Quantification of the different 
defects observed at CFS upon aphidicolin treatment. 
3.1.2 Fragile locations in HCT116 cells 
CFS expression in HCT116 cells has been previously mapped following treatment 
with 0.15 M aphidicolin for 16 hours (Le Tallec et al. 2013). Since it is unknown 
how CFS expression varies between different clones of the same tissue culture cell 
line, I performed an independent mapping of fragile locations in HCT116 cells. I 
treated HCT116 cells with a range of aphidicolin concentrations - 0.1, 0.2, 0.3, 0.4 
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and 0.6 M aphidicolin for 24 hours and quantified the breaks I observed in 
metaphases derived from these cells. The number of metaphases assessed for each 
condition, the number of breaks observed and the rate of breaks per metaphase for 
the different conditions are summarised in Table 3-2. There seemed to be a general 
tendency for increased rates of breakages with increased aphidicolin concentrations 
up to 0.4 M. At 0.6 M, the rate of breakage appeared to be reduced, however 
this is due to the fact that at an aphidicolin concentration this high, a lot of 
metaphases appeared damaged, which impeded the identification and localisation 
of CFS lesions. At similar conditions of treatment as RPE1 cells – 0.4 M APH – 
HCT116 cells displayed higher rates of fragility: 0.98 breaks per metaphase in RPE1 
cells compared to 1.88 breaks per metaphase in HCT116 cells. This may be related 
to the higher levels of endogenous replication stress in the cancer-derived HCT116 
cell line. 
Condition Number of metaphases Number of breaks  
observed 
Average breaks per 
 metaphase 
0.1 M APH 96 28 0.29 
0.2 M APH 52 34 0.65 
0.3 M APH 59 29 0.49 
0.4 M APH 84 157 1.88 
0.6 M APH 80 124 1.55 
Table 3-2 Characterisation of the CFS repertoire in HCT116 cells under different aphidicolin 
conditions. 
In terms of break localisation, there was some variability between the different 
conditions, with a tendency for higher doses of aphidicolin to reveal more fragile 
locations. FRA3B, previously identified as the most fragile site in these cells, showed 
the highest frequency of breaks across the different concentrations.   The most 
frequently identified locations and their fragility at different aphidicolin conditions 
are summarised in Table 3-3. Many of the sites previously identified in Le Tallec et al  
(2013) were also fragile in my experiments, however I failed to find breaks at two of 
the previously identified locations- FRA4D and FRA16B.  I also identified recurrent 
frequent breaks at CFSs which were not previously defined as active in HCT116 cells, 
indicating that some variability is present between cell line clones, experimental 
conditions and different laboratories. These included breaks at FRA3G, FRA1C and 
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FRA3A. Unlike RPE1s, all of the locations I identified as fragile in HCT116 cells have 
been previously identified as CFSs. 
 
Location CFS 
Identified in Le 
Tallec et al 








 % of all 
breaks 
at 0.3 M 
aph 
% of all 
breaks 
at 0.4 M 
aph 
% of all 
breaks 
at 0.5 M 
aph 
3p14.2 FRA3B Yes 16.7 33.3 14.3 20 16.9 
3p22.2 FRA3G No 16.7 0 0 0 3.4 
4q22.1 FRA4F Yes 16.7 5.5 21.4 13.7 0 
1p31.2 FRA1C No 16.7 0 0 0 11.91 
3p24.3 FRA3A No 8.3 0 0 0 3.4 
2q22.2 FRA2F Yes 8.3 0 0 8.7 1.7 
2q33.2 FRA2I Yes 8.33 5.5 7.1 15 20.3 
3q13.31 FRA3L No 0 0 7.1 2.5 5.1 
3q26.31 FRA3O Yes 0 5.5 0 1.2 0 
2q24.2 FRA2T Yes 0 0 0 15 5.1 
4q31.1 FAR4C No 0 5.5 0 2.5 0 
5q31.1 FRA5C No 0 5.5 7.1 2.5 6.8 
7q31.1 FRA7K Yes 0 11.1 7.1 5 6.8 
7q32 FRA7H No 0 0 0 2.5 3.4 
Table 3-3: CFS repertoire in HCT116 cells upon treatment with different aphidicolin concentrations. 
In addition to defining active CFS locations, I also characterised the morphologies of 
the CFS lesions in HCT116 cells. I observed defects similar to the defects seen in 
RPE1 cells (chromatid gaps and breaks, chromosome gaps and constriction), but 
also more severe deformities. Many chromosomes carried more than one break per 
chromosome arm and sometimes this caused chromatid flipping (Figure 3-3). 
Constrictions in this cell type affected a larger region on the chromosome arm 
compared to RPE1 cells. In addition, the most common defect in this cell type was 
chromatid breaks, as opposed to RPE1s, where chromatid gaps were the most 
frequent. Again, there was no correspondence between particular locations and the 
defects observed. In addition to chromosomal lesions, defects affecting whole 
metaphases were seen in HCT116 cells. This included loss of sister chromatid 
cohesion across the metaphase and the appearance of condensed chromatin 
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fragments reminiscent of the “mitotic catastrophe” phenotype (Castedo et al. 2004) 
(Figure 3-3E). 
 
Figure 3-3 Characteristics of CFS expression in HCT116 cells. Metaphase spreads were prepared 
from HCT116 cells treated with 0.1, 0.2, 0.3, 0.4 and 0.6 M aphidicolin for 24 hours. The locations 
affected the types of lesions produced and the numbers of breaks per metaphase were 
characterised. A. Part of a representative metaphase with three CFS breaks. B-E examples of 
extreme morphologies at CFS lesions found only in HCT116 cells; B: Chromatid flipping caused by 
multiple breaks, C: Chromosome carrying multiple breaks, D: Constriction affecting a large 
chromosome area, E: Condensed fragments indicative of mitotic catastrophe. F. Quantification of 
the frequency of metaphases carrying breaks. G. Quantification of the different defects observed 
at CFS upon aphidicolin treatment. 
The characterisation of CFS expression in the two cell types indicated that most of 
the fragile sites were differentially expressed between RPE1 and HCT116 cells, with 
a very small number of sites shared between the two. As the sites with a lower 
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number of breaks indicated less frequent molecular events, I chose to focus only on 
the most highly expressed CFSs in each cell type in further experiments. For RPE1 
cells, this included FRA1C, FRA3O, and the novel fragile sites at 4q32.2 and 7q21.11-
7q21.12. For HCT116 cells, I focused primarily on FRA3B, FRA2I, FRA4F and FRA2T. 
Of the most fragile RPE1 locations, FRA1C and FRA3O showed weak fragility in 
HCT116 cells. FRA2F was a CFS showing some fragility in both cell types and was 
also included in further analyses (Figure 3-4). I anticipated that analysis of the 
molecular features of active CFSs and in particular CFSs shared between the two cell 
types would reveal which molecular processes are implicated in fragility. 
 
Figure 3-4 Highly expressed CFSs in RPE1 and HCT116 cell lines. CFS expression was mapped in 
RPE1 and HCT116 cells. Most recurrent break locations differed between the two cell lines. FRA1C 
and FRA2F, which were fragile in both the HCT116 and RPE1 cells, are shown in red. 
3.2 Molecular mapping of CFS 
Cytogenetic mapping of the CFS repertoire in RPE1 and HCT116 cells enabled 
localisation of CFSs to chromosome bands and previously defined fragile locations 
as well as a rough comparison between the CFS expression patterns in the two cell 
types. However, it provided very limited information on the exact genomic 
coordinates of the fragile regions, the sizes of the affected areas and whether any 
“drifting” of the breaks within the fragile regions was present. I therefore 
performed fine-scale molecular mapping for some of the highly expressed CFSs in 
the two cell types. The mapping strategy used fluorescent in-situ hybridisations 
(FISH) with BAC probes spanning the putative, cytogenetically identified locations to 
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chromosome spreads derived from cells exposed to aphidicolin. I then characterised 
the break locations relative to BAC positions and was able to identify the molecular 
coordinates of the fragile regions to the resolution of single BACs. This allowed me 
to assess relevant genomic features of fragile regions such as gene density, gene 
size and replication timing according to publicly available Repli-seq data for the 
IMR90 cell line.  
3.2.1 Fine-mapping of CFSs in the RPE1 cell line 
In the RPE1 cell line, I performed molecular mapping for two fragile locations- 
FRA1C and the novel CFS at 4q32.2. 
3.2.1.1 FRA1C 
To define the exact molecular localisation of the FRA1C CFS in RPE1 cells, I used five 
BAC probes spanning a 1.5 Mb region surrounding the 1p31.2 band. I performed 
FISH hybridisations using two or three of the BACs at a time and scored break 
location relative to the BAC positions (e.g. overlapping, telomeric and centromeric). 
In total, I analysed 265 chromosomes and found 12 breaks at FRA1C. A single BAC, 
RP11-482A14, located at chr1: 69399135-69576878, always overlapped with breaks 
(Figure 3-5).  Two BACs, RP11-452B11 and RP11-44E15, neighbouring RP11-482A14 
telomerically and centromerically, overlapped with 71% and 85% of breaks. 
However breaks frequently overlapped with these BACs only partially. BACs located 
telomerically from chr1:69176951 never overlapped with breaks, marking the 
telomeric boundary of the fragile core of FRA1C. I was unable to locate the 
centromeric boundary for FRA1C. However, the frequency of break overlap was 
dropping at the centromeric neighbour of RP11-482A14, suggesting that the fragile 
core of FRA1C is approximately a 0.6 Mb region covered by the three BACs. 
Inference of the size of individual breaks is challenging, but most breaks were found 
to span a region larger than RP11-482A14, which has a size of 177 kb and extend 
into the two neighbouring BACs, without completely occupying them. As there was 
some difference in the break overlap for the two neighbouring BACs it is likely that 
there is some minimal drift of lesions within the 0.6 Mb region defined by the three 
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BACs, but they are always centred on RP11-482A14. The 0.6 Mb fragile core of 




Figure 3-5 FISH-based fine-mapping of the FRA1C fragile region in RPE1 cells. BAC probes spanning 
a 1.5 Mb region between 1p31.1 and 1p31.3 (chr1: 68915438-69781569) were hybridised to 
chromosome spreads prepared from RPE1 cells treated with aphidicolin.  BACs are shown in red. 
The locations of breaks relative to BACs were scored by how frequently the BAC overlaps with a 
cytogenetic break when such break is present on the chromosome. Genomic bands are shown in 
grey and black and RefSeq genes in blue. Bottom panel shows replication timing tracks for IMR90 
cells, where higher values correspond to earlier replication timing. Inset, a representative 
hybridisation image showing BAC probe at 1p31.2 telomerically flanking a break on chromosome 1 




Fine-mapping of the novel fragile location at 4q32.2 was less detailed than for 
FRA1C. Following the cytogenetic identification of a CFS at 4q32.2, I examined the 
region on the UCSC Genome Browser (Kent et al. 2002) and noticed that the long 
gene MARCH1 was located at the boundary of 4q32.2 and 4q32.3. Long genes are 
frequently associated with CFSs, therefore I expected the fragile region to be 
located around MARCH1 and used just two BACs, RP11-946L12 (chr4: 164101959 - 
164282405) and RP11-153D1 (chr4: 165720700 - 165883800), which flank the gene. 
I analysed 82 chromosomes and found three breaks at that site. In all cases, the two 
BACs partially overlapped the breaks and partially flanked them (Figure 3-6), 
suggesting that the fragile core of this novel CFS is contained within the 1.3 Mb 
region between the two BAC probes and overlapping with the MARCH1 gene 
(Figure 3-6). Inference of the size of breaks at this site is difficult- the two BACs are 
located a megabase apart and both BACS are only partially overlapped by the 








Figure 3-6 FISH-based molecular localisation of breaks at the 4q32.2 region. Two BACs surrounding 
the long MARCH1 gene were used to investigate if fragility at this locus coincided with the location 
of the gene. In the top left corner, an example of a chromosome 4 carrying a break at 4q32.2, 
hybridised to RP11-946L12 (green) and RP11-153D1 (red), which flank the MARCH1 gene. The two 
BAC probes flank the break, suggesting that fragility occurs over the MARCH1 gene body.  Bottom 
panels: Genomic locations of the BAC probes (red and green) and the MARCH1 gene. All analysed 
breaks within that region appeared over the gene and coincided with a late-replicating domain in 
IMR90 cells. The inferred fragile region is shown in black. 
3.2.2 Fine-mapping of CFSs in the HCT116 cell line 
Although CFSs in HCT116 have been mapped previously, the mapping was 
performed cytogenetically and the precise molecular localisations of the fragile 





FRA3B, along with FRA16D, is one of the best studied common fragile sites. It is 
active in lymphocytes, the colon epithelial cell line LoVo and the breast epithelial 
cells MCF7 and CAL-51 (Le Tallec et al. 2013; Wang et al. 1999). The molecular 
localisation of cytogenetic lesions at FRA3B in lymphocytes has been the subject of 
a number of studies; the most conclusive characterisation was performed by 
hybridisation with BAC probes spanning the region and positioned the breaks to a 4 
Mb region spanning from 3p14.1 to the FHIT gene at 3p14.2 (Becker et al. 2002).  
However, the localisation of breaks in HCT116 cells is unknown. I mapped the break 
positions using three fosmid probes, spaced 1 Mb apart across a 3 Mb region 
centred on the FHIT gene (Figure 3-7). I scored the position of 18 breaks from 62 
metaphases relative to the fosmids.  In my analysis, all breaks appeared within a 1 
Mb region between two of the three probes, which I called F3B1 (chr3: 59423151- 
59459364) and F3B2 (chr3: 60950550- 60993172). F3B1 flanks FHIT telomerically 
while F3B2 is near the centromeric end of the gene (Figure 3-7). F3B1 and F3B2 
flanked the breaks in most cases and were occasionally partly inside the breaks, 
suggesting some minimal drifting of the lesions within the 1 Mb region. As 
previously described for FRA3B, the whole region coincides with a late-replicating 




Figure 3-7 FISH-based molecular localisation of breaks at the FRA3B site.  A. Three probes, 
spanning a 3 Mb region (chr3: 59423151-62450319) centred on FHIT were used to map break 
positions at the FRA3B locus.  All breaks localised between the F3B1 (red) and F3B2 (green) probes. 
The fragile region (black, top panel) corresponded to a late replicating domain (bottom panel). B.  
Representative image of chromosome 3 carrying a break at FRA3B hybridised to F3B1 (red) and 
F3B2 (green), which flank the break. Chromosome is counter-stained with DAPI. 
3.2.2.2 FRA4F 
The molecular localisation of lesions at the FRA4F CFS was mapped via FISH 
hybridisations with seven BAC probes spanning a 10 Mb region surrounding the 
4q22.1 – 4q22.2 boundary and including two large genes: CCSER1 and GRID3. A 
total of 342 chromosomes were analysed for that locus and they contained 28 
breaks. All breaks overlapped with probe RP11-351L22, located at  
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chr4: 92912674-93073948, towards the telomeric end of GRID2 (Figure 3-8). Most 
breaks overlapped with probes located both centromerically and telomerically from 
RP11-351L22, but not completely, suggesting some drift of lesions, or variability of 
their extent, within a 5 Mb region.  The telomeric boundary of the fragile regions 
was marked by probe RP11-688G4 (chr4: 96196712- 96376784) at 4q22.3. 
Centromerically, very few lesions extended beyond probe RP11-1053C2 (chr4: 
89213170-89389643), located in 4q22.1, centromerically from the CCSER1 gene 
body. Therefore, fragility at FRA4F extended along a 5 Mb region, making it larger 
than all other sites mapped within this project. This site also overlaps a late-
replicating domain. 
 
Figure 3-8 FISH-based molecular localisation of breaks at FRA4F. Fine-mapping of this site was 
performed with seven BAC probes spanning a 10 Mb region at chr6: 87485968- 96376784 (shown 
in red). Top panel shows break overlap for each BAC probe across the region. RP11-351L22, 
located at the 5’ end of the GRID2 gene (blue) was overlapped by all breaks within the region. 
Breaks also frequently overlapped with probes surrounding RP11-351L22 within a 5 Mb region. 




1.1.7.1  FRA2F 
The final fragile location I fine-mapped was the FRA2F locus at the 2q22.1 – 2q22.2 
boundary. This location contains the LRP1B gene, which is nearly 2 Mb long and sits 
at the boundary between the two cytogenetic bands. I expected fragility would 
occur in the vicinity of the gene and selected four BAC probes within a 5 Mb region 
centred on the gene for the fine-mapping. 126 chromosomes were analysed of 
which 19 carried a break at the FRA2F CFS. All of the breaks occurred telomerically 
from RP11-436I1 (chr2: 136818800-137001238) and RP11-236P10 (chr2: 
141182186-141337859), the two probes within 2q22.1.  RP11-15G12 (chr2: 
142948672-143108539) and RP11-56K5 (chr2: 145006565-145166970) overlapped 
with breaks. Breaks sometimes extended beyond the two probes and were 
sometimes flanked telomerically by them, indicating some drift of the telomeric 
boundary of this region. The localisation of the breaks around this region is 
surprising – they appear telomerically from the LRP1B gene body and just outside 





Figure 3-9: FISH-based molecular localisation of breaks at the FRA2F site. Four BAC probes over a 5 
Mb region were used to map the localisation of breaks at the FRA2F region. Surprisingly, breaks 
were found to cluster at the telomeric end of that region, at the 2q22.2 -2q22.3 boundary and 
outside the LRP1B gene body and the late replication timing domain (defined from publicly 
available data from the IMR90 cell line) that encompasses it.  The location of breaks is indicated by 
the red bar. 
3.3 Investigating mitotic chromatin structure at CFS 
An unresolved question about common fragile sites is related to the nature of the 
molecular structures underlying the metaphase cytogenetic lesions. Historically, 
these lesions were assumed to represent single-stranded or double-stranded DNA 
breaks. However, as the interplay between the processes of DNA replication and 
mitotic compaction becomes clearer, the idea that CFS lesions may represent 
problems with mitotic condensation, rather than breaks, has become more popular. 
It has been demonstrated that condensin binding and the subsequent processes of 
chromosome condensation and sister chromatid separation are dependent on 
successful and timely DNA replication (Ono et al. 2013). CFS regions are likely to 
experience replication delays or even remain unreplicated in G2, and it is easy to 
imagine how this may reverberate through subsequent steps of mitotic chromatin 
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assembly. Therefore, I set out to investigate the chromatin structures of active CFS 
regions on metaphase chromosomes using FISH. I focused on two CFS regions: 
FRA1C and FRA4F, which I assayed in RPE1 and HCT116 cells, respectively. I used 
FISH-based hybridisations with BAC probes validated in the fine-mapping 
experiments as a tool to examine chromatin state in the two CFSs in chromosomes 
derived from control cells and from cells treated with aphidicolin.  
3.3.1 Mitotic chromatin across CFS 
Throughout my fine-mapping experiments, I was able to observe interesting 
features of chromatin compaction at common fragile sites. At some of the breaks, I 
observed that FISH probe signals appeared within the breaks, suggesting that there 
might be DNA present within the site. I quantified the fluorescence intensity for 
probes at two break sites – FRA1C and FRA4F, on chromosomes with cytological 
abnormalities. I found that the fluorescence intensity of the probes peaked over the 
DAPI – faint regions marking the CFS, consistent with DNA being present within the 




Figure 3-10 Fluorescence intensity of FISH probes spanning CFS breaks. I quantified the 
fluorescence intensity over breaks at the FRA1C (left) and FRA4F (right) CFSs. Top panel shows FISH 
images for the two sites and bottom panel shows the fluorescent intensities for the region marked 
in red in the images. High intensity signals appear over DAPI-faint areas at both sites. 
In addition to chromosomes carrying cytogenetic breaks, I also observed the 
chromatin states, as identified by the BAC probes, on chromosomes which did not 
carry any obvious abnormalities. Curiously, BAC probes hybridising to fragile loci 
frequently displayed atypical signals: instead of the symmetrical signals frequently 
observed on mitotic chromosomes, signals at CFSs would appear asymmetric, 
fragmented, concatenated between two chromatids and in the most extreme cases, 
appear to extend outside of the chromosome scaffold, reminiscent of uncompacted 
chromosome loops (Figure 3-11). Curiously, a similar phenotype has been described 
at telomeres previously, resulting from replication stress and depletion of 
components of the shelterin complex (Sfeir et al. 2009). I did not find any 
correspondence between the types of signals present and different CFS locations. 
However, I hypothesised that these signals indicated problems with the underlying 
chromosome structure, suggesting that even on cytogenetically normal 
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chromosomes, CFS regions show abnormal mitotic compaction. I therefore 
quantified the frequency of these atypical signals for two CFSs: FRA1C in RPE1 cells 
and FRA4F in HCT116 cells. 
 
Figure 3-11 Atypical FISH probe signals at CFS loci. From top to bottom: regular signals showing 
symmetrical spots on the two chromatids; fragmented: signals appear “fragmented” and are 
formed by multiple spots; concatenated: a single spot between two chromatids; extended –signal 
extends from chromosome scaffold, reminiscent of an uncompacted loop. 
3.3.2 FRA4F 
I quantified the frequency of irregular mitotic signals for six of the seven BAC probes 
used to fine-map FRA4F, only including cytogenetically normal chromosomes in my 
analysis.  I performed the scoring in chromosomes derived from cells that have 
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been treated with 0.4 M APH for 24 h and scored the BAC signal as either “regular” 
or “irregular”. The regular group included symmetrical signals made up of two 
spherical spots, while the irregular group encompassed all asymmetric, 
concatenated, fragmented and extended signals. Interesingly, the distribution of 
the irregular signals across the BACs correlated to the frequency of break overlap: 
the highest frequency of irregular signals was found around BAC probes which most 
frequently overlapped breaks at FRA4F, and tailed off at BACs which rarely 
overlapped with breaks (Figure 3-12). Similarly to the break distribution at this site, 
the frequency of atypical signals peaked at the centromeric boundary of the GRID2 
gene body and within the late replicating domain overlapping it. If the irregular 
signals are a sign of chromatin misfolding, this result suggests that the cytogenetic 
abnormalities at the FRA4F CFS site arise within a region that is highly prone to 




Figure 3-12 Atypical FISH probe signals across the FRA4F locus. Quantification of the frequency of 
atypical signals across six BAC probes used for fine-mapping FRA4F (red). Top panel shows the 
lesion overlap for each probe, while the mid panel shows the frequency of irregular signasl at each 
BAC. Bottom panel shows replication timing data for the IMR-90 cell line. 
3.3.3 FRA1C 
I next wanted to determine whether the observations for FRA4F could be confirmed 
for a different fragile site and in a different cell line. I therefore quantified the 
frequency of irregular signals across the FRA1C site in RPE1 cells following 
treatment with 0.4 M APH for 24 hours. Again, I scored BAC signals using the same 
criteria as for FRA4F. Although the frequency of atypical signals was lower in the 
RPE1 cell line, I observed a similar trend as for FRA4F: the highest proportion of 
atypical signals was seen for the BAC probes where breaks were most frequently 
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found. The rates of atypical signals were then reduced towards the boundary of the 
fragile region, suggesting that there is an overlap between the area of mitotic mis-
folding and the fragile core of the site. Unlike the FRA4F site, no long genes are 
present within FRA1C, although like most fragile sites it overlaps a region of late 
replication. This indicates that altered chromosome folding accompanying fragility 
at these two CFSs are independent of site-specific features such as long genes. 
 
Figure 3-13 Atypical FISH probe signals across the FRA1C locus. I quantified the frequency of 
atypical signals across five of the BAC probes used for fine-mapping FRA1C (shown in red). Top 
panel shows the lesion overlap for each probe, while the mid panel shows the frequency of 
irregular signal at each BAC. Bottom panel shows replication timing data for the IMR-90 cell line. 
Similar to the case at FRA4F, frequency of irregular signals at BAC probes mirrors the prevalence of 
break overlap for this site. 
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This data indicates that FRA4F and FRA1C both overlap with regions of localised 
mitotic mis-compaction in HCT116 and RPE1 cells respectively. It is highly likely that 
such mis-compaction mechanistically contributes to the generation of mitotic 
lesions at these two sites. I therefore set out to investigate how replication stress 
contributes to mitotic folding problems at these two loci. 
3.3.4 Influence of replication stress on mitotic compaction at 
FRA4F and FRA1C 
Initially, I set out to assess the frequency of mis-folding signals in the two locations 
in the absence of aphidicolin-generated replication stress. I performed 
hybridisations with the probes showing the highest frequencies of mis-folding in the 
FRA1C and FRA4F regions in chromosomes derived from cells which were not 
exposed to aphidicolin. In addition, I also performed hybridisations with two control 
BAC probes localising to non-fragile locations in the genome and assessed the 
frequency of regular and irregular signals at these probes. For both of the CFS 
probes, I found a significant increase in the frequency of irregular signals when cells 
were treated with aphidicolin (Figure 3-14). For FRA1C, the proportion of regular 
signals decreased from 70% in the absence of aphidicolin to 53 % upon induction of 
replication stress (-squared test p-value = 0.001). At FRA4F, the proportion of 
regular signals decreased from 45% to 26% upon aphidicolin treatment (-squared 
p-value = 0.01). However even in the absence of aphidicolin, some mis-folding was 
present in these regions, especially at the FRA4F locus in HCT116 cells: 51 % of 
signals at that site appeared irregular, which may be a reflection of the endogenous 
replication stress present in cancer-derived cells. The high rates of misfolding at 
FRA1C and FRA4F in untreated cells may indicate that CFS regions suffer problems 
with mitotic compaction even when cells go through an unperturbed replication. In 
contrast, the control probes showed very low level of mis-folding in untreated cells 
(6.8 % in RPE1 cells and 10.9 % in HCT116 cells). Surprisingly, these probes also 
showed a significant increase in the frequency of irregular signals upon aphidicolin 
treatment, despite the fact that they never overlapped with mitotic lesions.  
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However even after aphidicolin treatment, the rates of mitotic misfolding at the 
control probes remained substantially lower than at CFS regions. These results 
indicated that replication stress interferes with mitotic compaction, particularly at 
CFS regions.  
 
Figure 3-14 Effect of aphidicolin on mis-compaction in mitosis. Chromosome spreads from 
aphidicolin-treated and control RPE1 and HCT116 cells were hybridised to probes for FRA1C (RPE1 
cells), FRA4F (HCT116 cells) and control BACs mapped to non-fragile regions. Frequency of regular 
signals for each locus under each condition was calculated. Top graph summarises results from 
RPE1 cells. Both the control probe and the FRA1C probe showed a significance increase in 
misfolding upon aphidicolin treatment, however rates of misfolding at FRA1C were much higher 
compared to the control. A similar trend was observed in HCT116 cells (bottom panel).  FRA4F and 
a probe hybridising to a non-fragile genomic location both showed an increase in mis-folding 
signals upon replication stress induction. Rates of mis-folding were substantially higher at FRA4F 
compared to the control region.  
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3.3.5 Investigating the process of mitotic compaction at CFS 
regions 
I next aimed to investigate how the process of chromatin folding for mitosis differs 
at CFS regions compared to non-fragile regions. To do this I used the drug calyculin, 
a protein phosphatase inhibitor known to trigger chromosome compaction 
whatever the cell cycle stage - a process known as premature chromosome 
condensation (PCC). A remarkable property of PCC – derived chromosomes is that 
their morphology is indicative of the cell cycle stage they originated from (Kanda et 
al. 1999). G1-derived chromosomes have a single, zig-zag shaped chromatid (Figure 
3-15). S-phase chromosomes do not have the ability to compact completely and 
instead form condensed fragments, resulting in a “pulverized” appearance. Late S 
and G2 cells form chromosomes which are morphologically very similar to their 
mitotic counterparts, but are longer with a “fuzzy” appearance. Mitotic 
chromosomes from calyculin – treated cells appear normal and cannot be 
distinguished from chromosomes derived from untreated mitotic cells, although an 
increased frequency of breaks at CFSs has been observed following calyculin 
treatment (El Achkar et al. 2005).  To test the ability of a CFS region and a non-
fragile region on chromosome 11 to compact at different stages of the cell cycle, I 
treated HCT116 cells with 50 ng/ml calyculin for 1 hour to induce PCC. Prior to 
calyculin treatment, I pulsed cells with EdU for six hours, which allowed 
visualisation of replicated regions and aided the morphological categorisation of 
chromosomes into the different stages of the cell cycle: G1 chromosomes were 
EdU-negative, while S and G2 chromosomes were EdU positive. I prepared 
chromosome spreads from the calyculin –treated, EdU-labelled cells and hybridised 
them to RP11-351L22, the BAC probe showing the highest frequency of mis-folding 
at the FRA4F locus as well as a control BAC hybridising to chromosome 11, which 
never overlapped with breaks. Following FISH, a click-chemistry based staining was 
also performed on the slides to allow visualisation of EdU – positive cells. I 
quantified the frequency of uncompacted, “extended” signals at each of the two 
probes and throughout different cell cycle stages (Figure 3-15).  Interestingly, I 
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found that these “extended” signals had similar prevalence at the two locations 
during the G1 and S phases in the cell cycle. However, as cells transitioned into G2 
and M, the frequency of uncompacted signals sharply dropped off at the 
chromosome 11 locus. In contrast, at FRA4F, extended signals were present with 
comparable frequency throughout the cell cycle, indicating that the process which 
allows non-fragile locations to re-set their chromatin environment and compact for 








Figure 3-15 Premature chromosome condensation reveals differential compaction of CFSs and 
non-fragile sites prior to mitosis. HCT116 cells were pulsed with the thymidine analogue EdU, then 
treated with calyculin to induce premature chromosome condensation. Chromosomes from these 
cells were hybridised to probes for FRA4F CFS (green) and a control, non – fragile locus (red). PCC 
results in different chromosome morphologies, dependent on the cell cycle stage the cells were 
derived from which are shown in the top panel: G1 chromosomes have a single chromatid 
following a zig-zag path and are EdU negative. S-phase chromosomes have a “pulverised” 
appearance and have diffuse EdU staining. G2 chromosomes appear similar to mitotic 
chromosomes, but are longer and “fuzzier” and are also EdU positive. Mitotic chromosomes 
appear normal and only the late replicating bands were labelled with EdU. Bottom panel shows 
the quantification of extended, uncompacted signal for the two FISH probes across different cell 
cycle stages.  
To determine if FISH signals could be used as a probe for chromatin state, I also 
quantified the frequencies of single spot signals and signals consisting of two spots 
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or more at each cell cycle stage. I observed that as cells moved through the cell 
cycle, the frequency of single spot signals was decreased and the frequency of 
signals consisting of two or more spots was increased for both the FRA4F and the 
control probe. This indicated that FISH signals can provide a reliable readout for the 
underlying chromatin state of a locus and is consistent with previous studies which  
have used the number of separate signals at a locus as an indication of whether the 
site has replicated (Palakodeti et al. 2009).  
 
Figure 3-16 Number of separate signals at a FISH probe is indicative of the replication status of the 
locus. Chromosomes were prepared from calyculin treated cells and hybridised to probes for the 
FRA4F locus and a control locus. The frequency of probes producing single spot signals (top graph) 
and two or more signals (bottom graph) was characterised for different stages of the cell cycle. The 
frequency of single spot signals decreased for both probes as cells transitioned through S-phase. 
The frequency of two or more signals per probe increased throughout the cell cycle, indicating the 




3.4 Transcription at CFS 
The question of whether transcription influences the fragility of CFS regions is 
unresolved. Contribution from transcription is suspected, as a high proportion of 
CFSs are located in the vicinity, or span, long genes. The difficulty in correlating 
gene expression and fragility derives from the cell-type specific nature of these two 
factors- not many studies have measured CFS fragility and gene expression in the 
same cell type. A study in HCT116 measured expression levels across 24 CFS – 
associated genes and found no signs of relationship between transcription and 
fragility in the presence or absence of aphidicolin (Le Tallec et al. 2013). In contrast, 
a more mechanistic study found that transcribing the full length of long genes such 
as the CFS – associated FHIT and WWOX can take more than the entire cell cycle, 
which would suggest that transcription and replication must happen concurrently at 
these loci (Helmrich et al. 2011). This study also found a surprisingly good 
correlation between gene expression of very long genes and metaphase CFS breaks 
in lymphoblast and myoblast cells. Furthermore, the authors demonstrated the 
formation of R-loops at FRA3B and an increase in CFS fragility in the absence of 
RNase H, concluding that RNA: DNA hybrids are implicated in CFS breakage. CFSs 
have also been identified as regions where mutations accumulate as a result of 
transcriptional stress upon RECQL5 depletion (Saponaro et al. 2014). 
I wanted to investigate the effect of transcription across the set of CFSs I have 
identified in the RPE1 and HCT116 cell lines. As this included CFSs with differential 
fragility in the two cell lines, I reasoned that comparing the transcriptional 
landscapes across a number of fragile regions on stable and unstable backgrounds 
would be very informative. I therefore performed total, ribosome-depleted RNA 
sequencing in the RPE1 cell line and analysed a publicly available dataset of RNA-
seq for the HCT116 cell line. 
RNA-seq in the RPE1 cell line was performed as described in 2.4.3.  A total of 
26,476,759 50-bp reads were analysed, of which 78.73% mapped to ribosomal DNA 
genes and were removed from further analysis. PCR duplicates were also removed 
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and the remaining 3,767,750 reads were mapped to the transcriptome using the 
TopHat aligner (Trapnell et al. 2012). Fragments per kilobase per million reads 
(FPKM) values were then calculated with the Cufflinks package and the data was 
converted from the bam file format into the BigWig format using Samtools (Li et al. 
2009) and uploaded into the UCSC Genome Browser for visualisation.  
For the HCT116 cells, a dataset from the Gene Expersion Omnibus (GEO) database 
was selected (accession number GSM855450).  This dataset contained 28,208,553 
36-bp reads, of which only 1.17% mapped to ribosomal genes. The difference with 
RPE1 cells is likely due to the fact that RNA in this sample was prepared via positive 
selection for polyA RNA species, rather than rRNA depletion.  Following PCR 
duplicate removal, 11,444,955 reads remained and were analysed in the same 
manner as the RPE1 sample, using TopHat, Cufflinks and Samtools. As more reads 
were analysed for the HCT116 cell line, the genome coverage for that sample was 
higher. 
3.4.1 Correlations between transcriptional levels and fragility 
in RPE1 cells  
I first examined the relationship between steady state transcription levels and 
fragility in RPE1 cells. I selected the 13 fragile cytogenetic locations I defined in the 
RPE1 cell line (Table 3-1) and investigated how the distribution at FPKM values 
within those regions related to the frequency of breaks. If expression levels of 
transcripts across the region contribute directly to fragility in a simple, linear 
manner, it would be expected that locations where most breaks occur would also 
have the highest median levels of expression. I did not observe this tendency in the 
RPE1 cell line (Figure 3-17). The most fragile location in RPE1 cells, FRA1C at 1p31.2, 
contained no annotated transcripts. Another highly fragile CFS, FRA2F at 2q22.2, 
where 8.5% of all breaks occurred, also did not contain any transcribed genes. For 
the remaining locations, there was no correlation between fragility and median 
transcriptional levels across the region (measured in FPKM) and fragility. In fact, loci 
with lower frequency of breaks such as FRA5C and FRA7G contained more highly 
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expressed transcripts than highly fragile locations such as FRA3O. To assess whether 
single, highly expressed transcripts contribute to fragility, I also examined whether 
the highest FPKM within each CFS region correlated with fragility (Figure 3-17). 
Again, I found no evidence to support this hypothesis – the maximum FPKM values 
for each region showed no correlation with fragility.  
 
Figure 3-17 Relationship between transcription levels and fragility in the RPE1 cell line. Top panel 
shows the FPKM value for the most highly expressed transcript within each active fragile site in 
the RPE1 cell line, with CFSs ranked according to fragility levels. The bottom panel shows boxplots 
of all FPKM values for transcripts encompassed within each of the CFS regions. 
Another possibility is that expression of single, long transcripts rather than overall 
transcriptional levels contribute to fragility. To test this, I selected the largest 
transcript for each cytogenetic location and compared the FPKM values to the 
fragility at each site (Table 3-4). Again, there was no evidence for an increase in 
FPKM value corresponding to an increase in fragility, suggesting that no linear 
correlation exists between transcription levels and fragility. 
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CFS Rank Transcript 
length 
FPKM 
FRA3O 2 946,318 1.11256 
4q32.2 3 89,327 0 
7q21 4 1,436,517 1.04611 
FRA2F 5 64,691 0 
FRA4C 6 437,688 1.39494 
FRA13H 7 466,167 0 
FRA2U 8 1,162,911 0.148107 
3p24.3 9 585,587 22.464 
13q14.11 10 573,451 0 
FRA2G 11 203,116 15.907 
FRA7G 12 899,468 12.4517 
FRA5C 13 416,072 0 
Table 3-4 Expression levels of long transcripts at RPE1 CFS regions. 
3.4.2 Transcriptional Correlations at HCT116 CFSs 
I performed a similar analysis in the HCT116 cells to determine if a correlation 
between fragility and expression levels could be observed in the context of a cancer 
cell line. I determined the maximum and median FPKM values for all transcripts 
spanning fragile regions from the HCT116 CFS repertoire. Similarly to the RPE1 cells, 
I found no evidence for correlation between transcriptional levels and fragility. 
FRA5C, which was ranked as the 8th most frequent site of breakage and represented 
just 5.2% of all breaks, contained the most highly expressed transcripts. Sites like 
FRA2I and FRA4F, which were the 2nd and 3rd most frequent, had very low levels of 
transcription. The highest FPKM value within a region also showed no correlation 
with fragility (Figure 3-18). When the expression levels of the longest transcripts 
within each region were considered, there was still no clear correlation between 
transcription and fragility (Table 3-5). Notably, FHIT, spanning the most fragile CFS, 
FRA3B, was expressed at higher level than long transcripts at the other less 
frequent CFSs. That tendency was not observed for other frequent CFSs in the 
HCT116 cell line, such as FRA4F and FRA2T, where the longest transcripts were 




Figure 3-18 Relationship between transcription levels and fragility in the HCT116 cell line. 
Transcription levels across a number of fragile locations in the HCT116 cell line were investigated. . 
Top panel shows the FPKM value for the most highly expressed transcript within each active 
fragile site in the RPE1 cell line, with CFSs ranked according to fragility levels. The bottom panel 
shows boxplots of all FPKM values for transcripts encompassed within each of the CFS regions. 
CFS Rank Transcrip 
length 
FPKM 
FRA3B 1 1502098 14.6316 
FRA2I 2 203116 1.93857 
FRA4F 3 1474687 0.165873 
FRA2T 4 467341 0.00414 
FRA7K 5 899468 6.37539 
FRA2F 6 164691 0 
FRA1C 7 NA NA 
FRA5C 8 311401 3.26769 
FRA3L 9 809181 2.4204 
FRA3G 10 367469 1.0942 
FRA3A 11 387513 10.9447 
FRA4C 12 437688 2.62547 
FRA3O 13 946318 0.27698 
Table 3-5 Expression levels of long transcripts at HCT116 CFS regions. 
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3.4.3 Transcription as a determinant of instability at CFS 
The analysis above indicates that no linear correlation exists between levels of 
transcription at a CFS and its fragility. However, it is possible that transcription still 
plays a role in determining fragility at CFS loci. I exploited the differential CFS 
repertoires of the HCT116 and RPE1 cell line and compared the transcriptional 
landscapes across the most fragile locations in the two cell lines (Figure 3-19). If 
transcription is necessary, or plays a substantial role in inducing CFS fragility, I 
would expect to observe higher levels of transcription across a CFS in the cell line 
where the site is active. Comparing the transcriptional landscape across four 
common CFSs in the RPE1 cell line reveals that three of them do show higher 
transcriptional levels in RPE1 cells compared to HCT116 cells. This was not case for 
FRA2F, which displayed extremely low levels of transcription in both cell types. This 
trend could not be confirmed in the HCT116 cell line:  three of the most fragile CFSs 
in that line showed lower overall levels of transcription in HCT116 than in RPE1 
cells. The most fragile location in the HCT116 cells, FRA3B, showed higher levels of 




Figure 3-19 Transcriptional levels across active and inactive CFS regions. Expression levels (FPKM) 
for transcripts within the most frequent CFSs in RPE1 (A) and HCT116 (B) cells. Boxplots for the cell 
line where the site is active are shown in red and boxplots for the cell line where the site is 
inactive are shown in black.  
Visual examination of the RNA-seq tracks at the FRA3B site confirmed that FHIT was 
expressed in the HCT116 cell line and not in the RPE1 cell line (Figure 3-20). While 
this is an interesting property of the FRA3B site, such tendency is not observed for 
other CFS regions in the HCT116 cell line. HCT116 CFSs with high fragility containing 
long genes included FRA4F and FRA3A. FRA4F contains the long genes GRID2 (1.46 
Mb) and CCSER1 (1.47 Mb). No transcription was seen across the gene bodies for 
either of these two genes in the HCT116 and the RPE1 cell line. CCSER1 appears to 
show extremely low expression in a number of tissues, including testis and brain 
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tissues. GRID2 codes for a protein from the glutamate receptor family, which is only 
expressed in cerebellar Purkinje cells. FRA3A contains ZNF385D, a 0.93 Mb long 
gene, which was also not transcribed in either of the two cell lines. In the RPE1 cell 
line, higher expression levels were observed at FRA3O and the novel sites 4q32.2-
4q32.2 and 7q21.12.  However, this was associated with shorter transcripts, rather 
than a single long transcript as in the case of FRA3B. Therefore the data does not 
support a simple model where transcription of long genes is necessary or 
contributes to fragility. However, it is possible that transcription plays a role in a 
subset of CFS locations, such as FRA3B. 
 
Figure 3-20 Transcriptional landscape across the FRA3B CFS in RPE1 and HCT116 cells. The 
positions of the fosmid probes used to fine-map the site are shown in black. The region where 
breaks occur is marked by a black bar. FPKM values for the RPE1 cell line (top panel) and the 
HCT116 cell line (2nd panel) are shown. A difference in the expression levels between the two cell 




3.5 Modifying transcriptional levels at the FRA3B site 
Although RNA-seq data did not support the hypothesis that transcription 
contributes to CFS breakage, at FRA3B, the transcriptional landscape appeared to 
correlate with fragility. This was an intriguing observation and I looked to explore 
the influence of transcription at this CFS further. I therefore used the CRISPR 
genome editing system to modify the expression levels of FHIT in sub-clones of the 
HCT116 cell line and investigated the effect of these changes on the fragility of the 
FRA3B locus.  
The CRISPR system has been used to modify gene expression in many studies. These 
studies are mostly based on using CRISPR to recruit transcriptional activators (such 
as VP16) or repressors (such as SETB1) to defined genomic locations (Sander & 
Joung 2014). I avoided these approaches, as they are very transient and work 
through modifying the surrounding chromatin structure. Although changes in 
transcriptional levels are likely to be accompanied by changes in chromatin 
structure, I hoped to avoid large-scale alterations and preserve the local chromatin 
context at FRA3B, since I aimed to measure the direct effects of transcriptional 
levels on fragility and avoid confounding factors.   With that aim, I targeted the 
CRISPR Cas9 system to the FHIT promoter to induce random breaks within a 
population of HCT116 cells, anticipating that some of the changes will result in 
alterations in transcriptional levels. Screening of multiple isolated clones revealed 
that some clones showed differential transcription at FHIT as a result of small 
sequence changes, which I then used in subsequent experiments. 
3.5.1 CRISPR guideRNA design 
Since the experimental design was based on modifying FHIT expression via 
induction of promoter mutations, it was important to establish whether FHIT is 
transcribed from a single promoter. The UCSC Genome Browser does not list any 
transcripts initiating from alternative promoters. I also examined publicly available 
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datasets containing information on nascent RNA reads, generated by GRO-Seq (GEO 
Database Sample GSM1124062) and found no evidence of transcripts originating 
from additional promoters in the HCT116 cell line. I then focused on the promoter 
region of FHIT. The transcription start site was identified via the RNA sequencing. 
Immediately upstream from the transcription start site was a region of reversal of 
GRO-seq read direction from the anti-sense to the sense strand, indicating the 
promoter position. I selected a 100 base pair sequence centred on the transcription 
start site, which I input into the Zhang Lab Optimised CRISPR Design tool (Ran et al. 
2013). The design tool suggested five target sites on the positive strand and five 
target sites on the negative strand. I then performed a BLAST search with the guide 
RNA sequences to ensure they were not hybridising to off-target genomic locations 
and assessed the predicted off-target effects for each target site. Ultimately, I 
selected two target sites (called 2 and 8), both of which overlapped with the FHIT 
transcription start site, however one was located on the positive strand and the 
other - on the negative strand (Figure 3-21). I then designed two complementary 
oligos for each target site, which included the target site sequence, surrounded by 
the overhangs generated by the BbsI enzyme used to clone the RNAs into the px458 
CRISPR vector (Ran et al. 2013), Table 3-6. 
















Table 3-6 Target sites and oligo sequences used to target CRISPR Cas9 to the FHIT start site. 
Overhangs used for cloning are highlighted in bold. 
The two oligos for each target site were annealed and cloned into a linearized 
px458 vector, which carries the wild type Cas9 protein, as well as ampicillin 
resistance and EGFP for selection.  Successful ligation of the annealed oligoes into 




Figure 3-21 Selection of CRISPR target sites in the FHIT promoter region. HCT116 RNA-seq data is 
shown in the bottom panel, indicating the transcription start site. The FHIT gene track on UCSC is 
shown in blue.  GRO-seq data for the HCT116 cell line is shown in the mid panel. Reversal of read 
direction can be seen just upstream of the transcription start site, indicating the promoter 





Figure 3-22 Sequencing traces showing successful ligation of the guide RNAs gRNA2 and gRNA8 in 
the px458 vector. Transformed DH5 cells were plated on ampicillin plates. Colonies were selected 
and grown overnight and plasmid DNA was isolated. Plasmid DNA was then sequenced with the 
U6 forward primer (GACTATCATATGCTTACCGT), corresponding to the U6 promoter present in the 
px458 plasmid. 
3.5.2 Assessing the efficiency of CRISPR in the HCT116 cell line 
Next, I wanted to determine the efficiency of each of the two gRNAs in generating 
sequence changes at the target sites and examine the types of mutations that the 
CRISPR-Cas9 system can induce in these conditions. 
To do this, I transfected the vectors containing the gRNAs 2 and 8 into HCT116 cells.  
Successfully transfected cells expressed EGFP and were quantified by flow 
cytometry, indicating that transfection efficiency was 40% for gRNA8 and 29% for 
gRNA2. I isolated the EGFP-positive population via FACS and grew the cells for 72 
hours, allowing the CRISPR-Cas9 to induce various sequence alterations. Next, I 
extracted genomic DNA from this cell population and amplified a 594 bp region 
surrounding the target site, using primers listed in Table 3-7. If the CRISPR-Cas9 
complexed with the selected gRNAs is efficient at inducing mutations at the target 
sites, I would expect that the amplified DNA would be made up of a pool of 
different amplicons with various mutations. Therefore, I performed TA cloning with 
the products of the PCR amplification reaction, which allowed me to isolate and 
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sequence individual amplicons. For the guide RNA8 samples, I was unable to find 
any examples of sequence changes. However, I found a range of alterations in the 
samples derived from cells transfected with the guide RNA2 vector. Among 78 
different sequences derived from the TA-clones, 51 carried sequence changes. The 
most common changes were single base substitutions. Small deletions were also 
common and there was a recurrent 10 base pair deletion which was present in four 
of the sequenced samples. Larger deletions were rarer, but still present: a 49 bp and 
a 78 bp deletions were among the alterations in the 78 samples sequenced. Only 
two insertions were observed- one was 20bp long and the origin of the donor 
sequence could not be determined; the other insertion was 150 bp long and 
mapped to the U6 promoter region, indicating that a part of the px458 vector was 
integrated into the genome. The locations of the deletions induced by the gRNA2 
targeted CRISPR Cas9 are shown on Figure 3-23. Overall, my conclusion was that 
oligo gRNA2 successfully guided CRISPR Cas9 to the FHIT start site, where it induced 
a wide range of sequence alterations with the potential to impact on transcription. 
FHIT sequencing forward FHIT sequencing reverse 
GTGCGGTACAGCCTTTCGTTACACG CTCGTGGGGCGGAAGAGTAC 





Figure 3-23 Sequence alterations at the FHIT promoter region. HCT116 cells were transfected with 
the px458 vector carrying the guide RNA2 or guide RNA8, which target the CRISPR Cas9 nuclease to 
the FHIT promoter region. Genomic DNA was isolated from the cells after 72 hours, the region 
surrounding the target sites was amplified and the amplicons were TA-cloned to assess individual 
mutations. A. Positions of the guide RNAs used in the experiment are outlined in red and shown at 
the top panel. The panel below shows the locations and extent of deletions induced by Cas9 
targeted by gRNA2, ranging from 1 to 78 bp. RNA-seq FPKM values are shown in green below, 
indicating the FHIT transcription start site. B. Frequency distributions of sequence alterations in 78 
TA clones derived from the HCT116 cell population targeted with gRNA2. 
3.5.3 Identification of clones with differential FHIT expression 
After confirming that one of the guide RNAs, gRNA2, could successfully target 
CRISPR Cas9 to induce a range of mutations around the target site, I grew single cell 
clones carrying mutations at the FHIT locus and assessed their effect on gene 
expression. I transfected an HCT116 cell population with the CRISPR Cas9 gRNA2 
vector and allowed 48 hours for the nuclease to induce mutations. I then used FACS 
to isolate single cells from the transfected, GFP-positive cell population. I expanded 
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the single cell clones and screened them altered FHIT expression. To perform the 
screening, I extracted RNA from each clonal population and investigated the mRNA 
levels of the FHIT transcript using qPCR with three sets of primers located 
throughout the gene body. Screening with primers located at various points 
throughout the FHIT gene allowed me to determine if any alternative transcripts 
replaced the full-length transcript in the different clones (Figure 3-24). A total of 50 
clones were screened. Clones which showed changes in FHIT expression were 
analysed independently at least three times. Two clones showing a consistent 
change in FHIT expression compared to the parental cell line were finally identified: 
F15 showed a reduced expression, while F3 demonstrated a consistent increase in 
transcriptional levels at the site. 
 
Figure 3-24 Screening clones for altered FHIT expression. Single cell clones were grown from a 
population transfected with gRNA2- targeted CRISPR-Cas9. The clones were expanded and 
screened for expression of FHIT with three different qPCR reactions spanning six exons of the 
gene. The positions of the qPCR primers and amplicons are shown in the top panel. The bottom 
panel shows fold changes for two clones showing differential expression of FHIT compared to the 
parental cell line. 
I next examined the underlying sequence changes in the F15 and F3 clones by 
sequencing a 594 bp region surrounding the FHIT transcription start site using 
primers listed in Table 3-7. The clone over-expressing FHIT compared to the 
parental cells, F3, was a compound heterozygote. It carried a 10 bp deletion on one 
allele and a 19 bp deletion on the other. Both deletions partially overlapped with 
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the gRNA2 target site and were immediately upstream of the FHIT promoter (Figure 
3-25). It is not clear how these deletions resulted in the consistent overexpression 
of FHIT. F15, the clone showing a reduced level of FHIT expression, carried a 
homozygous indel: 10 base pairs were deleted from the original sequence around 
the gRNA2 target site and a 425 bp insertion from an intronic region on 
chromosome 9 was present on both alleles. This is likely to have arisen from 
homologous recombination, with one allele first becoming mutated and then 
replacing the wild type allele. Interestingly, rs9880846, a SNP located 75 bp from 
the gRNA2 target site, was homozygous in that clone (G/G) and heterozygous in the 
parental HCT116 cell line (A/G), supporting the conclusion that homologous 
recombination took place in this clone. Again, it is not clear how the insertion of this 
intronic sequence resulted in a decrease of expression. 
 
Figure 3-25 Sequence alterations in clones with modified FHIT expression. The F3 and F15 clones, 
showing modified expression of FHIT compared to the parental HCT116 cell line, were sequenced 
to determine the underlying genomic changes.  F3, which shows increased FHIT expression 
compared to the parental cell line is a compound heterozygote carrying a 10 bp deletion on one 
allele and a 19 bp deletion on the other (black).  F15, a clone consistently under-expressing FHIT 
compared to HCT116 cells, had a homozygous indel, encompassing a 10 bp deletion and an 
insertion of a 425 bp intronic sequence from chromosome 9. The gRNA2 target site is indicated in 
black and the bottom panel shows the FHIT transcription start site, as indicated by RNA-
sequencing reads in the HCT116 cell line. 
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3.5.4 FRA3B fragility in clones with differential FHIT 
expression 
After identifying clones with variant FHIT expression, I investigated how these 
changes in transcription influence the fragility of FRA3B. I treated F3 and F15 clones 
with 0.4 M APH for 24 hours and prepared metaphase spreads with chromosomes 
derived from these cells. I determined the frequency of breaks at the FRA3B site, as 
well as the mean break frequency for the two samples and compared them to the 
frequencies in the HCT116 cell line under the same treatment conditions. I assessed 
53 and 57 metaphases for the F15 and F3 clones respectively and compared them 
to the HCT116 data generated in the process of CFS repertoire characterisation 
(Section 3.1.2).  In the under-expressing F15 clone, the average rate of breakage at 
FRA3B was 0.22 breaks/metaphase, compared to 0.19 breaks/metaphase for the 
HCT116 cells, while the mean number of breaks per metaphase was increased in the 
clonal population, at 2.86 compared to 1.88 in the parental cells (Figure 3-26). The 
difference in fragility at FRA3B was clearly significant (two-tailed t-test,  p = 0.02), 
but contrary to what would be expected if transcription contributed to fragility, 
FRA3B was more fragile in this under-expressing clone, compared to the parental 
cells. Notably, the difference in the overall frequency of breaks was also statistically 
significant (two-tailed t-test p = 0.003). The increase in the overall fragility in these 
cells could be due to a number of reasons. FHIT encodes a diadenosine 5', 5’’’-P1, 
P3-triphosphate hydrolase involved in purine metabolism and its loss results in 
increased replication stress and genomic instability (Miuma et al. 2013) and it is 
possible that the decrease in FHIT expression could lead to an increase in fragility. 
Therefore, the slight increase in fragility at FRA3B in the F15 clones could reflect a 
general increase in CFS instability, rather than a locus-specific effect, related to the 
change in transcription. In F3, the clone over-expressing FHIT, the rate of breakage 
at FRA3B was higher than in both F3 and the HCT116 cell line (0.40 breaks per 
metaphase at FRA3B) and highly statistically significant (two-tailed t-test p = 0.004). 
In this cell line, the average number of breaks per metaphase was also higher than 
the HCT116 cells (2.5 breaks / metaphase), however that increase was not 
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statistically significant. Therefore, the big increase of fragility at FRA3B is likely to be 
locus-specific and due to modified transcriptional levels. These results suggest that 
there is a complex relationship between transcription and fragility at the FRA3B 
locus and possibly, other CFSs. The fact that fragility was preserved in the F15 cells, 
which express FHIT at a very low level, implies that transcription is not necessary or 
needed for fragility. On the other hand, the increase in the F3 population suggests 
that transcription can contribute to increased fragility once a CFS is active and 
unstable within a genomic context. 
 
Figure 3-26 Break frequencies in clones with modified FHIT expression compared to the parental 
HCT116 cells. Top graph shows the break frequencies at FRA3B for HCT116 and the two modified 
cell lines. Both the under-expressing F15 and the over-expressing F3 showed a statistically 
significant increase in fragility compared to the parental cell line. p-values are given for  two-tailed 
t-tests.  Bottom graph shows the overall frequency of CFS breaks (given as breaks per metaphase) 
for the three cell lines. CFS fragility was significantly increased in the F15 cell line, possibly 
reflecting the damaging effects of FHIT under-expression. 
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3.5.5 Influence of transcription on mitotic chromatin 
structure at CFS 
Finally, I wanted to investigate how a change in transcription could affect the 
mitotic chromatin structure at FRA3B. I hybridised probes used for fine-mapping the 
FRA3B region (Section 3.2.2.1) to chromosome spreads prepared from F3 and F15 
cells treated with aphidicolin and quantified the frequency of atypical signals at 
each probe for the two clones compared them to the frequencies of atypical signals 
observed in the parental cell line. I assessed a total of 208 and 176 metaphases 
from the F3 and the F15 clone, respectively. I did not observe a difference in the 
frequency of atypical signals at Probe 2, which hybridises immediately upstream of 
exon 3 and is closest to the FHIT promoter (Figure 3-27). However, I observed an 
increase in the frequency of atypical signals in both clones for probe 1, which 
hybridises downstream from the 3’ end of FHIT and flanks the fragile region in the 
HCT116 cell line telomerically. The increase was especially pronounced for the F3 
clone, which over-expresses FHIT, where only 54% of the signals appeared normal 
versus 82 % in the parental cell line. Intriguingly this suggests that the increase in 
FHIT transcription rates results in a corresponding increase in mitotic mis-folding at 
FRA3B. Unfortunately, as both measurements are performed on a population level, 
it is impossible to determine whether this is due to an increased transcription of the 
gene or an increased proportion of cells expressing FHIT. Similarly to the increased 
rate of breaks at FRA3B in the F3 clone, this result hints at a complex relationship 
between transcription and CFS fragility. 
In addition to mapping the frequency of mis-folding signals, these experiments 
enabled me to analyse the localisation of FHIT breaks in the two sub-clonal 
populations. In the parental HCT116 cell line, all FRA3B breaks occurred between 
probes 1 and 2, over the FHIT gene body. Surprisingly, there appeared to be drifting 
of breaks in the two sub-clones. In F3, the breaks appeared to drift slightly 
centromerically compared to the parental line, with a small proportion of breaks 
overlapping with Probe 3. The tendency for centromeric drift of breaks was even 
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stronger in the under-expressing F15 clone. With a single modified site, it is difficult 
to assess whether the break drift appeared as a consequence of the change in 
transcription at FHIT or due to inherent clone-to-clone variation, but again shows 
heterogeneity in fragile site behaviour. 
 
Figure 3-27 Mitotic chromatin structure in clones with modified FHIT expression. Metaphase 
spreads were prepared from F3 and F15 cells following treatment with 0.4 M aphidicolin for 24 
hours and hybridised to probes used for fine-mapping FRA3B.  The percentage of regular signals 
and break overlap for each probe was quantified and compared to the parental cell line. Probe 
positions and the extent of the fragile region in the HCT116 cells are indicated in the top panel. 
The middle panel shows the frequency of regular sequence for Probe 1 and Probe 2 in the two 
clones and the HCT116 cell line.  An increase in the frequency of atypical signals was observed for 
both clones at Probe 2. Bottom panel shows break positions for Probes 1, 2 and 3 in the F3 and F15 
cells. The percentage of breaks where the probe is located telomerically (dark grey) 




In this chapter, I have assessed the CFS repertoire in the RPE1 and HCT116 cell lines, 
the structure of mitotic chromatin at fragile regions and the contribution of 
transcription to instability at CFS. 
I found that as expected, the RPE1 and HCT116 cell lines show differential CFS 
expression. Three of the fragile locations appeared to be shared between the two 
cell types- FRA1C, FRA2F and FRA3O, however breakage at these sites occurred at 
very different frequencies between the two lines. CFS mapping revealed some novel 
fragile sites in the RPE1 cell line, while fragile locations in the HCT116 line were 
consistent with previous mapping (Le Tallec et al. 2013), although at different break 
frequencies. Interestingly, the repertoire of fragility in both of the cell types was 
primarily made up of a small group of sites showing frequent, recurrent breaks 
combined with a larger number of locations forming breaks very rarely. Even at the 
most frequent sites, cytogenetic breaks were observed in only 20% of metaphases, 
underlying the stochastic nature of CFS breakage. Interestingly, more breaks and 
more severe phenotypes were observed in the tumour-derived HCT116 line, 
consistent with evidence that cancer cells show endogenous replication stress 
(Miron et al. 2015).  
While many of the lesions in the two cell types presented as chromatid gaps and 
breaks, other types of defects, such as constrictions and concatenations were also 
observed. This raised the long running question of the underlying chromatin state at 
CFS regions: while widely accepted as breaks in the past, recent literature also 
speculates that these sites may represent regions of defective chromosome 
condensation. Decondensation effects induced by ethidium bromide and 5-
azacytidine resemble fragile site lesions, while in a recent study  CFSs were 
identified as sites of mitotic DNA synthesis and the authors speculated that mitotic 
compaction exposes CFS regions to facilitate repair synthesis (Minocherhomji et al. 
2015). Hybridisation of BAC probes at CFS regions resulted in a high frequency of 
abnormal FISH signals specific to non-fragile locations, suggesting they can be used 
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as a tool to study defects in mitotic folding at CFS regions. The atypical signals were 
highly suggestive of problems such as concatenations and failure of mitotic 
condensation. Interestingly, the frequency of these signals on cytogenetically 
normal chromosomes mirrored the frequency of breaks and the domain of 
misfolding overlapped and extended beyond the fragile region. This suggests CFSs 
are located within regions prone to misfolding in mitosis, which is frequently 
present at the molecular level even when cytogenetic abnormalities are not 
observed. Presence of replication stress increases the likelihood of misfolding, 
although some problems with compaction persist even when cells go through the 
cell cycle unperturbed. I also observed the mis-compaction in both of the cell types, 
and across two distinct CFS loci with different features: FRA1C is gene-poor, while 
FRA4F spans two genes with a length over 1 Mb; this raises the exciting possibility 
that mitotic mis-folding is a universal and specific feature of common fragile sites. It 
is notable that the HCT116 cell line showed higher frequency of compaction failure, 
consistent with the higher frequency of breaks observed in this cell line. Triggering 
premature chromosome condensation indicated that at non-fragile locations, 
chromatin is re-set through the cell cycle to allow mitotic condensation, while this 
process does not happen at the FRA4F CFS locus. These observations implicate 
chromatin state as an important contributor to CFS fragility. 
Following the determination of the cytogenetic and molecular locations for a set of 
CFSs, I was able to assess the contribution of transcription to fragility. Due to the 
significant association of CFS regions with large genes, transcription has long been 
suspected as a determinant of breakage at CFS. This idea is strengthened by 
evidence that RNaseH expression reduces CFS fragility (Helmrich et al. 2011) and 
that depletion of the elongation factor RECQL5 is found to induce genomic 
alterations at CFS regions. Confusingly, efforts to relate transcription levels to 
fragility have yielded negative results (Le Tallec et al. 2013). RNA-seq data from the 
two cell lines indicated that there was no direct relationship between transcription 
and fragility and that transcription was not necessary for CFS expression. However, 
these observations do not exclude transcription as a possible determinant of CFS 
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fragility. To approach the question in a novel manner, I used CRISPR-Cas9 to modify 
transcriptional levels at one of the best studied CFS regions, FRA3B.  Genome-
editing has never been used to modify and dissect the features of CFS formation to 
date. I was able to successfully generate HCT116 clones with modified expression of 
the FRA3B-associated gene FHIT and observe the effects of this alteration on break 
formation and mitotic folding within the region. The results were surprising. 
Reduced transcription did not lead to a reduction in the fragility of FRA3B, 
reinforcing the idea that gene expression is not required for instability.  However, 
an increase in the expression levels led to a corresponding increase in fragility and 
the frequency of abnormal mitotic structures, indicating that once instability is 














4 Chapter 4: Characterisation of replication timing in 
the RPE1 and HCT116 cell line using Click-seq 
 
Replication of the genome follows a carefully regulated temporal order, which 
varies between different cell types. It is not completely clear how this order is 
established:  studies of replication timing in a range of cells of varying lineages and 
developmental stages show that half of the genome retains constant timing across 
cell types, whilst the rest of the genome shows variable replication timing across 
different linages (Ryba et al. 2010). It is also well known that temporal replication 
order is related to the functional organisation of the genome: gene-rich regions, 
encoding expressed genes tend to replicate earlier than heterochromatic regions.  
Consequently, replication timing shifts are known to correspond to changes in 
transcriptional state. Replication domain boundaries are also known to correspond 
to boundaries of topologically associated domains and are structurally established 
in early G1, at the same time as TADs (Dileep et al. 2015). 
The careful orchestration of the replication program is achieved through regulation 
of origin activation. While the exact sequence and chromatin context determinants 
of mammalian replication origins are not defined, it is known that they frequently 
appear in clusters, with different origins firing stochastically at the individual cell 
level.  Numerous origins are licensed in early G1, by the loading of the MCM2-7 
complex and the assembly of the pre-replicative complexes (pre-RCs), however, 
only a small number of the licensed origins initiate replication in S phase, with 
estimates that as few as one in three to one in ten licensed origins ultimately fire 
(Blow et al. 2011). The licencing of a sufficient number of origins is verified at the 
licensing check point in G1 and if necessary, dormant origins can be recruited in 
response to fork stalling or DNA damage signalling (Blow et al. 2011). Firing of an 
origin is initiated via activation of the pre-loaded MCM2-7 complex at the onset of 
S-phase, which, when activated, encompasses a helicase working to unwind DNA in 
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front of the replication fork. Replication then proceeds bi-directionally from each 
origin. 
The most prevalent method for studying replication dynamics is through 
incorporation of modified nucleotides into newly synthesised DNA. The use of 
modified nucleosides dates back to 1950s, when tritium-labelled thymidine was first 
used to track DNA synthesis via radiolabelling. The modified bases BrdU, chloro-
deoxyuridine (CldU) and iodo-deoxyuridine (IdU) were later used in a similar 
manner, allowing detection through antibodies, which resulted in better signal and 
resolution. The use of multiple analogues also enabled double pulse experiments, 
which made studies examining fork speed and symmetry feasible. The antibody-
based detection of BrdU also resulted in the development of Repli-seq, an 
immunoprecipitation (IP) -  based method for isolating and sequencing newly 
replicated DNA (Hansen et al. 2010). In the Repli-seq methodology, cells are pulsed 
with BrdU for a short period of time and subsequently FACS sorted into different S-
phase populations. Genomic DNA is extracted from the different cell stages and 
newly replicated, BrdU labelled DNA is enriched via IP with an anti-BrdU antibody. 
The isolated DNA can then be sequenced, hybridised to arrays or used in qPCR 
reactions to interrogate specific genomic regions. A recent improvement in the field 
of modified nucleotides is presented by the thymidine analogue 5-Ethynyl-2′-
deoxyuridine (EdU).  EdU incorporates an alkyne group which can be attached to an 
azide moiety in a copper-catalysed cycloaddition termed a “click” reaction (Salic & 
Mitchison 2008). The azide group can be linked to either a fluorescent molecule or a 
biotin group to facilitate either detection or isolation of newly replicated DNA.  Click 
reactions are used widely in biology as they are highly specific, since no azide 
groups occur naturally in cells. EdU has therefore been widely used in imaging 
replication dynamics and has also been used to isolate nascent chromatin 
associated with newly replicated DNA (Alabert et al. 2014; Sirbu et al. 2012). 
However, to date, EdU has not been used to replace BrdU in the Repli-seq 
technique. I set out to optimise and use a variant of Repli-seq in which EdU is used 
instead of BrdU and have termed this technique Click-seq. In Click-seq, cells are 
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pulsed with EdU and FACS (fluorescence activated cell sorting) into different S-
phase stages. DNA is isolated from the different cell populations and a biotinylated 
azide group is attached to incorporated EdU molecules in a click reaction.  The 
biotinylation of newly replicated DNA harbouring incorporated EdU allows the 
antibody immuno-precipitation step from the original Repli-seq protocol to be 
replaced with a more robust and specific biotin enrichment. The enriched newly 
replicated DNA can then be analysed through qPCR or massively parallel 
sequencing. 
I used Click-seq to analyse replication timing across the RPE1 and HCT116 cell lines, 
in unperturbed conditions and upon pharmacological induction of replication stress 
triggered by aphidicolin treatment. These experiments allowed me to investigate 
both the genome-wide effects of aphidicolin on replication timing as well as its 
locus-specific effects across active and inactive CFS regions in the two cell lines. 
4.1 Optimisation of Click-seq 
4.1.1 Assessment of EdU incorporation into cells 
EdU was originally developed as a method for detecting nascent DNA to replace 
more labour-intensive and less practical alternatives such as BrdU and the 
radioactive analogue [3H] thymidine incorporation. As a part of the characterisaiton 
process, authors showed that EdU was cell permeable and was specifically 
incorporated into DNA during replication (Salic & Mitchison 2008). I confirmed 
these results in the RPE1 and HCT116 cell lines, by incubating actively dividing cells 
in the presence of EdU for periods from 30 minutes to one hour and then visualising 
incorporated EdU by clicking it to a fluorescently labelled azide. I observed distinct 
staining patterns, which correspond well to the patterns observed for BrdU and 
replication machinery components such as PCNA in cells at an early, mid or late 
stage of the S cell cycle phase(Dimitrova & Berezney 2002). These included diffuse 
staining excluded from the nucleolus and periphery, corresponding to early S-phase 
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cells, foci formation for mid S-phase cells and bright heterochromatic staining in 
late-S phase cells (Figure 4-1). 
 
Figure 4-1 EdU staining patterns throughout S-phase. RPE1 cells were pulsed with the thymidine 
analogue EdU for one hour. To visualise EdU incorporation into newly replicated DNA, EdU was 
attached to fluorescent azide in a click chemistry reaction. The resulting patterns were indicative 
of the S-phase stage of the cell. A, B: Cells in early S displaying diffuse staining patterns, with signal 
excluded from the periphery and nucleolus. C: Mid-S phase staining with foci of active replication 
and signal near the nuclear periphery. D,E: Late S phase staining  with signal localised to 
heterochromatic regions. Scale bar measuring 5 m is shown in white. 
4.1.2 EdU influence on PCR dynamics 
Following the confirmation that EdU can be successfully incorporated in RPE1 and 
HCT116 cells, I explored how the presence of this modified nucleotide affects PCR 
dynamics. Specifically, I assessed if the presence of EdU in a PCR template affects its 
amplification rate. A substantial reduction in the amplification efficiency of EdU - 
containing templates would indicate that it is not a suitable nucleotide analogue to 
use in applications which require PCR amplification, such as massively parallel 
sequencing. 
I first generated an EdU-containing template by amplifying a 300-bp sequence from 
a purified pUC18 vector, using a forward primer with a 5’ 
GCTCACAATTCCACACAACATACGCGCC-3’ sequence and a reverse primer with the 
sequence 5’- GCGTTATCCCCTGATTCTGTGGATAAC-3’ using Taq polymerase and four 
different nucleotide mixtures. Each nucleotide mixture contained ATP, GTP and CTP 
in 1:1:1 molar ratios, as well as an equimolar combined concentration of EdUTP and 
TTP; each of the different mixtures contained varying proportion of EdUTP, 
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including 0%, 25%, 75% and 100% of the overall EdUTP : TTP pool. I found that no 
PCR products were generated for the samples where EdU exceeded 25% of the 
EdUTP/TTP pool. As Taq polymerase is not very efficient in incorporating modified 
nucleotides, I tested a number of other polymerases including Pwo, KodXL and 
DeepVent exo-, which have been shown to efficiently incorporate modified dNTPs 
(Tasara et al. 2003). While Pwo performed in a similar manner to Taq polymerase, I 
found that in reactions with KodXL and DeepVent exo- , PCR products were 
generated at 1:1 EdUTP to TTP ratios. I then proceeded to test whether the 
amplicons generated by these two polymerases contained incorporated EdU. I 
performed click reactions with the PCR products in the presence of biotinylated 
azide, which would result in the biotinylation of the amplicons. I ran the clicked 
amplicons on a gel and transferred them onto a nitrocellulose membrane, which I 
probed with a streptavidin antibody. The resulting signal confirmed that PCR 
products amplified by KodXL and DeepVen exo- in the presence of equimolar 
amounts of EdUTP and TTP contain incorporated EdU (Figure 4-2). I then proceeded 
to assess the impact of template EdU on PCR dynamics by using the EdU-containing 
PCR products as templates for subsequent amplification reactions. I performed PCR 
reactions from these templates using Taq polymerase and found that EdU in the 




Figure 4-2 Generating PCR templates containing EdU. EdU was incorporated into PCR reactions 
woith the KOD XL enzyme, using EdUTP and TTP in equimolar ratios. The PCR products were then 
labelled with biotin and run on a gel. A. PCR products: L- marker, phiX DNA digested with HaeIII 
enxyme; 1- control PCR reaction, amplified in the presence of TTP only; 2- PCR in the presence of 
EdU and TTP in 1:1 ratio and annealing tempetarture of 57°C; 3- PCR in the presence of EdU and 
TTP in 1:1 ratio and annealing tempetarture of 59°C; 4- PCR in the presence of EdU and TTP in 1:1 
ratio and annealing tempetarture of 63°C; 5- PCR in the presence of EdU and TTP in 1:1 ratio and 
annealing tempetarture of 65°C. B. Gel products were blotted onto a nitrocellulose membrane 
which was probed with streptavidin to assess the presence of biotinylated EdU. 1- control PCR 
reaction, amplified in the presence of TTP only; 2- PCR in the presence of EdU and TTP in 1:1 ratio 
and annealing tempetarture of 57°C; 3- PCR in the presence of EdU and TTP in 1:1 ratio and 
annealing tempetarture of 59°C; 4- PCR in the presence of EdU and TTP in 1:1 ratio and annealing 
tempetarture of 63°C; 5- PCR in the presence of EdU and TTP in 1:1 ratio and annealing 





Figure 4-3 Effect of EdU-containing templates on PCR amplification. PCR reactions were set up 
using the EdU-containing products from the KOD XL reactions as template.  Lane 1- PCR reaction 
set up with control template, which did not contain EdU; Lanes 2- 4 PCR reactions set up with EdU 
containing templates, corresponding to lanes 3,4 and in Figure 4-2. No difference in amplification 
efficiency was observed between EdU containing templates and templates generated in the 
presence of TTP only. 
4.1.3 Implementing the EdU methodology in live cells 
After I established that using EdU for labelling nascent DNA is unlikely to lead to a 
significant bias in the generation of sequencing libraries, I tested EdU as a 
replacement for BrdU in the Repli-Seq protocol in live cells. I pulsed RPE1 and 
HCT116 cells with EdU for one hour and 30 minutes, respectively. The different 
pulse times accounted for a difference in the cell cycle dynamics between the two 
cell lines: RPE1 cells progress through S-phase slower than HCT116 and I aimed to 
ensure sufficient uptake of the EdU molecule in RPE1 cells in unperturbed cells, as 
well as under conditions of replication stress, when less EdU is likely to be 
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integrated. Following the pulse, cells were harvested, fixed in 1% PFA and 
permeabilised as described in Section 2.7.2. 
To optimise FACS (fluoresccell sorting), I determined the position of the actively 
replicating cell population within the flow cytometry cell cycle profile. Staining an 
actively growing cell population with a DNA dye such as PI results in a well-
described fluorescence intensity profile when single cells are analysed by flow 
cytometry: a peak denotes the G1 population carrying 2n genomic content; another 
peak, located at approximately twice the fluorescence intensity of the G1 peak 
marks the G2/M population, carrying 4n karyotype; replicating cells with genomic 
content ranging from 2n to 4n are located between the G1 and G2 peaks. To 
investigate the exact location of replicating cells, I analysed an EdU-pulsed and PI-
stained HCT116 sample in which I had labelled the incorporated EdU with 
fluorescent azide. I found that the fluorescently labelled EdU population partially 
overlapped with both the G1 and the G2 peak and, as expected, fully overlapped 
with the population located between the two peaks (Figure 4-4). However, for Click-
seq, it would be impractical to fluorescently label incorporated EdU prior to cell 
sorting, as I found this results in a depletion of sites for subsequent biotin addition, 
reducing the biotinylation of nascent DNA. To encompass replicating cells located in 
the G1 and the G2 peak based only on PI staining and to keep gating constant 
among different samples, I opted for the following strategy: prior to sorting, I 
calculated the distance between the mid-points of the G1 and G2 peaks. I then 
allocated a third of the distance to each the early- S, the mid-S and the late –S 
sorting gate (Figure 4-4); a similar strategy has been previously employed for Repli-
seq sorting (Ryba et al. 2011). The three gates reflected three incremental increases 
in genomic content, but I also verified that replication was equally distributed 
between the three gates. To do that, I quantified the cumulative EdU intensity 
within each gate and expressed it as a percentage of the total EdU intensity 
observed in the replicating population. I found that the early gate accounted for 
36%, the mid gate for 28% and the late gate for 35 % of total EdU intensity, 
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indicating that the three gates encompassed similar percentages of total 
replication. 
 
Figure 4-4 Determining gates for FACS of replicating cells. A. The localisation of replicating cells on 
a cell cycle profile derived from PI-stained growing cell population was determined by 
fluorescently labelling EdU incorporated during replication. Inset, a profile of the same population 
showing PI intensity (x axis) and EdU label intensity (y axis). The gate used to define the 
replicating, EdU-positive population is shown in blue. Overlaying the replicating population (blue) 
on the total cell population (red) revealed that replicated cells overlap with the G1 and G2 peaks. 
B. Cell sorting gating strategy for Click-Seq. To encompass replicating cells within the G1 and G2 
peaks, the space between the mid-points of the G1 and G2 peaks was split into three equally sized 
gates, with each corresponding to early (E), mid (M) and late (L) S-phase populations. 
Following FACS of an initial test sample for both RPE1 and HCT116 cells, DNA was 
extracted from the early, mid and late-S phase fraction for each cell type and clicked 
to biotinylated azide (reaction conditions described in Section 2.9.2).  The addition 
of biotin was assessed by crosslinking the biotinylated-DNA to a nitrocellulose 
membrane and probing the membrane with an avidin- horseradish peroxidase 
conjugate. Biotinylated DNA was purified using streptavidin-coated magnetic beads. 
Successful enrichment was also confirmed by binding the purified DNA on a 
nitrocellulose membrane followed by biotin detection (Figure 4-5). 
Finally, I tested whether DNA isolated from each fraction contained sequences from 
genomic locations known for early or late replication.  I used the enriched DNA from 
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the three fractions for each cell line as templates in quantitative PCRs for eight 
primer pairs targeting known early and late replicating genes which have been 
previously used to perform QC for Repli-seq samples (Ryba et al. 2011). The primer 
pairs, the corresponding genes and the gene replication timing are listed in Table 4-
1.   However, as replication timing varies between cell types and has not been 
previously explored in HCT116 and RPE1 cells, some deviation from the assigned 
replication timing may be present. Primer pairs were found to produce a single 
band of the expected genomic size at their optimal annealing temperature. 
The results from the PCR quality check indicate that the streptavidin-based 
enrichment of biotinylated nascent DNA is specific. DNA fragments from each of the 
targeted genomic regions were usually present in a single fraction or two fractions, 
indicating that EdU pulse combined with FACS and a biotin-enrichment for newly 
replicated DNA can successfully separate genomic regions according to their 
replication timing. For both cell types, a control sample of genomic DNA containing 
no EdU did not retain any biotin following the Click reaction. When the control 
sample was subjected to streptavidin enrichment and used as a template in PCR 
reactions with the QC primers sets, no products or a very small amount of PCR 
products were amplified. 
In the HCT116 cell line, I found that results for the HBB, MMP15 and BMP1 genes 
were as predicted: they are classified as early replicating and the most amplified 
products corresponding to these regions were generated in the early sample (for 
MMP15 and BMP1) or the early and mid sample (HBB). Similarly, for DPPA2 and 
SLITRK6, classified as late-replicating regions, the most amplification was observed 
in the mid and late samples. NETO1, also a late region, showed signal 
predominantly in the late sample, but amplification was also present in the early 
and mid samples. Although ZFP42 is noted as late-replicating region, most 
amplification was observed in the “early” sample.  However, it is possible that the 
replication timing for the region containing ZFP42 may differ in HCT116 cells. PTGS2 
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did not amplify in any of the samples for this cell line – curiously, it overlaps with a 
CFS region, FRA1K, which is not fragile in the HCT116 cell line.  
In RPE1 cells, amplification in the MMP15 and BMP1 reactions was found mostly in 
the early samples, as expected. Surprisingly, amplification for the HBB PCR was 
found mostly in the mid sample, which may indicate differential replication timing 
for the HBB gene in this cell line. Amplification for DPPA2, NETO1, ZFP42 and 
SLITRK6 was observed mostly in the mid and late samples as expected. PTGS2 was 


















































































































Figure 4-5 QC for EdU-based isolation of nascent DNA. A. Detection of biotin in HCT116 early (E), 
mid (M) and late (L) samples. Top image shows total genomic DNA after a click reaction with 
biotinylated azide, while the bottom image shows the same samples following enrichment of 
biotinylated DNA with streptavidin. Standards on both images are biotinylated T7 primers (500, 
250 and 100 femtomoles from left to right). B. Results from qPCR reactions for eight genomic 
locations used previously in Repli-seq QC. Percentage of total replicating DNA is shown for each 
Early, Mid and Late samples. Percentage replication for each sample was calculated in the 
following manner: Fold change compared to input (pre-biotin enrichment) was calculated by 
subtracting the Ct value for the input sample (pre-biotin enrichment) from the Ct value of the 
enriched sample and using it to replace x in 2x. For each gene, the total fold change was calculated 
by adding the fold change for the early, mid and late samples. Percentage replication was then 
calculated as the contribution of each individual sample fold change towards the total fold change. 
4.1.4 Adapting Click-seq for next generation sequencing 
Since results obtained with the Repli-seq QC PCR primer sets were encouraging, I 
optimised the methodology for use with next generation sequencing and prepared 
sequencing libraries from the early, mid and late fractions for the two cell lines in 
unperturbed conditions and following replication stress. A major point of 
divergence from the original Repli-seq protocol is the streptavidin enrichment 
replacing an antibody-based immunoprecipitation. Streptavidin-based enrichment 
is more robust and specific than the antibody-based IP - in fact, the original Repli-
seq recommends a minimum of two hour BrdU pulse to ensure good IP effieciency.  
However, a minor disadvantage of the streptavidin method arises due to the high 
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temperature incubation in formamide required to break the biotin streptavidin 
bond and elute the DNA. The presence of formamide may impact on DNA quality, 
while the high temperature leaves DNA single stranded, which makes it 
inappropriate input material for Illumina NGS library preparation reagents. Some 
reports in the literature indicate that the biotin-streptavidin interaction can be 
disrupted in water, as well as formamide, at high temperatures. To determine if 
biotinylated DNA can be efficiently eluted from the streptavidin-magnetic beads in 
water, I biotinylated a sample of genomic DNA in a click chemistry reaction and 
performed the pull down protocol. Immediately prior to the elution step, I split the 
sample into two separate aliquots of equal volume and eluted one aliquot in water, 
while heating up to 98°C for 10 minutes, and the other - in formamide, at similar 
conditions.  I then compared the amount of biotin present in the two eluted 
fractions on a nitrocellulose membrane blot. I found that equal amounts of biotin 
were present in the two samples, indicating that water is suitable for elution (Figure 
4-6). I therefore eluted all subsequent Click-seq samples in water. 
 
Figure 4-6 Assessing the efficiency of eluting biotinylated DNA in formamide or water. Genomic 
DNA containing incorporated EdU was clicked to biotin and biotinylated DNA was enriched. Prior 
to elution, the sample was split into aliquots of equal volume; one aliquot was eluted in water and 
the other-in formamide. Eluted DNA from each reaction was crosslinked on a nitrocellulose 
membrane, which was probed with biotin to detect DNA. 
To adapt the single-stranded eluted DNA into a suitable substrate for the Illumina 
NGS library preparation protocol, I used a second strand synthesis reaction, 
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employing the mRNA Second Strand Synthesis Module from NEB, with random 
hexamers.  The enzymes contained in that kit are DNA Polymerase I, RNase H and 
E.coli DNA Ligase. As DNA Polymerase I has no strand displacement activity, the 
reaction is expected to result in no amplification of the sample: instead, the 
polymerase syntheses the 2nd strand until it runs into a hexamer or another 
synthesised strand. The DNA Ligase then repairs the nicks left by the polymerase 
(Figure 4-7). 
I processed Click-seq samples with the mRNA Second Strand Synthesis Module 
followed by the Ultra DNA Library prep kit by NEB, which contains components for 
Illumina adaptor ligation and amplification with the Illumina Universal primer, as 
well as the Illumina Index primers, which allow multiplexing. I found I was able to 
successfully generate Click-seq libraries using this protocol. I assessed the fragment 
distribution for the generated libraries using an Agilent bioanalyser. I found that the 
library fragments sizes corresponded well to the projected fragments sizes post 
sonication and following adapter ligation. The smooth distribution indicated there 





Figure 4-7 Optimised Click-seq workflow. Final version of the protocol for Click-seq sample 
generation for NGS.  Cells are pulsed with EdU (1) and sorted into early, mid and late replication 
fractions (2). DNA from each cell population is extracted and fragmented to 100 – 500 bp fragment 
distribution (3).  Next, biotin is attached to the incorporated EdU in a click reaction (3) and the 
biotinylated DNA is enriched by a streptavidin pull down with magnetic beads (4). The resulting 
single stranded DNA is used as a template in a second strand synthesis reaction (5):  random 
hexamers (shown in red) are used to prime the synthesis of a complimentary strand by DNA 
Polymerase I (shown in green). As Pol I does not have strand displacement activity, synthesis stops 
when it runs into a DNA strand, leaving a small nick; nicks are repaired by DNA ligase (blue). 
Finally, double stranded DNA is ligated to the Illumina sequencing adaptor and amplified using the 
Illumina universal primer (red) and an appropriate Illumina Index primer (yellow) (6). The 
fragment size distribution of the sequencing library is assessed on an Agilent bioanalyser.  
Using the optimised protocol, I prepared libraries from 24 samples from both cell 
lines in unperturbed conditions and under conditions of replication stress. Two 
biological replicates were prepared for each cell line and each condition. Details of 
the libraries are listed in Table 4-1. Although equal numbers of cells were harvested 
and prepared for cell sorting for each sample, the number of sorted cells varied 
substantially, from 71000 to over 2,000,000. This was due to variations in sample 
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quality- RPE1 cells, specifically, were found to have a tendency to form clumps 
during the sorting process, which reduced sorting efficiency. However, even 
samples with lower cell numbers were sufficient to generate high quality libraries. 
The 24 samples were pooled into four different pools, with six samples per pool. As 
per Illumina guidelines, index primers 2, 4, 5, 6, 7 and 12 were used to multiplex 
samples within the same pool. Prepared libraries were mixed proportionately so 
that the each sample had a final concentration of 5 nM per pool. The pooled 
















1 HCT116 Control Early 900,000 4.4 4 HCT116_1 5nM 
2 HCT116 Control Mid 350,000 2 6 HCT116_1 5nM 
3 HCT116 Control Late 600,000 1 12 HCT116_1 5nM 
4 HCT116 APH Early 1,300,000 0.7 2 HCT116_1 5nM 
5 HCT116 APH Mid 330,000 1 5 HCT116_1 5nM 
6 HCT116 APH Late 520,000 4 7 HCT116_1 5nM 
7 HCT116 Control Early 2,500,000 7.2 4 HCT116_2 5nM 
8 HCT116 Control Mid 1,100,000 6.2 6 HCT116_2 5nM 
9 HCT116 Control Late 1,300,000 6.4 12 HCT116_2 5nM 
10 HCT116 APH Early 730,000 3 2 HCT116_2 5nM 
11 HCT116 APH Mid 1,100,000 5 5 HCT116_2 5nM 
12 HCT116 APH Late 2,200,000 13 7 HCT116_2 5nM 
13 RPE1 Control Early 1,100,000 6 4 RPE1_1 5nM 
14 RPE1 Control Mid 450,000 3 6 RPE1_1 5nM 
15 RPE1 Control Late 670,000 0.8 12 RPE1_1 5nM 
16 RPE1 APH Early 125,000 0.9 2 RPE1_1 5nM 
17 RPE1 APH Mid 71,000 0.9 5 RPE1_1 5nM 
18 RPE1 APH Late 725,000 3.2 7 RPE1_1 5nM 
19 RPE1 Control Early 1,200,000 4 4 RPE1_2 5nM 
20 RPE1 Control Mid 580,000 2.8 6 RPE1_2 5nM 
21 RPE1 Control Late 580,000 3.2 12 RPE1_2 5nM 
22 RPE1 APH Early 190,000 0.64 2 RPE1_2 5nM 
23 RPE1 APH Mid 100,000 0.7 5 RPE1_2 5nM 
24 RPE1 APH Late 450,000 2.8 7 RPE1_2 5nM 
Table 4-2 Libraries prepared using the Click-seq methodology. 
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4.2 Sequencing results 
The total number of reads obtained for each pool is shown in Table 4-3. The 
maximum number of reads that can be generated per flow cell on the Hi Seq 
instrument is approximately 200 M.  Within the pools, the number of reads 
generated for individual samples were quite variable. Table 4-4 lists the number of 
reads for each of the 24 Click-seq samples: the lowest number was one of the two 
replicates of RPE1, mid-S fraction in the presence of APH, at 13 million; most reads 
were generated for a control HCT116 sample corresponding to a late-replicating 
fraction, at over 60 million.  





Table 4-3 Total number of reads for the four Click-seq pools 
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Sample Number of reads 
HCT116 E 1 19,451,240 
HCT116 M 1 15,370,744 
HCT116 L 1 61,241,098 
HCT116 APH E 1 27,111,925 
HCT116 APH M 1 35,550,942 
HCT116 APH L 1 29,737,295 
HCT116 E 2 24,614,757 
HCT116 M 2 21,851,034 
HCT116 L 2 15,909,980 
HCT116 APH E 2 26,513,518 
HCT116 APH M2 21,205,525 
 HCT116 APH L 2 15,128,003 
RPE1 E 1 25,096,178 
RPE1 M 1 25,005,795 
RPE1 L1 23,854,537 
RPE1 APH E 1 24,865,691 
RPE1 APH M 1 13,292,246 
RPE1 APH L 1 17,397,448 
RPE1 E 2 34,603,866 
RPE1 M 2 25,766,910 
RPE1 L2 40,108,337 
RPE1 APH E 2 32,496,647 
RPE1 APH M 2 23,295,640 
RPE1 APH L 2 33,795,352 
Table 4-4 Number of reads obtained for each Click-seq sample. 
4.2.1 Sequencing read quality 
Overall quality of the sequencing runs and read quality was analysed by FastQC.  
The sequence quality per base was good across all samples and showed no 
significant deterioration throughout the run. The GC distribution over all sequences 
metric showed a deviation from the theoretical distribution and a sharp peak 
characteristic of some limited adaptor dimer contamination. Quantification of the 
proportion of adaptor sequences across the different samples showed that the 





Figure 4-8 FastQC results for Click-seq libraries. A: A representative example of per base sequence 
quality across the reads, showing high quality was maintained throughout the run. B. An example 
of the GC content across reads (red) overlaid with the theoretical distribution for the human 
genome (blue). C.  Proportion of adaptor reads across the 23 libraries. Adaptor reads did not 
exceed 10% of any sample. 
4.2.2 Genomic alignment of reads 
Following FastQC assessment, the 24 libraries were mapped to the genome with the 
bowtie 2 aligner(Langmead 2010). Surprisingly, a proportion of reads within each 
sample could not be mapped to the human genome. The proportion differed from 
sample to sample but was particularly high in samples treated with aphidicolin 
(Table 4-5). The most affected sample was one of the two duplicates for the RPE1 
early fraction, in the presence of APH, for which only 22% of all reads aligned.  An 
alternative aligner, bwa, produced similar levels of alignment (Li & Durbin 2009). In 
addition, alternative bowtie2 alignment options were also tested, such as “–
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tryhard”, which relaxes the mapping criteria. However, that resulted in a minimal 
increase in the percentage of mapped reads (2%). To interrogate the reads that 
failed to map, I extracted 100 unmapped reads for three samples with varying 
proportions of unmapped reads, including the most affected sample, RPE1 APH E2. I 
tried to manually locate these reads to all known sequences using the NCBI 
Nucleotide Blast tool (Altschul et al. 1990). Surprisingly, 84 of the 100 reads in that 
sample could not be mapped by the Blast algorithm. The remaining few reads were 
mostly derived from E.coli or molecular biology reagents such as vectors and phages 
(Figure 4-9). I also blasted a 100 unmapped reads from the sample with the highest 
proportion of mapped reads – HCT116 E1. In contrast to the previous sample, 53 of 
the 100 reads did not match any known sequence, 24 reads were from human 
origin and surprisingly, 23 reads came from species not directly associated with the 
sample preparation procedure, such as the common carp. The human derived reads 
in that sample carried single substitutions, were only partially aligned or were 
mapped to contigs removed from the hg19 assembly. Finally, I assessed a 100 
unmapped reads from another aphidicolin treated sample-HCT116 APH E1, which 
had an alignment rate of 44%. Similarly to the RPE1 aphidicolin treated sample, a 
high proportion of reads failed to align to any known sequence (82). The remaining 
reads came from species not associated with the library preparation process, as well 
as a small number (5) of human-derived reads. Like in the other samples, the 
human-derived reads carried substitutions, mapped only partially or mapped to 
genomic locations which were not included in the hg19 index. A few possibilities 
may explain the high percentage of unmapped reads across the 24 libraries and in 
the aphidicolin-treated samples in particular. A simple possibility is that errors are 
introduced in the library preparation process: the Q5 polymerase used in the library 
preparation PCR reaction is an unlikely candidate as it has an extremely low error 
rate.  DNA Polymerase I, used in the second strand synthesis step, has a higher error 
rate at < 9x10-6 bases, however this would affect all samples equally. Another 
possibility is that aphidicolin treatment results in multiple errors during replication. 
In fact, a short treatment of human fibroblasts with a low aphidicolin dose resulted 
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in formation of deletions, duplications and novel CNVs (Arlt et al. 2009), however 
there was no evidence of wide-spread mis-incorporation of nucleotides. I also 
compared the library concentration following amplification to the proportion of 
unmapped reads and found there is some correlation: libraries with lower 
concentrations seemed to have higher representation of unmapped reads (Figure 4-
9). This was especially true of the badly affected RPE1 APH E2 library, which had the 
lowest concentration as well as the largest representation of unmapped reads. 
Therefore, no conclusive explanation could be found for the higher proportion of 
unmappable reads in these experiments, but a low concentration and quality of 










Final number of 
reads 
RPE1 E 1 25,096,178 78.1 19,600,115 25.40 13221655 
RPE1 E 2 34,603,866 78.84 27,281,688 44.57 21,860,313 
RPE1 M 1 25,005,795 75 18,754,346 67.84 5,883,239 
RPE1 M 2 25,766,910 75 19,325,183 15.82 15,273,127 
RPE1 L 1 23,854,537 75.55 18,022,103 12.18 15,115,571 
RPE1 L 2 40,108,337 70.78 28,388,681 31.62 15,704,194 
RPE1 APH E 1 24,865,691 41.02 10,199,906 23.10 4,457,218 
RPE1 APH E 2 32,496,647 22.08 7,175,260 14.44 2,481,525 
RPE1 APH M 1 13,292,246 51.78 6,882,725 16.88 4,638,573 
RPE1 APH M 2 23,295,640 50.67 11,803,901 27.34 5,435,771 
RPE1 APH L 1 23,854,537 58.8 14,026,468 0.326 9,852,726 
RPE1 APH L 2 33,795,352 63.24 21,372,181 61.21 6,713,929 
HCT116 E 1 19,451,240 85.73 16,675,548 17.74 13,225,572 
HCT116 E 2 24,614,757 63.85 15,716,522 30.52 8,203,007 
HCT116 M 1 15,370,744 68.77 10,570,461 42.08 4,103,256 
HCT116 M 2 21,851,034 77.44 16,921,441 23.89 11,704,736 
HCT116 L 1 61,241,098 79.44 48,649,928 29.17 30,786,004 
HCT116 L 2 15,909,980 67.41 10,724,918 27.63 6,329,560 
HCT116 APH E 1 27,111,925 44.35 12,024,139 22.08 6,038,060 
HCT116 APH E 2 26,513,518 64.98 17,228,484 16.07 12,967,712 
HCT116 APH M 
1 
35,550,942 58.7 20,868,403 26.03 11,613,567 
HCT116 APH M 
2 
21,205,525 69.07 14,646,656 14.56 11,559,978 
HCT116 APH L 1 29,737,295 64.09 19,058,632 20.27 13,032,514 
HCT116 APH L 2 15,128,003 61.55 9,311,286 13.87 7,212,056 





Figure 4-9 Properties of unaligned reads. Top graph: Results from blasting a 100 unmapped reads 
from three different samples. Most unmapped reads from all three samples failed to align to any 
known sequence. Bottom: a scatterplot of the library concentration (in ng/l on the y axis) vs % of 
aligner reads for the 24 libraries.  
Finally, following alignment, PCR duplicates were removed. The proportion of PCR 
duplicates also varied substantially among different samples, ranging from 12 to 
67% of the reads. The final read counts for each library are shown in Table 4-5. 
The final read numbers were used to calculate the genomic coverage for each 
sample. As each library is expected to contain only a proportion of the genome, I 
calculated the overall coverage for each sample, by summing the coverage achieved 
for the early, mid and late fraction for the sample. The final coverage for the eight 
samples is given in Table 4-6. It ranged from 0.24x to 0.88x per base due mainly due 
to the low mapping rates for the aphidicolin samples. 
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Sample Resulting Coverage 
RPE1 duplicate 1 0.570341 
RPE1 duplicate 2 0.880627 
RPE1+ APH duplicate 1 0.315809 
RPE1+ APH duplicate 2 0.243854 
HCT116 duplicate 1 0.801914 
HCT116 duplicate 2 0.437288 
HCT116+ APH duplicate 1 0.511402 
HCT116+ APH duplicate 2 0.528996 
Table 4-6 Genomic coverages for Click-seq samples. 
4.2.3 Read counts across the genome 
Finally, reads were counted in 1000 bp or 10, 000 bp windows and normalised, 
resulting in an FPKM value. FPKM values for the different samples were loaded as 
tracks on the UCSC Genome Browser and were visually assessed across the genome. 
Visual assessment showed that reads from each sample accumulated in visually 
distinct domains of sizes corresponding to known sizes for replication timing 
domains. At some locations, the replication wave could be followed from the early 
into the mid and then the late samples for each cell type. (Figure 4-10 and Figure 4-
11). Obvious differences in replication timing could also be observed between the 





Figure 4-10 FPKM counts for the HCT116 cell line in the 3p14.1-3p14.3 region.  FPKM values were 
calculated for all HCT116 samples and plotted across the genome. A 10 Mb region surrounding the 
FRA3B locus is shown here and the FHIT gene is shown in red. The top three panels represent the 
early, mid and late fractions for the HCT116 cell lines in unperturbed conditions, while the bottom 
three represent the early, mid and late fraction in the presence of aphidicolin. Arrows denote the 
replication wave, which can be clearly traced from an initiation zone in the early samples to 
putative termination sites in the late samples for both control and aphidicolin-treated samples. 





Figure 4-11 FPKM counts for the RPE1 cell line in the 3p14.1-3p14.3 region.  FPKM values were 
calculated for all RPE1 samples and plotted across the genome. Same 10 Mb region surrounding 
the FRA3B locus is shown here as in Figure 4-10, with the FHIT gene location shown in red. Top 
three panels represent the early, mid and late fractions for the RPE1 cell line in unperturbed 
conditions, while the bottom three represent the early, mid and late fraction in the presence of 
aphidicolin. Clear differences can be seen between the replication timing of this region in the RPE1 
and HCT116 cell line.  The replication wave from early to late samples can also be followed in this 
cell type and is denoted with arrows. Like in the HCT116 cell line, aphidicolin can be seen to cause 
clear changes in replication timing in the RPE1 cell line. 
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Assessment of the read density across larger genomic regions showed an even 
clearer distinction of different domains within the early, mid and late samples.  
Visually, segments of the genome with high density of early reads overlapped with 
locations of high gene density, while gene-poor locations were enriched for late 
reads, consistent with previous observations on replication timing (Rhind & Gilbert 
2013) (Figure 4-12). At this scale too, the domains across the different S-phase 
fractions could be seen to complement each other – domains with predominantly 





Figure 4-12 Replication timing across chromosome 3p in the HCT116 cell line. FPKM values are 
shown for this large genomic region in the HCT116 early, mid and late samples. High density of 
early reads and a depletion of late reads is found in gene-rich regions. Conversely, gene-poor 
regions are enriched for late reads. 
4.2.4 Click-seq reproducibility across biological replicates 
Next, I wanted to assess the reproducibility of the Click-seq technique across 
biological replicates. Visual inspection of read densities across genomic locations 
showed high similarity across most duplicates, with the exception of two samples 
from the HCT116 libraries and a single sample from the RPE1 libraries (Figure 4-13). 
HCT116 E rep1, HCT116 L rep1 and RPE1 M rep1 all appeared to show “flatter” read 
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density profiles compared to other samples and no obvious delineation of domains. 
However, the striking similarity between biological replicates for other samples 
suggests that Click-seq is a highly reproducible technique. 
 
Figure 4-13 Visual comparison of read densities across biological replicates in a 15 Mb region on 
chromosome 3p, spanning the region across 3p14.1-3p14.3.  The same region is shown with the 
corresponding reads for the six HCT116 libraries (A), the HCT116 + APH libraries (B), RPE1 libraries 
(C) and RPE1+APH libraries (D).  Similarities can be observed across most biological replicates, with 
the exception of HCT116 E rep1, HCT116 L rep 1 and RPE1 M rep1. 
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I next quantified correlations between biological replicates using the R-based 
corrplot package. Corrplot calculates a matrix of correlation coefficient between a 
number of variables and visualises the correlations. Prior to using the corrplot 
function, I calculated the number of reads for each library in either 1000 bp or 10 
000 bp windows and normalised them to the total number in the library. I then 
performed the correlation analysis on both 1000 bp window and 10,000 bp window 
datasets. The resulting correlations are shown in Figure 4-14 and Table 4-7. Overall, 
replicates showed very high correlations when 10,000bp windows were considered 
and reasonably high correlations when data was partitioned in 1000 bp windows. 
The increase in correlation in the 10,000 bp windows dataset may be due to a lower 
coverage of data in some samples, leading to more stochastic observations in the 
1000 bp dataset. The lowest observed correlation between replicates was 0.5, for 
RPE1 APH E rep 1 and rep 2, in 1000 bp windows. However, this was increased to 
0.87 in the 10,000 bp window dataset, indicating that the low correlation in the 1kb 
window dataset may be due to the low number of reads in the RPE1 APH E rep2 
sample, which had the highest number of non-aligned reads. 
 
Replicate 1 Replicate 2 1000 bp correlation 10,000 bp correlation 
HCT116 E rep1  HCT116 E rep2 0.66 0.83 
HCT116 M rep 1 HCT116 M rep 2 0.82 0.93 
HCT116 L rep 1 HCT116 L rep 2 0.91 0.96 
HCT116 APH E rep1  HCT116 APH E rep2 0.63 0.88 
HCT116 APH  
M rep 1 
HCT116 APH M rep 2 0.96 0.98 
HCT116 APH L rep 1 HCT116 APH Lrep 2 0.9 0.96 
RPE1 E rep1  RPE1 E rep2 0.79 0.94 
RPE1 M rep 1 RPE1 M rep 2 0.91 0.96 
RPE1 rep 1 RPE1 L rep 2 0.86 0.87 
RPE1 APH E rep1  RPE1 APH E rep2 0.5 0.82 
RPE1 APH M rep 1 RPE1 APH M rep 2 0.83 0.96 
RPE1 APH L rep 1 RPE1 APH  L rep 2 0.65 0.88 





Figure 4-14 Correlation analysis for Click-seq libraries in 1000 bp and 10,000 bp windows. Plots 
were produced using the corrplot package in R. Darker blue indicates stronger positive correlations 
and the size of the circle is proportional to the correlation coefficient for two samples. 
In addition to measuring the correlations for single libraries, I also combined the 
normalised read fragment per window values for the early, mid and late fraction for 
each sample into a single replication timing value (Rvalue) in such a way that 
windows with predominantly early reads would tend towards values of 0.8 and 
windows with predominantly late reads would have values close to 0.2 (described in 
2.9.8).  As this approach is based on assessing the proportion of early, mid and late 
reads from all the reads within a window, it normalises for sequence-related bias 
across the genome, such as GC-content and differential mappability. I assessed the 
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correlation of Rvalues across biological replicates for a subset of chromosomes, 
including chromosomes 3 and 11 (Figure 4-15). I observed good correlation 
between Rvalues for the RPE1 samples and the HCT116+APH samples. An exception 
was provided by the control HCT116 sample, where the failure of two of the 
HCT116 rep1 libraries could be seen to affect the Rvalues. As a result, I excluded the 
HCT116 rep 1 from most subsequent analyses. Overall, the high correlations 
observed between biological replicates indicated that Click-seq is a robust and 
reproducible technique.  
 
Figure 4-15 Correlations between Rvalues for biological replicates. Rvalues were calculated for 
each sample according to the method described in 2.9.8, in 10,000 bp windows. R values in 
windows were plotted for the two replicates of each sample for chromosomes 3 (top) and 11 
(bottom). Good correlations could be observed for most replicates, with the exception of HCT116 
rep 1. 
4.2.5 GC content across Click-seq libraries 
I also examined whether GC content varied across the different Click-seq libraries. 
Some variation between the libraries is expected, as GC-rich regions, which are 
associated with gene-rich portions of the genome, are known to replicate early. I 
calculated the number of reads across 50 bins of increasing GC content using the 
“read_GC” function of the RSeQC package (Benjamini & Speed 2012). This analysis 
was performed on the libraries following the removal of unmappable reads and 
included only reads that had been successfully mapped to the genome. I found 
some variation in GC content- as expected libraries derived from the early fractions 
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appeared to have higher GC content than libraries from the late fractions.  An 
additional peak could be observed in the early samples, at around 56 % GC content. 
The genomic origin of reads in this peak is unclear, but it was more prominent in the 
untreated early samples, suggesting it may be due to a real difference in replication 
timing for a subset of genomic locations, rather than a technical artefact. 
 
Figure 4-16 GC distribution among Click – seq libraries. Number of reads across 50 GC content bins 
was calculated using the read_GC function of the RSeQC package. Early samples were found to 
have a higher proportion of GC-rich reads than late samples. 
4.3 Replication timing features in the RPE1 and HCT116 
cell lines. 
Following the QC analysis of Click-seq data, I wanted to explore the replication 
timing features of the RPE1 and HCT116 cell lines in unperturbed conditions. I 
aimed to investigate how the replication timing programmes differed in the two cell 




4.3.1 Replication timing profiles in the HCT116 and RPE1 cell 
line 
To explore the replication timing profiles of the two cell types, I calculated the 
Rvalue in 10,000 bp windows and plotted it across all chromosomes for both 
HCT116 and RPE1 samples. I found that the Rvalues tended to be similar in 
neighbouring windows, forming regions of high (tending towards 0.8), low (tending 
towards 0.2) and medium values, corresponding to putative early, late and 
transition regions. The Rvalue profiles across chromosomes showed a lot of 
similarity between the two cell types, but many divergent regions were also 
observed. Rvalue profiles for the two cell types across chromosomes 18 and 19 are 
shown in Figure 4-17. Chromosome 18 and 19 are similar in size, but differ 
substantially in their make up: chromosome 18 is gene-poor and is located 
predominantly at the nuclear periphery, whilst chromosome 19 is gene-rich and can 
be found in the interior (Bickmore 2013). Consistently, the replication profile across 
chromosome 19 included many early replicating regions, in both cell lines, 
especially in HCT116 (Figure 4-17). The replication profile across chromosome 18, in 
contrast, was made up of alternating early and late regions. Interestingly, Rvalues in 
the RPE1 cell line appeared to vary less than in the HCT116 cell line, resulting in a 
“tighter” replication timing profile. This may be related to differential features of 
the two cell lines– while HCT116 is of tumour origin, RPE1 is derived from normal 




Figure 4-17 Replication timing profiles in the RPE1 and HCT116 cell lines across chromosomes 18 
and 19. Rvalues were calculated in 10 kb windows and plotted across chromosomes 18 (A) and 19 
(B). The replication timing profile for chromosome 18 showed alternating regions of early and late 
replication timing that showed a lot of similarity between the two cell types. In contrast, the 
replication timing profile of the gene-rich chromosome 19 included many early replicating regions, 




4.3.2 Partitioning of the genome into replication timing 
domains 
Since plotting replication timing across chromosomes revealed clear delineation of 
domains with differential replication timing, I set out to partition the genome into 
defined early, mid and late replicating regions. 
Such partitioning has been previously performed for Repli-seq data using different 
methodologies, including a Hidden Markov Model (HMM) in a 2014 publication 
(Lubelsky et al. 2014) and the segmentation package DNA Copy, originally 
developed to define copy number changes in CGH array samples (Ryba et al. 2011; 
Venkatraman & Olshen 2007). I determined that applying an HMM in this case 
would be unfeasible, as it would require a proportion of the data with known 
replication timing to be used as a “training” dataset. In addition, the results would 
be highly dependent on pre-defined transition probabilities, describing the 
likelihood of neighbouring windows displaying differential replication timing stages, 
which are difficult to estimate empirically. I also ruled out using the DNA Copy 
algorithm, as it is tailored to CGH array derived data in which sharp boundaries 
corresponding to breakpoints are expected, rather than the smooth transitions 
observed in replication timing data. Instead, I adapted an “edge filter” approach 
which has been previously used to define regions of differential supercoiling in the 
human genome and LADs (Naughton et al. 2013; Guelen et al. 2008).  In this 
approach, an edge filter was applied by calculating the difference in mean Rvalues 
in 250 1kb windows immediately left and right of a central window, sliding the 
central window across the chromosome. This resulted in a profile where regions 
with changes in replication timing corresponded to peaks in the edge filter value. 
Following a visual comparison of the edge filter and the Rvalue profile across 
chromosomes, I chose a cut-off value of 0.1 for the edge filter value (shown as a red 
line in Figure 4-18). Windows with edge filter above 0.3 were considered to span 
replication timing transition zones, while windows between the edge filter peaks 
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with values were considered to represent replication domains with stable 
replication timing. 
 
Figure 4-18 Edge filter partitioning of chromosome 3. Edge filter values were calculated across 
chromosome 3 in sliding windows of 250 x 1 kb. The edge filter values (top) were then compared 
to the replication timing profile across the chromosome (bottom). Shifts in replication timing 
corresponded to peaks in the edge filter value. An edge filter values of 0.1 was chosen as a cut off 
to define replication timing domains (red line across top plot). 
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Using an edge filter value of 0.1 as a cut off, I selected all the regions contained 
between two subsequent windows with an edge filter value of 0.1 or more. As 
replication timing domains are predicted to be at least 30 kb in size, regions smaller 
than that size were filtered out.  Finally, I determined the replication timing of the 
partitioned domains: first, I calculated the mean Rvalue across all 1000 bp windows 
encompassed within a domain; mean Rvalues across all domains and all samples 
were then clustered using kmeans clustering and assigned either to an early, mid or 
late cluster. A boxplot of the distributions of mean domain Rvalues within each 
cluster is shown in Figure 4-19. The early cluster contained 40.4 % of all identified 
domains, the late cluster- 30.6 % and the mean cluster-29 %.  
 
Figure 4-19 Distribution of mean domain Rvalues across the early, mid and late clusters defined by 
k-means clustering. Numbers of domains within each cluster is shown along the x-axis labels.  
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 A visual comparison of the partitioned domains to the raw data in the HCT116 
sample is represented in Figure 4-20. It showed that the edge filter correctly 
assigned regions with high Rvalues and high density of early reads as early domains 
and regions with low R values and predominantly late reads as late domains. 
 
Figure 4-20 Comparison of partitioned domains to raw data. A 20 Mb region on the p arm of 
chromosome 3 is presented along with data for the HCT116 cell line. The defined domains are 
shown as blocks at the top of the figure: early domains are shown as red blocks, mid domains are 
in black and late domains are shown in green. The regions corresponding to the early and late 
domains are shaded in red and green respectively. R values in 1000 bp windows across the 
genome are shown below the domains, while raw FPKM values from the early, mid and late 
samples are shown in the lower part of the figure. 
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4.3.3 Replication domain features in the RPE1 and HCT116 
cell line 
Following the edge filter analysis, a total of 1769 domains were identified in the 
HCT116 cell line and 2810 in the RPE1 cell line. The two cell types showed different 
numbers of domains designated as early replicating (40% in the HCT116 cells and 
45% in RPE1), and showed different distributions of mid and late domains (Figure 4-
21): HCT116 cells appeared to have similar proportions of mid and late domains, 
while regions designated as late were more prevalent in the RPE1 cell type.  Taking 
into account the size of each identified domain, I also assessed the proportion of 
the genome classified as early, mid or late in each cell line. I found that a smaller 
proportion of the genome was covered by the defined domains in the RPE1 cell 
type, which may suggest that this cell type has more transition zones between 
domains. Within the HCT116 cell line, around 45% of the genome was identified as 
early replicating and 31% as late replicating, while in RPE1 the corresponding 
numbers were 29% and 38%. The share of mid-replicating sequences was much 
lower: only 11% in HCT116 cell lines and 6% in RPE1, indicating that mid-replicating 
domains are smaller in size. To verify this, I plotted the size distribution of early, mid 
and late domains within each cell line (Figure 4-22).  I found that, as indicated by 
the previous analysis, mid domains were smaller than early and late domains in 
both cell lines. Surprisingly, the domain sizes in the RPE1 cell line appeared smaller 
than in the HCT116 cell line.  A visual inspection of the partitioning against the R- 
values across the chromosomes indicates that large early and late replication timing 
zones in the RPE1 cell type are more punctuated and less contiguous than in 
HCT116 (can be observed in Figure 4-17).  While differences in replication timing 
between different lineages are well described, variations in domain structure and 
size have not been characterised in detail. One possible explanation is that the 
tumour origin of HCT116 affects the temporal control of origin firing, resulting in a 




Figure 4-21 Domain distribution in the RPE1 and HCT116 cell lines. A. Percentage of domains in the 
early, mid and late category within the two cell types. B. Proportion of the total genomic sequence 
covered by early, mid and late domains in the two cell types. Remainder of the genome not 
covered by the domains is made up of transition zones and regions that cannot be mapped and 




Figure 4-22 Distribution of domain sizes in the RPE1 and the HCT116 cell lines. Frequencies of 
domain sizes were plotted for the HCT116 cell line (A) and the RPE1 cell line (B). Frequency of early 





I next examined GC content across the different domain categories. Previous 
replication timing studies have shown that GC-rich regions of the genome tend to 
replicate early, while GC-poor regions replicate later (Hansen et al. 2010).  As 
expected, I found a similar trend in both cell lines: on average, early replicating 
domains were made up of more GC-rich sequences than mid and late domains 
(Figure 4-23). 
 
Figure 4-23 GC content across different domains in the HCT116 and RPE1 cell lines. GC% was 
plotted for each domain within the early, mid and late category in the HCT116 (A) and the RPE1 (B) 
cell lines. 
I also investigated the gene overlap end expression rates across the different 
domains in the two cell types (Figure 4-24). First, I assessed the numbers of RefSeq 
genes contained within each domain type in each cell type. As expected, the early 
domains contained the majority of genes in both cell types. In both cell types, the 
late domains contained more genes than the mid domains, likely due to the fact 
that mid domains comprised a much smaller proportion of the genome than late 
ones. When only genes expressed in each cell line were considered, a similar 
relationship was observed: the overwhelming majority of expressed genes were 
contained within early domains, while mid and late domains contained a 
significantly smaller number of active genes.  Using the RNA-seq data described in 
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Chapter 3.4, I compared the FPKM distributions for genes located within early, mid 
and late domains within the two cell types. Unsurprisingly, I found that genes 
contained within early domains showed the highest FPKM values, while genes 
contained in late domains showed the lowest. 
 
Figure 4-24 Gene density and expression level across different domains in HCT116 and RPE1 cell 
lines. Top histograms show the number of RefSeq genes contained within early (E), mid (M) and 
late (L) domains in each cell type. Bottom boxplots show the distribution of FPKM values from the 
RNA-seq data discussed in Section 3.4 for transcripts located within the early, mid and late 
domains in each cell type. Labels below boxplots denote the number of transcripts for each 
domain type. 
Finally, I compared the domain overlap between the two cell types. Previous 
comparisons between distinct cell types showed that around 50% of the genome 
has a constant replication timing (Ryba et al. 2010). An intersection of the early 
domains in the two cell types resulted in 881 overlapping early domains, 
corresponding to 22% of the genome. For the mid domains, 151, corresponding to 
just 1.65% of the genome were shared between the two cell lines and when late 
domains were considered, I found that 205 overlapped, containing 13% of the 
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genome. Overall, 36% of the whole genome appeared to have identical replication 
timing in the two cell types 
4.4 Effect of replication stress on replication timing in the 
RPE1 and HCT116 cell lines 
“Replication stress” is a broad term which covers a range of conditions that 
interfere with the normal progression of DNA replication. Outcomes of replication 
stress include a slowdown in fork speed, fork stalling, accumulation of DNA damage 
and even structural genomic instability (Burrell et al. 2013; Chan et al. 2009; Gaillard 
et al. 2015).  Induction of replication stress has been described under many 
conditions: physiological replication stress has been observed upon oncogene 
activation and entry into S-phase with an insufficient nucleoside pool 
(Minocherhomji et al. 2015; Bester et al. 2011); endogenous replication stress has 
been described in CIN+ colorectal cancer lines (Burrell et al. 2013). 
Pharmacologically, it can be triggered by drugs such as aphidicolin and hydroxyurea. 
Aphidicolin, used to induce CFS formation, is an inhibitor of DNA polymerases, 
predominantly DNA polymerase  which works by blocking dCTP incorporation by 
polymerase (Krokan et al. 1981; Baranovskiy et al. 2014). Hydroxyurea functions 
through a different mechanism, by depleting the dNTP pool inside cells, which 
results in fork stalling and ultimately DSBs (Petermann et al. 2010). It is not known 
how aphidicolin leads to fork stalling or inactivation, however, it is well known that 
high concentrations of the drug can completely inhibit replication.  
Surprisingly, genome-wide changes in replication timing have never been studied 
under conditions of replication stress. DNA combing experiments have shown that 
over-expression of Myc causes premature origin firing and an increase in origin 
density (Srinivasan et al. 2013) and it is well known that aphidicolin in particular and 
replication stress in general can cause recruitment of additional origins to allow 
replication to proceed on time (Letessier et al. 2011; Blow et al. 2011).  However, it 
is not known how these cellular responses to replication stress affect the genome 
wide replication timing programme. To investigate this, I analysed Click-seq data 
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generated from RPE1 and HCT116 cells exposed to replication stress caused by low-
dose aphidicolin. 
4.4.1 Replication timing profiles in the HCT116 and RPE1 cell 
lines under conditions of replication stress. 
Low-dose aphidicolin treatment of asynchronously dividing HCT116 and RPE1 cells 
resulted in a pronounced accumulation of cells in S-phase, illustrating the inhibitory 
effect of the drug on replication dynamics (Figure 4-25).  The increase in S-phase 
cells suggests that replication is slowed down upon aphidicolin treatment. However, 
this may indicate either a delay affecting the whole genome, or a more-locus 
specific effect, with certain locations showing increased susceptibility to changes in 
replication timing in the presence of aphidicolin. A genome-wide delay in replication 
timing, affecting all loci in a similar manner, would result in a replication timing 
pattern which would be undistinguishable from the control population. On the 
other hand, if aphidicolin induces locus –specific effects, they could be observed as 
regions of differential replication timing between the control and the drug-treated 
population. The initial assessment of read density profiles indicated that changes 





Figure 4-25 Effects of aphidicolin on the cell cycle profile on RPE1 and HCT116 cells. Treatment 
with low dose of aphidicolin (0.4M) for 24 hours was found to cause an accumulation of S-phase 
cells in both cell types, as indicated by a change in the FACS profile of PI-stained cell populations. 
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To explore the extent of these changes, I plotted Rvalues for control and aphidicolin 
treated samples in 10,000 kb windows across different chromosomes and assessed 
the changes induced by aphidicolin. In the HCT116 cell line I found that aphidicolin 
induced subtle changes in the replication timing profile (Figure 4-26). Surprisingly, 
the induced changes were not uni-directional towards later replication; instead, 
both changes from an early to later and from a late to earlier replication timing 
were observed across the chromosome. 
 
Figure 4-26 Effect of aphidicolin treatment on replication timing across chromosome 3 in HCT116 
cells. Rvalues in 10 kb windows were plotted across chromosome 3 for the HCT116 control sample 
(top plot) and the HCT116 aphidicolin-treated sample (middle plot). An overlay of the two values is 
shown in the bottom plot, with control Rvalues shown in black and aphidicolin-treated Rvalues 
shown in red. Changes from both higher to lower R value (indicating an early to later shift) and 
lower-to-higher R value (indicating a late to earlier shift) can be observed. 
Next, I wanted to assess if similar changes could be observed across chromosome 3 
in the RPE1 cell line. Unlike the HCT116 cell line, where one of the biological 
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replicates was of insufficient quality, I could investigate if any observed changes 
were consistent across the biological replicates. An immediate observation for this 
cell line was that aphidicolin treatment resulted in a much “noiser” replication 
timing profile, indicating that replication stress caused some mis-regulation of 
replication progression (Figure 4-27). In addition, I observed similar effects upon 
aphidicolin treatment as in the HCT116 cell line: again, subtle bi-directional changes 
could be observed, with both regions transitioning from early to later replication 
timing and the opposite. Strikingly, a comparison between the two biological 
replicates revealed that these changes occurred at similar genomic locations across 
the replicates, suggesting that aphidicolin treatment may result in recurrent 




Figure 4-27 Effect of aphidicolin treatment on replication timing across chromosome 3 in the RPE1 
cell line. Rvalues in 10 kb windows plotted across chromosome 3 for the two control sample 
replicates and the two HCT116 aphidicolin-treated replicates. An overlay of the two datasets is 
shown for each replicate, with control Rvalues in black, and aphidicolin-treated Rvalues in red. 




In addition to chromosome 3, I also concentrated on chromosome 18 and 19, which 
were observed to show very different replication timing profiles (Chapter 4.4.1, 
Figure 4-17), consistent with the differences in GC composition, gene density and 
nuclear positioning between these two chromosomes. In both cell types, the early-
replicating chromosome 19 showed an overall change towards later replication 
timing. In contrast, across chromosome 18, early replicating regions appeared to 
shift to a later timing while late regions changed towards earlier values – a tendency 
that was especially clear in the HCT116 cell line (Figure 4-28). In conclusion, my 
observations across the different cell types and chromosomes suggested that rather 





Figure 4-28 Replication stress induced replication timing changes across chromosomes 18 and 19 in 
RPE1 and the HCT116 cell lines. Overlay of the Rvalues in 10,000 bp windows is shown for each 
chromosome and each cell type, with control values shown in black and values for the aphidicolin 
treated sample shown in red. 
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To further examine the nature of the changes, I constructed heatmaps of Rvalues 
calculated in 10 kb windows for the two cell lines, comparing controls and 
aphidicolin-treated samples (Figure 4-29). Confirming the data shown in Figures 4-
26, 4-27 and 4-28, the heatmaps indicated bi-directional changes in the aphidicolin-
treated samples, with some windows changing to an earlier replication and some 
windows-to later timing. Very few sharp changes could be seen, with most windows 




Figure 4-29 Rvalue changes in aphidicolin treated samples across chromosome 3. Rvalues in 
control RPE1 (A) and HCT116 (B) cell lines were calculated in 10,000 kb windows and ranked from 
lowest to highest. The corresponding Rvalue for each window in the aphidicolin treated sample is 
shown next to the control. 
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4.4.2 Replication timing domain changes upon replication 
stress. 
As Rvalues indicated subtle changes in replication timing in the presence of 
replication stress, I next explored how the aphidicolin treatment affected the 
domain structure within the two cell types. I segmented the genome in the 
aphidicolin treated samples following the method described in Section 4.4.2 and 
examined the differences in domain characteristics in the control and the 
aphidicolin-treated samples. Within the HCT116 cell line, I found that the number of 
identified domains had increased from 1769 to 2462; an increase was also observed 
in the RPE1 cells, from 2810 to 3347. In both cell types, while the total number of 
identified domains was increased, the proportions of early, mid and late domains 
stayed similar in the aphidicolin-treated and the control sample (Figure 4-30).  In 
HCT116 cells, the proportion of the genome contained within early domains was 
decreased in the aphidicolin treated sample (from 45% to 29%), while the 
proportion of the genome contained within late domains was increased (from 31% 
in controls to 39% in the drug-treated sample). In RPE1 cells, no big changes were 






Figure 4-30 Domain distribution in aphidicolin treated RPE1 and HCT116 cells.  Top graph shows 
the percentage of domains in the early, mid and late category within the two cell types. Bottom 
graph shows the proportion of the total genomic sequence covered by early, mid and late domains 
in the two cell types. 
I next investigated whether the size of domains changed upon replication stress 
induction (Figure 4-31). In both cell types, the domain size was decreased in the 
presence of aphidicolin; this reduction in size was particularly pronounced for the 
early and mid domains. The decrease could be due to reduced fork speed in the 





Figure 4-31 Changes in the distribution of domain sizes in the RPE1 (A) and the HCT116 (B) cell lines 
in response to replication stress. Frequency distributions of domain sizes are shown, with early 
shown in pink, mid in turquoise and late in blue. 
I also investigated how GC composition of domains changed upon replication stress 
induction (Figure 4-32).  As described in section 4.4.2, under control conditions, I 
found that early domains had higher average GC content than mid and late domains 
in both cell types. This trend could also be observed in both cell lines under 
conditions of replication stress, however an increase in the GC content of early, mid 
and late domains could be clearly observed in the HCT116 cell line.  Late domains in 
the RPE1 cell line also showed a small increase in GC content in the presence of 





Figure 4-32 GC content across different domains in the RPE1 (top) and HCT116 (bottom) cell lines 
under control conditions and in the presence of aphidicolin. GC% is plotted for each domain within 
the early, mid and late category. 
There were also differences in the gene density between domains following 
induction in replications tress. In HCT116 cells, early domains overlapped with 20% 
fewer RefSeq genes in the aphidicolin sample compared to the control. In both cell 
types, late domains overlapped with an increased number of genes in the samples 
treated with aphidicolin: around 60% more RefSeq genes were contained within the 
late domains in the aphidicolin samples compared to the controls (numbers 
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presented in Figure 4-33). When only genes expressed in each cell lines were 
considered, this trend was preserved: early domains in the HCT116 cell line 
overlapped with 34,389 expressed genes in control cells and just 23,053 expressed 
genes in the aphidicolin-treated sample. Late domains in HCT116 cells overlapped 
with 3657 expressed genes in the aphidicolin treated sample and 2305 in the 
control cells. In conclusion, replication stress causes a disruption in the replication 
timing program which causes a subtle loss of features normally associated with 
early and late replication timing. 
 
Figure 4-33 Gene density and expression rates across different domains in HCT116 and RPE1 cell 
lines following aphidicolin treatment. Top histograms show the number of RefSeq Genes 
contained within early (E), mid (M) and late (L) domains in each cell type following aphidicolin 
treatment. Bottom boxplots show the distribution of FPKM values for genes located within the 
early, mid and late domains for each cell type following aphidicolin treatment. Labels below 




Finally, I assessed the extent of domain overlap between the control and aphidicolin 
treated sample in each cell line. Within the HCT116 cell line, I found that 742 early 
domains retained their early replication timing following aphidicolin treatment, 
comprising 24% of the genomic sequence. In contrast, only 139 late domains, 
comprising just 2.17% of the genomic sequence retained late replication timing 
following aphidicolin treatment. . In the RPE1 cell line, 386 early domains retained 
their replication timing under replication stress, covering 7.87% of the genome. 
Only a small fraction of the genome, less than 0.3%, retained late replication timing 
in this cell type. In both cell types, very small proportions of the genome changed 
from early to mid and late to mid, or showed more extreme changes such as early 
to late and the opposite. Curiously, none of the small number of domains showing 
extreme changes in replication timing mapped to active CFS regions. 
4.5 Replication timing and CFS instability 
Late replication timing is considered to be one of the defining characteristics of CFS 
regions. Initial FISH-based experiments were performed across FRA3B, FRA7H and 
FRA6E and indicated that they span regions which replicated late and were delayed 
in the presence of aphidicolin (Wang et al. 1999; Palumbo et al. 2010; Hellman et al. 
2000).  The late replication timing of FRA3B was later confirmed with results by SNS 
fragment isolation (Palakodeti et al. 2009) and by Repli-seq (Letessier et al. 2011). 
Due to the cell type specificity of CFS regions, only two studies to date have tried to 
correlate CFS expression to Repli-seq generated tissue-specific replication timing 
profiles, with results suggesting that CFS regions replicate later and span fewer 
origins in the cell types in which they are fragile (Le Tallec et al. 2011; Letessier et al. 
2011). The effect of aphidicolin on replication speed across the genome and at the 
FRA3B locus has been studied through the DNA fibre FISH technique, which 
revealed that aphidicolin caused a slow-down in fork speed across the genome, 
which was not more severe at the FRA3B site. However, in-depth, cell type matched 
studies of how aphidicolin affects the replication timing programme across CFS 
regions have never been performed.  With my Click-seq dataset, I was able to define 
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for the first time the replication timing features across active and inactive CFSs in 
unperturbed cells and in the presence of aphidicolin. 
4.5.1 Replication timing across CFS regions 
To investigate the replication timing features of CFSs, I plotted the distribution of 
FPKM values from the early, mid and late fractions in 10,000 kb windows across the 
sites I identified in Chapter 3.1.  
4.5.1.1 Replication timing across fragile locations in the RPE1 cell 
line 
I first examined the replication landscape across FRA1C at chromosome 1p31.2, the 
most fragile location in the RPE1 cell line, which harboured 18.6 % of all CFS breaks 
(Figure 4-34). In both the RPE1 and HCT116 cell line, this location appeared to be 
replicated from long travelling forks originating from early initiation zones located 
from 0.5 Mb to 1 Mb away. The fragile location was replicated late in both cell types 
in control cells and also in the presence of aphidicolin. Unfortunately, it was not 
possible to determine if the site was passively replicated by forks converging from 
long distance or if late origins were activated instead. Surprisingly, a delay in 
replication across FRA1C was not observed upon aphidicolin treatment. On the 
contrary, the origins surrounding the site, where forks originated, appeared to shift 
from a mid to an early timing in conditions of replication stress. The replication 
landscape at this region did not differ substantially between RPE1 and the HCT116 
cell line, where breaks at this CFS accounted for only 5.8 % of all breaks.  In the 
unperturbed HCT116 population, a smaller proportion of the region appeared to be 
replicated late, suggesting that forks may be able to move faster across FRA1C in 
this cell line. Like in the RPE1 cell line, the origins surrounding FRA1C appeared to 




Figure 4-34 Replication landscape at the FRA1C site. FPKM read density in 1000 bp windows are 
presented for each early (red), mid (green) and late (blue) fractions across FRA1C for the two cell 
lines in unperturbed conditions and upon aphidicolin treatment. The fragile region is shaded in 
blue and the locations of the BAC probes used for fine-mapping FRA1C (discussed in Section 
3.2.1.1) are shown at the top, with the corresponding break overlap for each probe. Underneath 
the tracks, a schematic diagram of replication dynamics is drawn with suspected initiation zones 
represented as rectangles and travelling forks represented as arrows. Black vertical arrows denote 
initiation zones which fire earlier in the presence of aphidicolin. 
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The other fine-mapped location in RPE1 cells, the novel 4q32.2 – 4q32.3 site, also 
appeared to be late-replicating in both cell types (Figure 4-35). In unperturbed RPE1 
cells, the site was replicated by forks converging from origins firing in early/mid S-
phase, located 0.5 Mb away. In the presence of aphidicolin, the origins surrounding 
the fragile site appeared to fire slightly earlier, however the fragile location 
appeared to replicate later. It is possible that an additional origin cluster was fired 
at this site in late – S phase, however the signal may also represent a termination 
zone of two forks. The landscape surrounding the region was remarkably similar in 
the HCT116 cell line, where the site is not fragile. In this cell line origins surrounding 
the region also appeared to fire earlier in the presence of aphidicolin, but there was 




Figure 4-35 Replication landscape at the 4q32.2 -4q32.3 site. FPKM read density in 1000 bp 
windows are presented for each early (red), mid (green) and late (blue) fractions across FRA1C for 
the two cell lines in unperturbed conditions and upon aphidicolin treatment. The fragile region is 
shaded in blue and the locations of the BAC probes used for fine-mapping) are shown at the top, 
along with the MARCH1 gene. Diagrams of replication dynamics are drawn underneath the graphs, 
with suspected initiation zones represented as rectangles and travelling forks represented as 
arrows. At locations where late origin firing cannot be differentiated from termination zones, both 
arrow and rectangles are drawn. 
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4.5.1.2 Replication timing across fragile locations in the HCT116 
cell line 
In HCT116 cells, FRA3B was the most fragile location. Investigating the replication 
landscape around this site showed that FRA3B span a late replicating zone in both 
HCT116 and RPE1 cells (Figure 4-36). However, unlike the active sites in RPE1 cells, a 
clear difference could be seen between the replication profiles in the two cell types 
across the FRA3B core. In RPE1 cells, where the site is not fragile, FRA3B appeared 
as a transition zone replicated by forks travelling from early and mid/early initiation 
zones and converging over the core of FRA3B in late-S. In HCT116, the replication 
profile was more complex: while similar initiation zones surrounded FRA3B, it 
appeared that the fragile region spans some late-firing origins, with an extra origin 





Figure 4-36 Replication landscape at the FRA3B site. FPKM read density in 1000 bp windows are 
presented for each early (red), mid (green) and late (blue) fractions across FRA3B for the two cell 
lines in unperturbed conditions and upon aphidicolin treatment. The fragile region is shaded in 
blue. Diagrams of replication dynamics are drawn underneath the graphs, with suspected 
initiation zones represented as rectangles and travelling forks represented as arrows. A clear 
difference in the replication timing profile can be seen between RPE1 and HCT116 cells over the 




FRA4F was the largest CFS region identified during the dine-mapping process: 
fragility at that site extended over a 10Mb region in the HCT116 cell line. This large 
region spans a range of replication timing domains, which showed some consistency 
between the two cell lines (Figure 4-37). In both the RPE1 and HCT116 cells, the 
centromeric side of FRA4F showed an early to mid-replication timing. Close to the 
fragile core of the site where most breaks occurred, the profile transitioned towards 
a late replication timing. In RPE1 cells, where the site is not fragile the transition 
was relatively smooth, suggesting the region was replicated by forks moving from 
the early regions. In contrast, sharper peaks were seen in the same region in the 
HCT116 cells, indicating firing of late origins at the CFS region. In both cell types, the 




Figure 4-37 Replication landscape at the FRA4F site. FPKM read density in 1000 bp windows are 
presented for each early (red), mid (green) and late (blue) fractions across FRA4F for the two cell 
lines in unperturbed conditions and upon aphidicolin treatment. The fragile region is shaded in 
blue, and the positions of BAC probes used for fine-mapping and their overlap with CFS breaks is 
shown on the top. Diagrams of replication dynamics are drawn underneath the graphs, with 




Finally, I explored the replication landscape across the FRA2F site at 2q22.2 /2q22.3 
(Figure 4-38). This site showed some fragility in both RPE1 and HCT116 cells. Fine-
mapping showed that breaks were located telomerically from the LRP1B gene, 
which is 1.95 Mb long. The region was predominantly late replicating in both cell 
lines. Strangely, in HCT116 cells, an under-replicated region could be observed in 
both the control and aphidicolin treated sample, coinciding with the LRP1B gene 
body, and located centromerically from the break locations identified during fine – 
mapping. In RPE1 cells, the region showed a mixture between mid and late 
replication timing. Aphidicolin treatment appeared to increase the signal from mid-




Figure 4-38 eplication landscape at the FRA2F site. FPKM read density in 1000 bp windows are 
presented for each early (red), mid (green) and late (blue) fractions across FRA4F for the two cell 
lines in unperturbed conditions and upon aphidicolin treatment. The fragile region is shaded in 
blue, and the positions of BAC probes used for fine-mapping and their overlap with CFS breaks is 
shown on the top. Diagrams of replication dynamics are drawn underneath the graphs, with 




4.5.2 CFS regions do not show extreme replication timing 
changes upon APH treatment 
Careful characterisation of the replication timing programme across a number of 
CFS loci showed that there were no clear and defining features associated with 
fragility. Since CFS regions behave in a unique manner compared to the rest of the 
genome upon aphidicolin treatment, I went on to explore whether active CFS are 
the regions showing most extreme replication timing changes in the presence of 
replication stress. To do that, I used the Rvalues calculated in 1000bp windows 
across different conditions. For each 1000bp windows, I subtracted the Rvalue for 
the aphidicolin treated sample from the Rvalue for the same region under 
unperturbed conditions. This resulted in positive values for regions which showed a 
replication delay in the presence of aphidicolin and negative values for regions 
which replicated earlier upon treatment. I plotted this value, which I called deltaRT, 
across the genome and investigated how it compared at CFS regions and the rest of 
the genome. 
I first examined the FRA1C site; a visual assessment of the deltaRT across the site 
showed that there were some changes in replication timing, but they did not appear 
extreme when compared to the rest of chromosome 1p (Figure 4-39). In HCT116 
cells, a transition to later replication timing occurred across most of the fragile 
region, while in RPE1s, where the site is very unstable, no big changes could be 
observed. A small spike of negative Rvalues, indicating a transition to earlier 
replication timing, occurred at the centromeric side of FRA1C. However, similar 
spikes occurred at other locations throughout chromosome 1p, which were not 
associated with fragile regions. Therefore, a visual inspection of the differential 




Figure 4-39 Replication timing changes across chromosome 1p and FRA1C in the presence of 
aphidicolin. deltaRT values were calculated in 1000 bp windows and plotted across chromosome 
1p (A) and FRA1C (B) for both the RPE1 and the HCT116 cell line to determine if extreme 
replication timing changes are seen at FRA1C compared to the rest of chromosome 1. A. delta RT 
values are plotted across chromosome 1p for the HCT116 cell line (top) and the RPE1 cell line 
(bottom). Positive deltaRT values indicate later replication timing in the presence of aphidicolin 
and negative deltaRT values indicate earlier replication upon aphidicolin treatment. The location 
of FRA1C is indicated in red. No extreme replication timing shifts are seen across FRA1C. B. delta 
RT values across the FRA1C region in HCT116 cells (top) and RPE1 cells (bottom). The fragile core of 
the region, as defined by FISH fine-mapping, is indicated by a red bar. A slight delay across the 
region is seen in the HCT116 cell line, while no change can be observed in the RPE1 cell line, where 
the region is fragile. 
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To examine the changes in more detail, I plotted the frequency distribution of delta 
RT values across FRA1C region and compared it to the distribution of values across 
all of chromosome 1 (Figure 4-40). In RPE1 cells, I found that the distribution of RT 
values was slightly shifted towards a later replication timing upon aphidicolin 
treatment, compared to the distribution for all of chromosome 1. Surprisingly, this 
shift was a lot more pronounced in HCT116 cells, where the region was not as 
strongly fragile. This observation strongly suggests that the small replication delay 
seen across the site for RPE1 cells is not a determinant of instability at the site. 
 
Figure 4-40 Distribution of deltaRT values across FRA1C and chromosome one in the two cell lines. 
The frequency distribution of deltaRT values was plotted for FRA1C (in red) and all of chromosome 
1 (in black) in HCT116 and RPE1 cells. A small shift towards positive values, indicating a replication 
delay, was observed in the RPE1 cell type. The shift was even more pronounced in the HCT116 cell 
type, where breaks are formed at the site less frequently than in RPE1 cells. 
Finally, I also compared the relationship between Rvalues in the control and the 
aphidicolin-treated samples across FRA1C and chromosome 1. I plotted the R value 
for each 1000 bp window across chromosome 1 in control condition versus the R 
value in the same window under aphidicolin treatment (Figure 4-41). A relatively 
good correspondence could be seen between the two values for most regions. 
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However, some windows showed a discordance between the two values and 
appeared as outliers, displaying either lower or higher Rvalues in the aphidicolin 
treated sample compared to the control. Windows within the FRA1C site were not 
among the outliers and instead, appeared to be similarly affected by aphidicolin to 
the rest of chromosome 1.  
 
Figure 4-41 Relationship between Rvalues in control conditions and upon aphidicolin treatment on 
chromosome 1 and at the FRA1C locus. Rvalues were plotted for the control sample (on the x-axis) 
and the aphidicolin-treated sample (on the y-axis). Rvalues across chromosome 1 are shown as a 
blue scatter, while values for FRA1C are shown as black rectangles. 
I next assessed the changes at the novel fragile site in RPE1 cells, located at the 
4q32.2-4q32.3 boundary (Figure 4-42). This site behaved very differently to FRA1C: 
a region of positive delta RT values, indicating a replication delay in the presence of 
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aphidicolin, could be seen across the site. Furthermore, the delay was specific to 
RPE1 cells, where the site is fragile; in HCT116s, the opposite trend for earlier 
replication timing was observed. Similarly to the FRA1C region, comparison of the 
delta RT values at this site with a larger surrounding region in the chromosome 4q 
arm revealed that the delay at this site was not the most extreme within the region: 
locations with larger delta RT values were seen, which did not correspond to active 







Figure 4-42 Replication timing changes across chromosome 4q and the 4q32.2/4q32.3 site in the 
presence of aphidicolin. deltaRT values were calculated in 1000 bp windows and plotted across a 
20Mb region on chromosome 4q  (A) and the 4q32.2-4q32.3 region(B) for both the RPE1 and the 
HCT116 cell line to determine if extreme replication timing changes are seen at the fragile site 
compared to the surrounding region. A. delta RT values are plotted across chromosome 4q for the 
RPE1 cell line (top) and the HCT116 cell line (bottom). Positive deltaRT values indicate later 
replication timing in the presence of aphidicolin and negative deltaRT values indicate earlier 
replication upon aphidicolin treatment. The location of the CFS is indicated in red: no extreme 
replication timing shifts are seen across the fragile region B. delta RT values across the 4q32.2-
4q32.3 CFS region in the two cell lines. The fragile core of the region is indicated by a red bar. 
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When I compared the frequency distribution of delta RT values across the fragile 
region to the distribution across the whole chromosome 4 I observed a small but 
clear shift to higher values, indicating this region experienced a replication delay 
compared to the rest of the chromosome (Figure 4-43). This was also confirmed by 
a comparison of the Rvalues under control conditions and in the presence of 
aphidicolin across the chromosome and at the fragile region: windows within the 
fragile region showed a bigger change in Rvalues compared to the rest of the 
genome. This confirms that fragility at this site is accompanied by a cell-type specific 
delay in replication timing upon APH treatment. 
 
Figure 4-43 Replication timing changes at the 4q32.2-4q32.3 fragile location in the RPE1 cells. A. 
Distribution of deltaRT values across the CFS and chromosome 4. The frequency distribution of 
deltaRT values is shown for the CFSC (red) and all of chromosome 4 (black) in RPE1 cells. A shift 
towards higher values, indicating later replication timing can be observed for the fragile site. B. 
Relationship between Rvalues in control conditions and upon aphidicolin treatment on 
chromosome 4 and at the CFS region. Rvalues for the control sample are shown on the x-axis and 
Rvalues for the aphidicolin-treated sample are on the y-axis. Rvalues across chromosome 4 are 
shown as a blue scatter, while values for the CFS region are shown as black rectangles. 
Next, I examined CFS sensitivity to aphidicolin in the HCT116 cell line. 
FRA3B, the most fragile location in this cell type, displayed changes in both 
directions: the core of the site spanned changes from towards an earlier and a later 
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replication timing. None of the changes appeared extreme when compared to the 
landscape across the chromosome 3p arm (Figure 4-44).  Less changes were seen 
across the CFS region in the RPE1 cell line, where FRA3B is not fragile.  Comparison 
of the distribution of delta RT values for the FRA3B region to all of chromosome 3 
revealed a very similar distribution between the two, indicating that FRA3B does 
not show extreme changes in response to aphidicolin (Figure 4-45). A comparison of 
R values in control conditions and following aphidicolin treatment showed that 
windows across FRA3B deviated slightly in their response compared to the general 
trend for chromosome 3. Specifically, a number of windows appeared to shift to an 




Figure 4-44 Replication timing changes across chromosome 3p and the FRA3B site in the presence 
of aphidicolin. deltaRT values were calculated in 1000 bp windows and plotted across 
chromosome 3p (A) and the FRA3B region(B) for both the RPE1 and the HCT116 cell line. A. delta 
RT values are plotted across chromosome 3p for the HCT116 cell line (top) and the RPE1 cell line 
(bottom). The location of the CFS is indicated in red: no extreme replication timing shifts are seen 
across the fragile region B. delta RT values across the FRA3B CFS region in the two cell lines. The 




Figure 4-44 Replication timing changes at the FRA3B fragile location in the HCT116 cells. A. 
Distribution of deltaRT values across the CFS and chromosome 3. The frequency distribution of 
deltaRT values is shown for the CFS (in red) and all of chromosome 3 (in black) in HCT116 cells. B. 
Relationship between Rvalues in control conditions and upon aphidicolin treatment on 
chromosome 3 and at the FRA3B region. Rvalues for the control sample are shown on the x-axis 
and Rvalues for the aphidicolin-treated sample are on the y-axis. Rvalues across chromosome 3 are 
shown as a blue scatter, while values for the CFS region are shown as black rectangles. 
Finally, I examined FRA4F, a site responsible for 11% of breaks in the HCT116 cell 
line, which was not fragile in RPE1 cells. Surprisingly, this site changed to an earlier 
replication timing upon treatment with aphidicolin (Figure 4-45). This change 
appeared to be specific to the HCT116 cell line, where the site is fragile and did not 
occur in RPE1s. Similarly to the other CFS regions analysed, it appeared that the 
change this fragile site was not larger than the changes seen across chromosome 
four (Figure 4-46). Consistently, windows from that site did not appear as outliers 
when Rvalues from the control sample were plotted versus the Rvalues from the 




Figure 4-45 Replication timing changes across chromosome 4q and the FRA4F site in the presence 
of aphidicolin. deltaRT values were calculated in 1000 bp windows and plotted across 
chromosome 4q (A) and the FRA4F region(B) for both the RPE1 and the HCT116 cell line. The 





Figure 4-46 Replication timing changes at the FRA4F fragile location in the HCT116 cells. A. 
Distribution of deltaRT values across the CFS and chromosome 3. The frequency distribution of 
deltaRT values is shown for the CFS (red) and all of chromosome 4 (black) in HCT116 cells. B. 
Relationship between Rvalues in control conditions and upon aphidicolin treatment on 
chromosome 4 and at the FRA4F region. Rvalues for the control sample are shown on the x-axis 
and Rvalues for the aphidicolin-treated sample are on the y-axis. Rvalues across chromosome 4 are 
shown as a blue scatter, while values for the CFS region are shown as black rectangles. 
 
In summary, CFS regions do not appear to be uniquely sensitive to aphidicolin. 
While some sites display changes in their replication timing, the changes induced 
vary in their directionality and do not appear to be more extreme than the rest of 
the genome. Therefore, my Click-seq data does not support a model for CFS fragility 
based on a simple replication timing delay in the presence of aphidicolin. 
4.5.3 Regions of the genome showing most extreme 
replication timing changes in the presence of APH 
As CFS regions did not show extreme sensitivity to aphidicolin, I set out to 
determine which genomic locations show the largest changes in replication timing 
upon aphidicolin treatment. I examined the distribution of deltaRT values across the 
genome and selected windows that had deltaRT values removed at least three 
standard deviations from the mean. Surprisingly, I found that some of these 
clustered in similar locations for both the RPE1 and the HCT116 cell lines. It 
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appeared that these clusters of extreme changes were formed around large 
domains of early or late replication timing and probably corresponded to disruption 
of domain boundaries observed upon APH treatment. 
4.6 Discussion 
In this chapter, I have described the optimisation and application of a novel variant 
of the replication timing mapping method Repli-seq, which I have termed Click-seq. 
While I have not performed a direct comparison between the Repli-seq and the 
Click-seq methodology and the data generated using the two methods, Click-seq 
appears to clearly delineate early and late replicating regions of the genome with 
good reproducibility. The Click-seq protocol is faster than the Repli-seq protocol and 
the two-hour BrdU labelling pulse recommended in Repli-seq can be replaced by a 
shorter, 30 minute EdU pulse, allowing better resolution of replication timing 
domains. An unresolved issue of the Click-seq protocol is the generation of reads 
that cannot be matched to the human genome reference sequence. However, this 
appeared to be connected to the quality and the concentration of the sequencing 
libraries, suggesting that consistent preparation of high-quality libraries would 
reduce the problem.  
Utilising the Click-seq methodology, I assessed genome-wide replication timing 
patterns in the RPE1 and HCT116 cell lines; although the replication programmes of 
many different cell types have been analysed via Repli-seq and Repli-chip as a part 
of the ENCODE project, the two cell types used in this project had not been studied 
yet. The general characteristics of the replication programme within these two cell 
types are consistent with the well-established rules of replication timing: early, GC-
rich regions containing transcriptionally active genes replicate earlier, while gene-
poor, GC-poor regions tend to have a later replication timing. The RPE1 cell type, 
which derives from normal tissue, appeared to show more defined replication 
timing profiles, indicating less variation at the individual cell level. Domain size in 
this cell type was also smaller and the domains appeared less contiguous than in the 
tumour-derived HCT116 cells, which again may be due to more controlled 
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progression of replication. In addition to studying the replication timing profiles of 
the two cell types under unperturbed conditions, I also investigated the effect of 
replication stress on the replication programme of the two cell types. Surprisingly, 
rather than a universal delay across the genome, I found that aphidicolin induced 
bi-directional locus-specific changes in replication timing, with some regions 
replicating earlier and some regions replicating later. In addition, the low 
concentration of aphidicolin used in this study caused a subtle loss of features 
normally associated with early or late replication timing: early replicating regions in 
the aphidicolin-treated sample showed lower GC content and a lower density of 
expressed genes compared to early regions in control sample, while the inverse was 
true for late regions. Therefore, I can conclude that pharmacologically induced 
replication stress causes a mis-regulation of replication timing, rather than a 
genome-wide shift towards later replication.  Recently, a similar observation was 
made about Rif1, a genome-wide regulator of replication timing: depletion of the 
protein resulted in bi-directional shifts in replication timing. However, the shifts 
observed upon Rif1 depletion were more significant than the aphidicolin-induced 
changes (Foti et al. 2016). As aphidicolin can mimic endogenous replication stress 
present in CIN+ve colorectal cancer cell line, it is tempting to speculate whether 
similar shifts in replication timing can be observed in tumour cells (Burrell et al. 
2013). A shift towards later to earlier replication timing could explain some features 
of cancer cells, such as abnormal DNA methylation. 
Surprisingly, investigation of the replication timing landscape across active fragile 
sites within the two cell types in the presence and absence of aphidicolin failed to 
reveal e signature features of replication associated with CFS expression. As 
expected, most CFS regions span late replicating regions; two of the most fragile 
CFS locations within the RPE1 cell line showed remarkably similar replication 
patterns, composed of a late replication zone, replicated by long-travelling forks 
initiating from origin zones with an earlier replication timing. Surprisingly, 
aphidicolin treatment caused a shift towards earlier replication timing at the 
initiation zones surrounding the fragile regions at both FRA1C and 4q32.2-4q32.3 
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sites. The replication profiles of highly fragile locations within the HCT116 cell line 
showed less similarity; a common feature of FRA3B and FRA4F was the appearance 
of peaks in the late-replication track not present in RPE1 cells, suggesting possible 
firing of late origins both in control cells and in the presence of aphidicolin. Finally, a 
comparison of the replication timing of these sites in control and aphidicolin-
treated cells indicated that their fragility is not rooted in an extreme change in 
replication timing in the presence of aphidicolin, but is likely a result of more subtle 



















5 Chapter 5: Replication stress and interphase 
chromatin state at CFS  
  
Fragility at CFS regions extends over large genomic distances: the smallest site 
identified in this study, FRA1C, spans 0.5 Mb, while breaks at FRA4F extend over a 5 
Mb genomic segment. Historically, CFS regions have been defined as affecting an 
entire chromosome band, or a boundary between two cytogenetic bands, 
encompassing millions of base pairs of genomic sequence (Durkin & Glover 2007; 
Debatisse et al. 2006). These observations strongly suggest that fragility at CFS is a 
feature associated with large-scale chromatin structures, at the level of organisation 
well above the 30nm fibre. However, no studies to date have explored the 
chromatin dynamics at CFS regions: in fact, only limited efforts have been made to 
study chromatin at CFS regions, with a focus on chromatin composition rather than 
structure. A 2009 study found that the most unstable CFS regions in lymphoblastoid 
cell lines were hypo-acetylated compared to the regions surrounding them and 
treatment with the deacetylase inhibitor TSA decreased the frequency of breaks 
(Jiang et al. 2009); the H3K4me1 mark has also been identified as a significant 
predictor of CFS fragility in a computational analysis which did not take into account 
the cell type specificity of breakage (Fungtammasan et al. 2012).  
Chromatin structure is the background for all of the processes implicated in CFS 
fragility and has never been assessed as a potential contributor. In this chapter, I 
investigate large-scale chromatin structure at the FRA1C and FRA3B fragile regions 
using fosmid pair FISH. This approach is based on two fosmid pairs, mapping to the 
region of interest and separated by a linear distance ranging between 100 kb and 
1.5 Mb, which are hybridised to a cell population; the distance between the two 
fosmids signals is then measured in a large number of nuclei. The distribution of 
distances across the population is reflective of the underlying large-scale chromatin 
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states. This approach has been used successfully to demonstrate altered large scale 
structure at the inactive X chromosome and during development  (Naughton et al. 
2010; Williamson et al. 2012). Employing this approach, I characterise the effect of 
replication stress induction on chromatin surrounding the sites in both 
asynchronous populations and synchronised cultures transitioning through S-phase. 
I also compare aphidicolin-induced replication timing changes to alterations in 
large-scale chromatin structure. 
5.1.1 Replication stress effect on chromatin compaction in 
asynchronous cell populations 
I first set out to explore how aphidicolin affects the chromatin landscape across 
different genomic regions in the RPE1 cell line. As well as the fragile FRA1C region 
and FRA3B, which is not active in this cell type, I investigated the effects of 
replication stress on two chromosome 11 loci with differing functional 
characteristics. This allowed me to differentiate between effects associated with 
CFS regions from genome-wide effects of replication stress, including direct effects 
on chromatin structure and indirect effects, such as biases arising from cell cycle 
differences between the control and the aphidicolin-treated sample. I selected 
fosmid probe pairs surrounding the different locations and hybridised them to PFA-
fixed cells, grown either in unperturbed conditions or in the presence of various 
concentrations of aphidicolin. The length of aphidicolin treatment was always 24 
hours. I measured the distance between the probe pairs in a large number of nuclei 
and compared how the distribution of distances varied between loci and upon 
induction of replication stress.  
5.1.2 Interphase chromatin compaction at 11p14.1 and 
11p15.1 
To define if replication stress exerts genome-wide effects on chromatin structure, I 
first assessed chromatin response to aphidicolin at two chromosome 11 locations 
with differing functional properties: the gene-rich 11p15.1 and the gene-poor 
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11p14.1. In addition to gene-density, these two loci are known to differ in their 
chromatin structure, with 11p15.1 showing negative supercoiling, associated with 
open chromatin and 11p14.1 forming a domain of positive supercoiling with 
compact chromatin architecture (Naughton et al. 2013).  Previously, a CFS was 
identified at chromosome 11p15.1 (FRA11C) and the region was found to overlap 
with breakpoints in chromosomal rearrangements in bladder cancer (Moriarty & 
Webster 2003). However, no breaks were observed within that region in RPE1 cells. 
Although the fosmid pairs at the two loci were located a similar distance apart, the 
physical distances between the fosmids at the 11p14.1 locus were much smaller 
than at 11p15.1, likely due to the more compact conformation of the positively 
supercoiled, gene poor region (Figure 5-1).  Aphidicolin treatment did not cause a 
significant change in compaction at either of the two loci. This suggested that 








Figure 5-1 Chromatin compaction at the gene-poor 11p14.1 region (A) and the gene-rich 11p15.1 
locus (B) in RPE1 cells upon aphidicolin treatment. RPE1 cells were grown under control conditions 
or in the presence of two different concentrations of aphidicolin. Cells were then hybridised to 
pairs of fosmid probes hybridising to either 11p14.1 or 11p15.1. Fosmid pairs were located 1.5 Mb 
apart. Probe positions are shown in red and green in the top diagram. The bottom graphs show a 
boxplot of the distance between the two fosmids across the different samples. Numbers of nuclei 
included in the analysis is shown for each category. Inset, a representative image showing a 
nucleus with hybridised probes labelled in red and green. 
5.1.3 Interphase chromatin compaction at FRA1C 
I next examined the consequences of aphidicolin treatment at the FRA1C locus, the 
most fragile region in the RPE1 cell line. Surprisingly, at FRA1C, I found that 
aphidicolin treatment caused a change in chromatin state towards a more compact 
conformation (Figure 5-2). Significant compaction of chromatin was observed in 
cells treated with 0.6M APH, and the trend for a more compact state was also 
present in the population treated with just 0.4M of the drug. As this compaction 
was not observed at the chromosome 11 loci, I could exclude the possibility that it is 
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due to a genome-wide effect of aphidicolin. To investigate the chromatin change 
further, I examined the frequency distribution of distances across the control and 
the two aphidicolin treated samples; in particular, I wanted to determine if there 
was evidence of a bi-modal distribution in the presence of aphidicolin, indicating 
two distinct conformations of the locus, corresponding to a stable and a fragile 
state. A small extra peak could be observed among the distribution of distances for 
cells treated with 0.4 M aphidicolin, but due to a small sample size (n=56), it was 
difficult to determine if the peak reflected two distinct states of the locus. However, 
there was no sign that two distinct chromatin states existed at the locus upon 
treatment with 0.6 M APH: instead, a shift in frequency towards a more compact 
state in the treated samples compared to the controls appeared (Figure 5-3). This 
observation was highly surprising, and counter intuitive to the expectation that a 
break at the region would result in an increase in inter-fosmid distance, due to the 
physical separation of the probes.  The fact that this observation was made in an 
asynchronously growing cell population which has been treated with aphidicolin for 
the length of a full cell cycle made interpretation difficult. Specifically, it was unclear 
whether compaction occurred prior to the formation of metaphase lesions at the 
site or as a consequence of the instability at FRA1C. I therefore decided that 
experiments in synchronised cell populations were necessary to delineate 
chromatin dynamics at the site and determine if replication stress – associated 





Figure 5-2 Chromatin compaction changes at the FRA1C locus in RPE1 cells upon aphidicolin 
treatment. RPE1 cells were grown under control conditions or in the presence of two different 
concentrations of aphidicolin. Cells were then hybridised to a pair of fosmid probes located 1.1 Mb 
apart, which surrounded the FRA1C locus. Probe positions are shown as black bars in the top 
diagram; the fragile region is shown as a red bar. The bottom graph shows a boxplot of the 
distance between the two fosmids across the different samples. Numbers of nuclei included in the 





Figure 5-3 Frequency distributions of fosmid pair distances at the FRA1C locus.  Distributions are 
shown for the control sample (black), and 0.4 M (red) and 0.6M (blue) aphidicolin treatment. 
5.1.4 Interphase chromatin compaction at FRA3B 
I next wanted to determine if the effect of aphidicolin observed at FRA1C is specific 
to this active fragile site or can also be observed at a non-expressed CFS location, 
such as FRA3B. I selected fosmid probes surrounding the FHIT gene and performed 
fosmid FISH in unperturbed RPE1 cells and under the same aphidicolin treatment 
conditions as for FRA1C. Contrary to my observations at FRA1C, I found that the 
compaction of this region did not change in response to aphidicolin treatment 
(Figure 5-3). This reinforced the finding that aphidicolin treatment does not cause 
genome-wide chromatin compaction and the effect observed at FRA1C is specific 




Figure 5-4 Chromatin compaction at the inactive FRA3B locus in RPE1 cells upon aphidicolin 
treatment. RPE1 cells were grown under control conditions or in the presence of two different 
concentrations of aphidicolin. Cells were then hybridised to a pair of fosmid probes located 1 Mb 
apart, which surrounded the FRA3B locus. Probe positions are shown in red and green in the top 
diagram; the fragile region is shown as a black bar. The bottom graph shows a boxplot of the 
distance between the two fosmids across the different samples. Numbers of nuclei included in the 





5.2 Interphase chromatin compaction at CFS regions in 
synchronised cells 
Since the investigation of chromatin compaction in asynchronous RPE1 cells 
indicated that replication stress induced compaction specific to the FRA1C locus, I 
wanted to examine the cell-cycle dynamics and dependencies of this compaction. 
Specifically, I wanted to determine if the changes in compaction precede mitotic 
fragility at the locus and how they relate to replication timing changes in the 
presence of aphidicolin. To achieve this, I employed an experimental strategy based 
on arresting the cells at the G1/S boundary, followed by a release, allowing the cell 
cycle to continue into S phase, G2 and mitosis. At the time of release, cells were 
either released in drug-free culture media or in the presence of a low dose of 
aphidicolin, which induces replication stress and CFS fragility. I harvested cells at 
different times throughout the transition from the G1/S boundary into G2 and 
assayed chromatin state through FISH at each time point. I performed these 
experiments in RPE1 cells, monitoring the compaction of FRA1C, as well as in 
HCT116 cells, in which I focused on the highly fragile FRA3B site. Although analysis 
of multiple CFS locations would be beneficial, the time-consuming and labour 
intensive nature of these experiments allowed only two sites to be analysed. 
5.2.1 Cell synchronisation 
To synchronise cells, I followed a protocol based on arresting cells at the G1/S 
boundary by adding a high dose of aphidicolin which completely blocks replication 
(Pedrali-Noy et al. 1980). Aphidicolin is preferred to other agents used for 
synchronisation at the G1/S boundary, such as hydroxyurea and thymidine, due to 
the fact that it does not affect the levels of dNTPs and DNA polymerases inside cells, 
allowing progression into S phase immediately upon release.  
Prior to performing the FISH experiments, I wanted to verify that synchronisation 
was efficient and determine if a low dose of aphidicolin upon release would 
influence the rate of progression into S phase.  I performed the synchronisation 
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protocol in RPE1 and HCT116 cells and assessed the cell cycle distribution at 
different time points following release, both when cells were released in non-
supplemented media and with release in a low dose of aphidicolin, used to induce 
replication stress and trigger CFS expression.  Cells were pulsed with EdU for 30 
minutes prior to harvesting and characterisation of the cell cycle state at each time 
point was performed by flow cytometry. 
In the HCT116 cell line, I found that aphidicolin arrest and release resulted in a 
synchronised G1/S population which then transitioned through S phase and into G2 
within 10 hours (Figure 5-5). Within the first 2 to 6 hours, cells within different S-
phase stages were enriched, with early S most prominent at two hours, mid-S at 4 
hours and late-S most prominent at 6 hours post release from the aphidicolin block.  
I found that addition of a small dose of aphidicolin upon release from the G1/S 
block caused a moderate delay in S-phase progression; surprisingly, the delay 
appeared more obvious at the later stages of replication, with aphidicolin-treated 
cells completing replication nearly two hours after non-treated cells (Figure 5-5). 
Similar dynamics were observed in the RPE1 cell line (Figure 5-6).  Cells appeared to 
complete replication up to 10 hours following release, with early, mid and late-S 
phase enrichment at 2, hours, 4 hours and 6/8 hours, respectively.   Aphidicolin 
addition post release also caused a moderate delay in replication progression in the 




Figure 5-5 Cell synchronisation in the HCT116 cell line. A. Synchronisation protocol. 
Asynchronously growing cultures were treated with a large dose of aphidicolin for 24 hours, 
leading to synchronisation at the G1/S boundary.  Cells were then released into S phase, either in 
unperturbed conditions or in the presence of a low dose of aphidicolin, which triggers replication 
stress and CFS fragility. Progression through S phase and into G2 was tracked by harvesting cells at 
2 hour intervals up to 10 hours following release. B. Flow-cytometry based assessment of cell cycle 
distribution of samples at different time points following release. Samples were pulsed with EdU 
30 minutes prior to harvesting to identify replicating cells. Top graphs show EdU intensity versus 
DNA content, enabling identification of replicating cells. Bottom graphs show PI histograms of the 




Figure 5-6 Cell synchronisation in the RPE1 cell line. A. Synchronisation protocol. Like in Figure 5-5, 
asynchronously growing cultures were treated with a large dose of aphidicolin for 24 hours, 
leading to synchronisation at the G1/S boundary.  Following arrest, cells were released into S 
phase, either in unperturbed conditions or in the presence of low dose aphidicolin. Progression 
through the cell cycle was tracked by harvesting cells at 2 hour intervals up to 10 hours following 
release. B. Assessment of cell cycle distribution of samples at different time points following 
release. Samples were pulsed with EdU 30 minutes prior to harvesting to identify replicating cells. 
Top graphs show EdU intensity versus DNA content, allowing identification of replicating cells. 
Bottom graphs show PI histograms of the cell populations at different time points 
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5.2.2 Chromatin changes at FRA1C throughout the cell cycle 
With the cell synchronisation protocol established, I characterised the changes in 
the large-scale chromatin state of FRA1C in RPE1 cells throughout the transition 
from G1/S to G2, under unperturbed conditions and in the presence of aphidicolin-
induced replication stress.  
I prepared cell populations at defined time points following release from the G1/S 
block and hybridised them to the fosmid pairs within the FRA1C region.  I then 
compared the distances between fosmid pairs across the different time points and 
in the presence or absence of aphidicolin. At least 60 images were analysed at each 
time point and each condition. I found that chromatin undergoes significant 
changes following release from a G1/S block into unperturbed conditions: 
significant compaction occurs during the transition between release and the two 
hour time point, coincident with the early replication stage (figure 5-7). The region 
then significantly decompacts by the four-hour time point, which marks the early to 
mid-replication stage.  Following this decompaction, the chromatin state of the 
region remains unchanged until the 10-hour time point. Comparison with Click-seq 
data within the region reveals that a transition between an early/mid and a late 
replicating region is contained between the fosmid pair; the early/mid replicating 
region is likely to be replicated by the four hour time point, when the decompaction 
is observed. Unfortunately, the timing resolution of Click-seq is not sufficient to 
determine if decompaction precedes replication of the locus or is only established 
once the site has been replicated. 
Chromatin dynamics are subtly different in the presence of aphidicolin. Similar to 
control cells, the locus significantly compacts between release and the two hour 
time point. Curiously, unlike the control sample, there was no significant 
decompaction between the two hour and four hour time point in the presence of 
aphidicolin, leading to a significant difference in chromatin state between the 
control sample and the aphidicolin treated sample at the four hour time point. In 
the presence of aphidicolin, the early/mid portion of the region replicated earlier, 
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indicating that a change in replication timing was matched by a change in chromatin 
dynamics at this site. Unlike the asynchronous cell cultures, where it was not 
possible to determine if the change in chromatin compaction preceded mitotic 
lesion formation, this experiment demonstrates the change precedes breakage, 




Figure 5-7 Chromatin dynamics throughout the cell cycle at the FRA1C site in RPE1 cells. Top 
schematic depicts the position of the two fosmid probes relative to the fragile location. Middle 
panel shows the replication timing across the locus in unperturbed cells and following replication 
stress, and the fragile location is shaded in blue and schematics represent inferred initiation 
clusters and fork direction. Bottom panel shows a boxplot of fosmid distances across the different 
time points; control samples are shown in black and aphidicolin-treated samples are shown in red. 
P-values from a Wilcoxon test are shown. 
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5.2.3 Chromatin changes at FRA3B throughout the cell cycle 
Unlike FRA1C, no significant changes in chromatin state occurred at the FRA3B locus 
in the HCT116 cell line.  The FRA3B region appeared to have a less compact 
chromatin state compared to FRA1C – although the probes were separated by a 
similar distance to probes at FRA1C, the physical distance separating the probes 
appeared to be larger in that region.  Although a small trend for decompaction 
could be seen as cells transitioned into G2, no statistically significant differences 
were found between the different categories. The probes at this location span a 
predominantly late replicating region; aphidicolin treatment seemed to trigger an 
extra origin within that window and induce a slightly later replication timing. It is 
possible that the core of that region is replicated so late into the cell cycle that any 
replication-associated chromatin shifts are not obvious before the final 10 hour 
time point in the experiment. Also unlike the FRA1C region, aphidicolin did not 
induce any significant changes in compaction in that region; however, replication 
dynamics at that site differed significantly from FRA1C. Unlike FRA1C, where a shift 
towards earlier replication timing occurred within the region framed by the fosmid 
pairs upon aphidicolin treatment, FRA3B shifted towards later replication timing, 
including the activation of a putative late origin. The FISH compaction data suggests 
that either these changes were not accompanied by changes of large-scale 





Figure 5-8 Chromatin dynamics throughout the cell cycle at the FRA3B site in HCT116 cells. Top 
schematic depicts the position of the two fosmid probes relative to the fragile location. Middle 
panel shows the replication timing across the locus in unperturbed cells and following replication 
stress, and the fragile location is shaded in blue. Bottom panel shows a boxplot of fosmid 
distances across the different time points; control samples are shown in black and aphidicolin-




In this chapter, I have described an investigation of large-scale chromatin structure 
at two fragile sites: FRA1C and FRA3B, in unperturbed conditions and following 
replication stress, in asynchronous cultures and in cell populations moving 
synchronously through S-phase. 
Although the fosmid FISH approach has been used extensively before to 
demonstrate changes in large scale chromatin structure throughout development, X 
inactivation and upon gene activation, it has never been used to track chromatin 
dynamics throughout the cell cycle. Cell cycle changes in chromatin structure have 
been previously analysed in chromosome conformation capture based studies, 
which showed that the higher order structure of the genome was disrupted in 
mitosis and re-established early in the following G1 (Naumova et al. 2013; Dileep et 
al. 2015).  No differences were found at the genome-wide level TAD structure 
throughout S-phase- compartments remained relatively stable and matched the 
boundaries defined in G1. However, at the chromosome 1p31.2 region (FRA1C), the 
use of fosmid FISH at defined time points throughout S phase showed that 
significant changes in large scale structure are under way in this part of the cell 
cycle. This result suggests that although labour-intensive, the application of fosmid 
FISH at defined cell cycle stages can yield insights about chromatin dynamics during 
S-phase. Another finding from the fosmid FISH approach described in this chapter is 
that replication stress, when induced by aphidicolin, does not cause a genome-wide 
change in large-scale chromatin structure. This is in contrast to drugs that interfere 
with transcription, such as alpha-amanitin or compounds that cause disruption in 
the regulation of histone marks, such as TSA (Naughton et al. 2013; Tóth et al. 2004) 
Finally, the use of fosmid FISH allowed me to explore the possibility that chromatin 
structure contributes to fragility at active CFSs. To investigate that, I characterised 
chromatin changes in the presence of aphidicolin at two fragile locations in 
different cell lines: FRA1C in RPE1 and FRA3B in HCT116. Surprisingly, the two 
locations yielded contrasting observations: while a structural change preceding 
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mitosis could be observed at FRA1C, no changes were induced by replication stress 
at FRA3B. Apart from chromatin dynamics, FRA3B and FRA1C differ in many other 
ways: while FRA3B spans two genes, both of which are expressed in the HCT116 cell 
line, no expressed transcripts are present at FRA1C. The replication profiles of the 
two sites also differ: although both sites are replicated late, FRA1C is replicated by 
forks travelling across from early/mid firing origins, while FRA3B appears to span 
late-initiating origins. These differences in characteristics and chromatin behaviour 
may raise the possibility that locus-specific effects are the main contributors to 
fragility at CFS, rather than shared features. Despite the observation that 
aphidicolin-induced compaction is an effect specific to FRA1C, it is easy to envisage 
how it may interfere with the stability of the site by creating a chromatin 
environment which is less conducive to replication, repair and mitotic compaction 















6 Chapter 6: Discussion 
 
Common fragile sites are a phenomenon that historically have been observed and 
defined through cytogenetic means. However, significant efforts to transition from 
a cytogenetic to a molecular definition of CFS have been made: studies from the 
Hickson lab suggested that the DNA repair protein FANCD2 can be used as a marker 
of CFS in G2 and mitosis (Chan et al. 2009) and Le Tallec et al (2013) proposed that 
genes over 300 kb mark the pool of all potential CFS loci. Another suggested 
molecular mark limits putative CFSs to late-replicating regions devoid of replication 
initiation zones and the replication origin protein ORC2 (Miotto et al. 2016; 
Letessier et al. 2011), while an analysis of cancer mutation catalogues showed that 
a large number of recurrent cancer deletion clusters are associated with CFSs 
(Bignell et al. 2010). However, identifying a molecular definition of CFS regions has 
been impeded by their cell type specific nature and the fact that their fragility 
appears to be dependent on multiple events across multiple cell cycle stages. In 
addition, most of the studies proposing a molecular definition of CFS regions have 
focused on a small number of sites, frequently within a single cell type. Here, I have 
presented the analysis of multiple CFS features across two cell types with distinct 
CFS repertoires. While I was unable to define a shared replication timing pattern 
associated with fragility, or a robust correlation with transcription, I found that CFS 
regions are characterised by disruptions in chromatin folding on metaphase 
chromosomes. My data raises the possibility that instability at different sites is 
driven by different mechanisms, converging into a shared phenotype of mis-folding 
prior to mitosis and the subsequent formation of chromosome lesions. A summary 
of all CFS regions investigated in this study and the experiments performed on them 
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1p31.2  Fine mapping with BAC probes 
Fragility found to span a 0.6 Mb region around 
chr1: 69176951- 69781569 
 Mapping of atypical probe signals across the locus 
Atypical probe signal distribution found to overlap 
with fragile region (3.3.3) 
Replication stress found to increase frequency of 
atypical signals (3.3.4) 
 Replication timing analysis 
Site found to be replicated late in S phase, by forks 
travelling from origins located 0.5 Mb to 1 Mb 
away; no delay in replication in the presence of 
aphidicolin (4.5.1.1). 
 Analysis of interphase chromatin structure 
Chromatin compaction of the locus observed upon 
aphidicolin treatment in asynchronous cells 
(5.1.3). Chromatin structure analysis in 
synchronised cells showed that the change 
appears during early to mid S phase and precedes 







4q32.2  Fine-mapping with BAC probes 
Fragility found to span a 1Mb region overlapping 




fragile  Analysis of transcriptional levels within the locus 
Increased transcription across the locus in RPE1 
cells (3.4.3) 
 Replication timing analysis 
Site replicated in mid to late S phase by forks 
travelling from origins located 0.5 Mb to 1 Mb 
away. Replication across the site is delayed in the 









3p14.2  Fine-mapping with fosmid probes 
Fragility localised to a 1 Mb region overlapping 
with the FHIT gene at 3p14.2 
 Analysis of transcriptional levels within the locus 
Increased transcription across the locus in  HCT116 
cells (3.4.3) 
 Modifying transcription levels at the site using 
CRISPR Cas9 (3.5) 
An small increase in the frequency of lesions upon 
reduction of FHIT transcription 
A larger increase in the frequency of lesions upon 
an increase in FHIT transcription 
 Replication timing analysis 
Site is late-replicating and overlaps late-firing 
origins. Replication at the site is delayed in the 
presence of aphidicolin and extra origin is fired 
(4.5.1.2). 
 Analysis of interphase chromatin structure 
No changes in chromatin structure at the locus 
upon aphidicolin treatment in asynchronous cells 
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4q22.2  Fine-mapping with BAC probes 
Fragility localised to a 5 Mb region between chr4: 
89213170-95121208 
 Mapping of atypical FISH probe signals across the 
locus 
Atypical probe signal distribution found to overlap 
with fragile region (3.3.2) 
Replication stress found to increase frequency of 
atypical signals (3.3.4) 
Calyculin experiment to analyse dynamics of 
mitotic folding at the locus (3.3.5) 
 Analysis of transcriptional levels within the locus 
Increased transcription across the locus in RPE1 
cells (3.4.3) 
 Replication timing analysis 
Site spans and early to mid-replicating domain and 





2q22.2  Fine-mapping with BAC probes 
Fragility localised to a 2 Mb region between chr2: 
142200000-144100000 
 Analysis of transcriptional levels within the locus 
No difference in transcription across the locus 
between the two cell lines (3.4.3) 
 Replication timing analysis 
Site is predominantly late-replicating. Aphidicolin 












  Analysis of transcriptional levels within the locus 










7q21.22  Analysis of transcriptional levels within the locus 










  Analysis of transcriptional levels within the locus 










  Analysis of transcriptional levels within the locus 
Increased transcription across the locus in RPE1 
cells (3.4.3) 
 
Table 6-1 Sumamry of CFS studied 
  
6.1 Replication and CFS  
The fragility of CFS regions has long been thought to be rooted in the process of 
replication. A simple replication-based model for fragility is built on the idea that 
CFS span regions devoid of replication initiation zones and are instead replicated by 
long-travelling forks originating outside the fragile regions. In this model, replication 
stress causes a slow-down in fork speed, which interferes with the complete 
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replication of the site. This mechanism was proposed after the observation that the 
FRA3B region does not span an initiation cluster in lymphoblastoid cell lines 
(Letessier et al. 2011) and is supported  by a recent study mapping the genome-
wide occupancy of the origin recognition complex component ORC2, which found 
that initiation-poor zones overlap with CFS (Miotto et al. 2016).    Across the sites 
investigated in this study, some CFSs, such as FRA1C and the novel chr4q32.2-32.3 
site, matched that pattern, while others, such as FRA3B and FRA4F, span late-firing 
origins and contained very small regions that appeared under-replicated. 
Disappointingly, no striking similarities in replication patterns were found for the 
CFS regions included in the study and the genomic regions considered did not show 
extreme replication timing changes in response to aphidicolin treatment. One 
possible explanation may be that lesion formation at CFS sites is a relatively rare 
event: even at FRA3B, the most common CFSs in this study, breaks occurred in only 
18% of metaphases. As Click-seq measures replication dynamics across the whole 
cell population, it is possible that replication events leading to fragility are too rare 
to define through this method.  For example, a failure to initiate the late origins at 
FRA3B and FRA4F in a small subset of cells may not be obvious at the population 
level. Another possibility is that temporal replication dynamics are not as strong a 
determinant of CFS behaviour as proposed previously: for example, it has been 
shown that the FRA3B sequence retained fragility even when integrated in a 
genomic location with an earlier replication timing (Ragland et al. 2008) and FRA7H 
was shown to span a transition between an early and a late replicating region 
(Hellman et al. 2000). However, as the majority of sites identified in this study were 
late-replicating, the Click-seq data supports late replication timing as a significant, 
but not complete determinant of instability at CFS. 
6.2 CFS in mitosis: structure and function 
In Chapter 3.3.1, I demonstrated that FISH probes hybridised to active CFS regions 
showed atypical signals, consistent with disruptions in the metaphase chromosome 
structure. Interestingly, similar FISH signals are associated with the fragile telomere 
phenotype, observed upon APH treatment or upon depletion of TRF1, a component 
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of the shelterin complex (Sfeir et al. 2009).  Both phenotypes are indicative of 
defective chromosome condensation. At telomeres, the phenotype is thought to 
result from replication problems such as fork collapses and G-quadruplex structures 
formed by the GC-rich telomeric repeats; however, CFSs are devoid of repetitive 
sequences and it is unclear how small-scale events such as fork collapses can lead to 
fragility and failure of mitotic compaction on such a large genomic scale.  At CFS 
regions, there are two yet unknown questions relating to the phenotype: what are 
the mechanisms leading to mis-folding and how does it relate to the lesions 
historically observed at the sites. A recent study by the Hickson lab found that DNA 
synthesis by POLD3 can be observed at CFS in mitosis following aphidicolin 
treatment and speculated that under-replicated regions are “exposed” by the forces 
of mitotic compaction, allowing this synthesis to take place (Minocherhomji et al. 
2015). Given that condensin localises to replicated regions of the genome, coupling 
replication to mitotic compaction, it is highly likely that the misfolding phenotype is 
a consequence of replication problems and a possible precursor of mitotic repair 
synthesis. Consistently, premature chromosome condensation experiments 
described in Chapter 3.3.5 showed that the atypical signals at CFSs are a result of a 
failure to prepare the chromatin environment for mitosis.  
An interesting characteristic of the misfolding phenotype is that it also occurred on 
cytogenetically normal chromosomes, suggesting that CFS regions may experience 
problems with mitotic compaction more frequently than indicated by the formation 
of cytogenetically visible breaks. In the case of HCT116 cells, the misfolding was 
even present at a low level in the absence of replication stress. This is 
complementary with another long-standing observation on CFS: aphidicolin 
treatment and the subsequent lesion formation do not trigger cycle checkpoint 
activation. Intuitively, breaks, gaps and constrictions at CFS regions appear 
pathogenic, however the idea that they are just a stage of the processing of these 
regions has been gaining support. This is substantiated by findings that depletion of 
the nuclease Mus81 results in a decreased appearance of CFS breaks on mitotic 
chromosomes, but an increase in DNA damage in the subsequent G1 (Naim et al. 
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2013).  Inhibition of mitotic DNA repair also resulted in increased DNA damage in 
the following G1 (Minocherhomji et al. 2015). These observations may suggest the 
presence of a dedicated pathway for resolving mitotic misfolding, operating through 
Mus81 and mitotic DNA synthesis, with cytogenetic lesions marking areas prone to 
mis-folding in mitosis and representing a processing intermediate.  
6.3 Consequences of replication stress 
Replication stress is a phenomenon with a significant physiological relevance in the 
field of cancer biology.  It is well established that replication stress accompanies 
early tumour development and promotes genomic instability; oncogene activation 
has been shown to trigger cells into replication with an insufficient nucleotide pool 
and induce fragile site expression (Bester et al. 2011; Miron et al. 2015). In addition, 
the origin checkpoint in G1 which ensures a sufficient number of origins are 
licensed, can be impaired in cancer cells (Shreeram et al. 2002), meaning cells can 
enter S phase with reduced origin numbers. Consistently, the replication landscape 
of the tumour-derived HCT116 cell line appeared to have larger, more contiguous 
domains than the non-tumorigenic RPE1 line, compatible with fewer initiation 
clusters and the forks travelling longer distances between initiation zones. Reduced 
origin licensing and increased inter-origin distance in the HCT116 cell line may also 
explain the cell line’s increased sensitivity to aphidicolin, as indicated by the higher 
rate of CFS breakage and mitotic misfolding. 
While changes in fork speed and origin activation rates in condition of replication 
stress have been thoroughly investigated through DNA fibre FISH and other 
methods, the Click-seq experiments described in Chapter 4 provide new 
information on genome-wide changes in replication timing in such conditions. The 
most surprising outcome of aphidicolin treatment was the induction of bi-
directional changes in replication timing, rather than a universal delay as expected 
from evidence that aphidicolin causes a slow-down in fork speed. Especially 
surprising was the observation that some origin clusters fired earlier in the presence 
of aphidicolin than in the control sample. However, previous studies have indicated 
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that the speed of replication fork can affect origin firing and extra origins can be 
recruited upon fork slow down, potentially causing some genomic locations to 
replicate earlier. A study from the Debatisse lab even indicated that effects of 
replication stress can be traced into the subsequent G1, with additional origins 
licensed compared to cells not exposed to replication stress (Courbet et al. 2008). 
As cells in the Click-seq experiments were treated with aphidicolin for 24 hours 
prior to the EdU pulse and harvest, it is possible that earlier firing of some origins 
may be the result of replication stress in the previous S-phase and illustrate the 
consequences of on-going replication stress. It is intriguing to speculate that earlier 
replication timing of a region may lead to changes in the composition of chromatin 
assembled at the site post-replication, ultimately relating to some of the epigenetic 
changes characteristic of tumour cells. 
A major drawback of the Click-seq technique is that it cannot define origin locations 
unambiguously. This is especially problematic for late replicating regions: while 
early initiation clusters are easy to infer, peaks in the late replicating sample could 
indicate both termination zones where forks converge with high frequency or a 
firing of a late cluster. Click-seq data would be maximally informative if combined 
with information on changes in origin firing under conditions of replication stress.  
While techniques designed to map origins in mammalian cells were previously 
deemed somehow unreliable, a newly developed methodology, OK-seq, appears 
more robust and informative (Petryk et al. 2015). OK-seq is relatively easy to 
implement, particularly for our lab where related techniques are already setup, 
enabling the mapping of origins in multiple cell lines and under multiple conditions.  
 Chapter 5 showed that at some sites large-scale structural changes can accompany 
replication timing changes, illustrating some of the unsuspected consequences of 
replication stress. Given that the partition of replication timing is related to the 3D 
organisation of the genome (Dileep et al. 2015) and that replication stress can have 
knock-on effects on chromatin loop size in the following cell cycle (Courbet et al. 
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2008), chromosome conformation capture experiments  in conditions of replication 
stress may also provide valuable insights. 
 
6.4 Perspectives 
Cytogenetic CFS breaks on metaphase chromosomes have fascinated biologists for a 
long time. As the understanding of the underlying mechanisms deepens, it becomes 
clearer that they are a result of complex dependencies between cellular processes 
such as transcription, replication, and chromatin dynamics. As regions uniquely 
responsive to replication stress, these sites also represent a valuable model of 
genomic instability. In this thesis, I have shown a previously unknown tendency for 
CFS to form regions of misfolding in mitotic chromosomes, which fits with the 
current understanding of mitotic dynamics and processes of these sites. I have also 
defined for the first time the cell type specific replication programmes across these 
regions and characterised how they change in the presence of replication stress. I 
conclude that rather than sharing a single replication pattern, problems at CFS arise 
as a result of a variety of replication configurations, converging in their tendency to 
fail to prepare the chromatin environment for mitosis. My findings contribute 
towards a more complete view of CFS regions, how they fit within the genomic 
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